stock_AMGN r_up	comment:1 says:1 looked:1 cancer:4 tumble:1 being:1 ongoing:1 increased:2 design:1 raises:2 analysis:3 unit:1 ground:2 increase:1 death:5 review:1 expectations:1 shares:1 eighth:1 late:1 drugs:3 clinical:1 safety:1 earnings:1 which:1 provider:1 quarterly:1 new:1 associated:2 patients:4 treat:1 week:1 anti-anemia:2 's:6 risk:5 may:1 clots:3 after:1 involving:3 blood:3 using:1 come:1 anemic:2 anemia:1 11:2 10:1 --:2 amid:1 study:3 51:1 50:2 reports:1 published:2 suggests:2 below:1 products:2 lose:2 agents:1 drops:2 studies:3 comes:1 software:1
stock_AMGN r_down	strongly:1 associated:1 woes:2 scales:1 gold:1 sclerosis:1 blood:1 some:1 focus:2 increased:1 trade:3 active:2 see:2 session:2 against:2 slip:3 further:2 multiple:1 declined:1 ground:1 drugs:1 whose:2 heads:1 plumbing:1 rivals:1 ease:2 deaths:1 damage:1 shares:3 heights:1 their:1 risk:1 certain:1 expected:2 new:1 before:1 cause:1 stock:3 gaining:2 's:3 users:1 emerges:1 may:1 dollar:2 clots:1 after:3 biggest:2 liver:1 losing:1 feature:2 chief:1 stocks:5 declining:2 euro:1 goods:2 profit-taking:1 --:2 warned:1 study:1 futures:4 companies:2 according:1 drug:1 record:1 slide:2 continue:1 afternoon:1 testimony:1 action:1 crude:1 durable:2 lows:1
stock_AMGN r_down	sticking:1 rate-cut:1 now:2 medication:1 says:1 investors:1 sales:1 ending:2 '':1 held:1 manager:1 opportunities:1 portfolio:1 financial-services:2 open:1 violates:1 market:1 said:1 additional:1 federal:1 equities:1 handed:1 also:1 details:1 anemia:1 worth:2 economy:1 tentatively:1 finish:1 jury:1 gains:1 mostly:1 funds:1 offered:1 after:1 but:1 following:2 inflation:1 allowing:1 judge:1 stocks:5 beginning:1 buying:2 he:1 has:1 reassurances:1 --:1 many:1 value:2 monthly:1 barred:1 so:1 talk:2 mixed:3 found:1 patents:1
stock_AMGN r_down	temporarily:1 issued:1 violated:1 injunction:1 share:1 held:1 jury:1 open:1 its:2 market:1 letting:1 onto:1 federal:1 won:1 has:1 launching:1 tentatively:1 selling:1 's:2 price:1 possibility:1 but:1 preliminary:1 judge:1 anemia:2 target:1 --:2 prevents:1 drug:3 patent:1 barred:1 ruling:1 following:1 found:1 changes:1 left:1
stock_AMGN r_down	respond:1 among:1 antibody:1 deal:1 limited:1 results:1 tumors:1 '':1 decided:1 identify:1 analysis:1 human:1 gene:1 factor:1 information:1 cancer:1 said:5 based:1 $:1 trial:1 positive:1 showed:2 normal:1 two:1 uniform:1 other:1 520:1 treatment:2 recommend:1 chemotherapy:1 effectiveness:1 worth:1 ``:1 used:1 's:1 whose:1 may:1 company:2 million:1 symptomatic:1 12:1 opinion:1 not:1 growth:1 anemia:1 10:1 made:1 survival:1 target:1 license:1 --:1 fully:1 could:2 companies:1 up:1 drug:1 patients:3 amend:1 range:1 prescribing:1 were:1 biotechnology:2 pivotal:1 changes:1 study:1 first:1
stock_AMGN r_down	shortened:1 revenue:1 coming:1 ``:1 states:1 warning:2 lung:1 shares:1 have:1 year:2 apply:1 plunge:1 its:2 decline:1 said:1 would:1 best-selling:1 since:1 fears:1 per:1 than:1 cell:1 also:1 clinical:1 black:1 which:1 new:1 anemia:1 2007:1 updated:2 anti-anemia:1 's:1 greater:1 again:1 drugs:3 survival:1 after:1 overall:1 early:1 27:1 breast:1 two-thirds:1 head:1 investor:1 approved:1 target:1 box:1 '':1 12:1 neck:1 --:2 past:1 patients:1 reflecting:1 cancers:1 25:1 drops:1 studies:1 could:1 dropped:1
stock_AMGN r_up	proposed:3 trade:1 session:1 comments:2 its:2 whose:1 20:1 disorders:3 immune:2 updated:2 black-box:1 which:1 seeking:2 survival:1 overall:1 bear:1 breast:1 amp:2 retreat:1 --:4 companies:1 officer:3 disorder:6 bleeding:2 see:1 said:4 patients:1 shares:1 cell:1 new:1 falling:1 anti-anemia:1 active:1 approval:2 declining:2 rare:3 carried:3 drug:5 published:1 studies:1 major:1 marked:2 lung:1 article:1 apply:1 market:1 per:1 additional:2 would:1 mark:1 clinical:1 treat:5 biggest:2 ``:1 drugs:2 but:3 expected:1 known:4 than:1 states:1 12:1 target:1 17:1 record:1 below:1 cancers:1 risks:3 shortened:1 illness:3 autoimmune:2 head:1 '':1 warning:2 greater:1 information:2 indexes:1 also:1 other:3 fourth:2 9:1 gaining:2 's:7 after:1 levels:2 blood:7 stocks:2 approved:1 neck:1 effective:3 considered:1 medical:3 1.29:1 banks:1 starting:2
stock_AMGN r_down	illness:1 financial:1 help:1 cancer:1 bleeding:1 certain:1 into:1 move:2 used:2 laggard:2 second:1 anti-anemia:1 experts:1 broader:1 approval:1 temporary:1 its:1 market:1 even:1 said:1 but:1 mostly:2 disorders:1 immune:1 would:1 positive:1 seeking:1 proposed:3 should:1 needed:1 outside:1 program:1 treat:3 which:1 under:1 territory:1 markets:1 lending:1 risks:1 marked:1 global:1 's:4 extend:1 warnings:1 drugs:1 boosted:1 brand:2 setting:1 effective:1 carried:1 additional:1 sold:1 ask:1 news:1 stocks:3 panel:1 known:1 restrictions:1 rare:1 name:2 stabilize:1 --:2 medical:2 drug:3 whether:2 patients:1 levels:1 products:1 officer:1 graph:1 including:1 climb:3 other:1 disorder:2 order:1 autoimmune:1 blood:2
stock_AMGN r_up	proposed:4 focus:1 including:1 committee:1 its:5 disorders:3 complain:1 program:3 under:2 might:3 risk:1 far:1 possibly:1 anticipates:1 during:1 continued:1 him:1 anemia:1 treating:1 --:2 standards:1 serious:3 quarter:1 because:2 reduce:1 second:1 discussions:1 makers:1 concern:1 said:3 lead:1 federal:1 restricted:2 comments:1 research:1 medicine:1 discovery:1 patient:1 sold:3 backed:3 approval:2 panel:3 restrictions:2 rare:3 puts:1 drug:9 studies:1 tough:1 cancer:2 regulatory:1 considering:1 use:1 management:1 additional:1 would:3 two:2 their:1 clinical:1 treat:3 biggest:1 meeting:1 ``:1 drugs:2 some:2 company:1 effort:1 believes:1 patients:1 distribution:2 inhibitor:1 illness:3 proprietary:1 backing:1 contribute:3 sales:1 '':1 have:1 blockbuster:1 information:1 productive:1 agency:3 also:1 other:3 fourth:1 out:1 's:7 collaboration:2 blood:3 biotechnology:1 included:1 data:1 concerns:2 kept:1 center:1 programs:3 chief:1 advocates:1 so:1 position:1 starting:1
stock_AMGN r_up	advisory:1 smaller:1 prompted:1 cancer:2 clinical:1 plunged:1 over:1 demand:1 sales:1 growth:2 expect:1 vote:1 move:1 death:2 trial:1 federal:1 positive:1 marketed:2 had:1 shares:1 should:2 increase:2 failed:2 concerns:2 surprise:1 territory:1 into:1 poor:1 anti-anemia:2 's:2 risk:2 drugs:4 cars:1 rise:1 but:2 results:1 said:1 gain:2 despite:1 news:1 stocks:3 than:1 panel:2 plunges:2 --:5 could:2 later:1 gasoline:1 drug:1 believes:1 tumor:2 whether:1 patients:2 continue:2 a.m.:1 climb:1 retail:1 study:2
stock_AMGN r_down	saying:1 adds:2 significantly:2 cancer:3 well:1 anemia:1 some:1 period:1 risk:2 restrict:2 second:1 growth:2 adopted:1 vote:1 blockbuster:1 unit:1 comments:2 superior:1 use:3 said:4 end:1 additional:1 would:1 granted:1 stockholders:1 least:1 should:2 current:2 program:2 voted:2 sixth:1 performance:4 stock-based:1 anti-anemia:2 's:1 continue:2 information:1 drugs:5 background:1 company:2 after:1 focus:1 award:1 results:2 death:2 awards:1 designed:1 pay-for-performance:1 new:1 sustained:1 delivering:1 eighth:1 panel:4 concerns:2 made:1 operating:1 limits:1 third:1 --:2 amid:2 could:2 marketed:2 but:2 according:1 value:1 called:1 tumor:2 patients:3 determined:1 2004:1 recommendations:1 long-term:1 biotechnology:1 2008:1 increase:2 starting:1 filing:1 executives:1
stock_AMGN r_down	they:1 move:1 focus:2 trade:1 session:1 including:1 its:2 ground:2 whose:1 giant:1 going:1 treatment:1 factor:1 has:1 giants:1 risk:2 tuberculosis:2 not:1 --:1 medicines:1 companies:2 labeling:1 benefit:1 prescribing:1 financial:1 consistent:1 see:2 trading:1 year:1 casual:1 provided:1 said:1 selected:1 shares:1 late-session:2 medicine:1 firms:1 previous:1 screen:1 diagnostic:1 losing:2 relating:1 last:1 industry:1 changed:1 drug:3 tumor:1 place:1 suitable:1 outlook:1 cancer:2 into:1 active:1 dayside:1 determine:1 pharmaceutical:1 use:1 been:2 class:1 their:1 expected:1 company:1 dramatic:1 versions:1 whether:1 likely:1 patients:2 risks:1 following:1 inhibitor:1 similar:1 biotech:1 investors:1 defined:1 warning:3 have:1 boxed:2 information:1 end:2 dining:1 other:1 test:1 personalized:1 bets:1 play:1 's:2 arthritis:1 included:1 approved:1 performances:1 infections:2 latest:1
stock_AMGN r_down	proposed:2 move:1 focus:2 trade:1 held:2 session:1 including:2 broader:3 its:4 whose:1 had:2 include:2 dispute:2 get:1 royalty:5 background:1 judge:6 accepted:4 anemia:5 made:2 --:5 companies:1 payments:2 stock:1 see:1 investment:1 said:4 plays:1 federal:2 shares:1 firms:1 conditions:4 terms:2 reported:1 active:1 brokerage:1 declining:2 zig-zag:2 discount:1 drug:7 onto:1 patents:2 statements:1 down:1 market:5 fee:3 two:1 rates:1 interest:1 expected:1 company:6 biggest:2 lowered:1 brokers:1 than:2 paying:2 has:4 called:2 acquisition:1 adds:1 sales:4 weighed:1 moves:1 court:2 patent:2 pay:1 seeking:1 same:1 violates:2 recommended:2 parts:1 earnings:1 offered:1 higher:5 gaining:2 begin:4 's:9 producers:1 accepting:2 stocks:5 rallied:1 off:1 well:1 pacing:2 banks:1 fresh:1 filing:2
stock_AMGN r_down	appeals:4 infringed:4 held:3 comments:2 lawyer:1 said:1 court:4 federal:4 decision:4 long:3 spokesman:1 fourth:1 ruled:3 stock:2 's:4 reversed:4 but:4 drug:4 updates:2 prices:2 imported:4 anemia:4 whether:4 could:8 sale:4 rule:4 n't:8 so:3 patents:4
stock_AMGN r_up	development:1 saying:1 trial:1 prove:1 effective:1 lost:1 failed:1 --:1 after:2 value:1 halting:1 depression:1 drug:2 nearly:1 half:1 its:1 market:1
stock_AMGN r_up	heart:1 primary:1 its:1 said:2 no:1 positive:1 two:1 adverse:1 clinical:1 safety:1 stable:2 objective:1 heart-failure:1 events:1 product:2 patient:1 evaluate:1 company:1 infusion:1 results:1 failure:1 well:1 trial:2 patients:2 ongoing:1 serious:1 first:1
stock_AMGN r_down	his:1 's:1 pushed:1 --:1 decision:1 grant:1 back:1 sale:1 n't:2 federal:1 permanent:1 injunction:1 whether:1 treatment:1 judge:1 has:1 block:1 anemia:1
stock_AMGN r_down	acquisitions:1 dwindle:1 deeper:1 patent:1 pockets:1 into:1 companies:1 drug:1 research:1 their:1 through:1 digging:1 approach:1 grow:1 mergers:1 expirations:1
stock_AMGN r_up	salary:2 received:1 giant:1 his:1 $:5 1.48:1 plan:1 company:1 million:3 up:1 paid:1 according:1 1.53:1 compensation:1 2006:1 disclosed:1 1.54:1 incentive:1 slightly:1 filing:1 2007:4
stock_AMGN r_up	body:1 total:1 its:1 osteoporosis:1 surveys:1 said:2 late:1 3:2 denosumab:1 stage:1 events:1 treatment:2 hip:1 increased:2 company:1 early:1 compared:1 wrist:1 those:1 women:1 spine:1 study:1 patients:1 were:1 biotechnology:1 placebo:2 similar:1 taking:2 bone:2
stock_AMGN r_down	injections:1 said:1 increased:1 showed:1 study:1 drug:1 denosumab:1 two-year:1 its:2 bone:1 mineral:1
stock_AMGN r_down	down:1 product:1 developers:1 door:1 than:1 get:2 --:1 rather:1 drug:1 easier:1 break:1 their:1 lucrative:1 foot:1 trying:1 find:1 market:1 more:1
stock_AMGN r_down	smaller:1 orphan:1 down:1 wider:1 patient:1 find:1 market:2 concern:1 targeting:1 eventual:1 rather:1 its:1 their:2 pursuing:1 new:1 developers:1 conditions:1 easier:1 more:1 product:1 door:1 increased:1 get:3 drugs:1 approvals:1 scrutiny:1 break:1 applications:1 suffering:1 lucrative:1 groups:1 foot:1 article:1 trying:1 than:1 has:1 rare:1 --:1 companies:1 drug:2 while:1 published:1
stock_AMGN r_up	biotech:1 attorney:1 because:1 office:1 largely:1 demand:1 dollar:1 focus:2 now:1 trade:1 price:1 date:3 see:1 session:1 drug:3 multimillion-dollar:1 pipelines:1 first-quarter:1 should:1 withdrawn:1 expirations:1 whose:1 said:1 23:3 patent:1 continued:1 decision:3 three:1 shares:1 its:1 late:1 also:1 program:1 expected:2 has:1 boost:2 final:1 requested:1 product:1 his:2 's:3 risk:1 pharmaceutical:1 weakness:1 company:1 delayed:2 looming:1 sales:1 maven:1 increases:1 management:1 plague:1 plan:1 decide:1 filed:1 active:1 major:1 general:1 lawsuit:1 day:1 must:1 gets:1 antitrust:1 --:2 industry:1 months:1 companies:2 drive:1 against:1 used:1 whether:1 while:1 properly:1 ensure:1 pick:1 worries:1 biotechnology:1 approve:1 review:2 profits:1
stock_AMGN r_up	biotech:1 ordered:1 investors:1 fourth-quarter:2 cents:2 share:2 dose:1 report:1 see:1 session:1 66:1 ailing:1 market:1 whose:1 doctor:1 shares:1 forecast:1 looking:1 earnings:1 7:1 expected:2 today:1 's:2 may:1 safe:1 active:1 post:1 trade:1 haven:1 loss:1 --:1 companies:1 according:1 analysts:1
stock_AMGN r_up	cancer-drug:1 biotech:1 raised:1 benefited:1 says:1 deal:1 strengthen:2 companies:2 chip:2 heated:1 results:2 biggest:2 down:2 see:1 buy:1 reports:1 slip:1 upgrades:1 rally:1 makers:1 market:1 whose:1 cancer:2 upgrade:1 $:5 broad:1 it’s:1 expectations:1 shares:5 much:1 earnings:1 boosted:1 quarterly:1 going:1 outlook:1 boost:2 8.8:3 expected:1 gaining:2 pay:3 evening:1 led:1 get:2 weakness:1 after:3 trade:1 sales:2 brewers:1 9:2 pursuit:1 offset:1 active:1 producer:1 stocks:6 first-quarter:1 analyst:1 declining:2 drugmaker:2 billion:3 disappointing:1 did:1 bellwether:1 up:3 's:3 n't:1 session:1 tech:2 retailers:1 were:1 meet:1 talk:1
stock_AMGN r_down	exotic:1 consulting:1 conferences:1 years:1 have:1 fees:1 rally:2 educational:1 deal:2 sponsoring:1 largest:1 has:1 roll:1 physicians:1 buy:1 's:1 attend:1 manufacturers:1 bid:1 free:1 nation:1 doctors:1 device:1 news:1 drugmaker:1 made:1 --:1 medical:1 companies:2 50:1 drug:3 premium:1 stoked:1 trips:1
stock_AMGN r_down	adjusted:1 polled:1 health-care:2 share:2 sales:2 its:2 $:2 due:2 per:2 earnings:6 largest:2 expected:3 higher:4 's:2 increased:2 company:2 slated:2 early:2 report:4 world:2 post:1 largely:2 --:1 medical:2 according:1 devices:2 products:2 analysts:1 1.20:1 1.24:1
stock_AMGN r_up	enhanced:2 cancer:2 health-care:2 results:1 agent:2 report:1 foreign-exchange:1 world’s:1 vivo:1 another:1 world:1 accounting:1 year-earlier:1 its:2 said:1 potential:1 devices:1 positive:1 due:2 occupancy:1 increase:1 models:1 other:1 rates:2 combined:2 largest:2 chemotherapy:1 has:1 boost:2 more:1 measuring:1 first-quarter:2 increased:1 drugs:1 earnings:2 company:1 's:1 emission:1 sales:2 early:1 imaging:1 alone:1 group:1 slated:1 medical:1 than:1 target:1 both:1 pancreatic:1 quarter:1 third:1 showed:2 40:1 charges:1 study:2 largely:2 rate:1 drug:1 reports:1 patients:1 products:1 either:1 higher:2 studies:1 tumors:1 profits:2 favorable:1
stock_AMGN r_up	alliance:1 woes:1 executive:1 dollar:1 sales:1 competition:1 helped:1 currency:1 growth:1 been:1 approval:1 partner:1 throughout:1 setbacks:1 use:1 generic:1 charges:1 profit:1 rose:1 quarterly:1 permission:1 fewer:1 comments:1 research:1 increase:1 health:1 details:1 affecting:1 rates:1 net:1 has:2 first-quarter:1 exchange:1 company:1 surged:1 weak:1 marking:1 results:1 reported:1 part:1 therapy:1 favorable:1 somewhat:1 new:1 regulatory:1 such:1 strong:1 continued:1 analyst:1 care:1 reaction:1 solid:1 amid:1 industry:1 drug:4 34:1 shielded:1 important:1 products:1 international:1 first:1 thanks:1
stock_AMGN r_down	warrants:1 sell:1 said:1 shares:1 units:1 include:1 company:1 offered:1 stock:4 contracts:1 registered:1 preferred:2 debt:1 purchase:3 rights:1 securities:5 amount:1 common:2 depositary:1 time:2 mixed:1 biotechnology:1
stock_AMGN r_down	weighs:2 adjusted:1 92:1 force:1 1.2:1 cents:4 heartburn:3 share:3 sales:1 competition:2 years:1 challenges:1 ended:1 growth:1 including:2 have:1 year:1 versus:1 's:2 1.25:1 throughout:1 its:3 market:1 89:1 decline:1 4.6:5 number:1 details:1 would:1 profit:3 top:1 three:1 same:1 94:2 reduction:1 difficulties:1 various:1 earnings:3 income:1 new:3 net:1 posted:1 company:1 stock:1 cost-cutting:1 program:1 over:1 first-quarter:3 10:1 eroded:1 drugs:1 price:1 said:1 falls:1 reported:2 restructuring:1 protection:2 updates:1 previous:1 2007:1 hurt:2 bringing:1 response:1 recent:1 billion:2 loss:2 compared:1 charges:1 period:1 31:1 work:1 well:1 drug:5 $:2 patent:2 recently:1 part:2 products:1 planned:1 faces:1 quarter:1 maker:2 fell:1 generic:2
stock_AMGN r_up	adjusted:1 1.2:1 cents:4 heartburn:1 share:3 focus:2 competition:1 trade:1 ended:1 see:1 session:1 89:1 same:1 have:1 year:1 first-quarter:1 its:1 previous:1 whose:1 4.6:1 $:2 would:1 profit:1 shares:1 various:1 earnings:1 income:1 expected:1 net:1 versus:1 charges:1 's:2 increased:1 said:1 hurt:1 reported:1 restructuring:1 part:1 active:1 92:1 94:2 posted:1 billion:2 compared:1 --:2 31:1 companies:1 drug:2 generic:1 fell:1 period:1 2007:1 quarter:1 maker:1 1.25:1
stock_AMGN r_down	profits:1 despite:1 kinds:2 focus:2 trade:3 ended:1 session:3 comments:1 cuts:2 its:7 cardiovascular:2 whose:3 giant:4 cut:1 1.12:2 $:17 1.11:2 rose:5 expectations:4 than:2 treatment:1 fuel:2 has:2 inventory:1 rise:2 results:2 early:3 updates:1 fall:1 report:1 2:1 anemia:6 1.04:4 --:5 1.08:2 drop:3 companies:3 higher:1 declines:1 see:3 cost:2 year:2 82:1 further:1 estimated:1 said:1 profit:2 since:2 recorded:1 projected:1 shares:5 forecast:2 increase:2 various:1 got:1 net:6 boost:1 announced:1 arthritis:1 business:1 1.14:2 acquisition-related:1 reported:1 restructuring:1 offset:2 active:3 20:1 post:3 come:3 quarter:3 last:2 prior-year:1 shift:1 31:1 according:4 drug:1 analysts:6 94:2 studies:2 software:1 comment:2 adjusted:1 cancer:2 revenue:4 into:1 nutritional:1 period:1 down:2 franchise:2 per-share:1 throughout:1 would:1 beginning:1 third-quarter:1 one-time:1 1.51:1 expected:5 's:12 4:1 fiscal:1 drugs:6 company:6 quarterly:2 analyst:1 posted:3 showed:2 up:1 below:4 growth:2 risks:2 were:4 more:1 world-wide:1 cents:4 certain:2 share:8 sales:7 2.3:6 have:1 sell:1 information:2 compared:2 45:1 same:1 also:1 5:4 earnings:7 fourth:1 income:6 94c:2 stock:1 first-quarter:7 plans:1 though:1 may:2 price:1 after:3 much:1 fell:3 billion:5 lower:2 charges:1 slightly:1 costs:2 2007:1 biotechnology:3 affirmed:1
stock_AMGN r_down	saying:1 over:2 results:1 quarters:1 cuts:1 its:4 issues:2 cardiovascular:1 1.17:1 giant:1 $:3 1.11:1 surprises:2 expectations:1 late:1 advisories:2 treatment:1 fuel:1 has:1 earnings:5 early:1 anemia:2 1.04:1 --:2 drop:1 companies:1 1.09:1 quarter:2 reduced:1 cost:1 result:1 year:2 2.3:1 's:2 since:1 shares:1 increase:1 future:1 got:1 net:2 boost:1 after:1 25:2 1.14:1 reported:1 offset:1 regulatory:2 article:1 first-quarter:3 roundup:1 last:2 shift:1 reports:4 rose:1 studies:1 cancer:1 revenue:1 franchise:1 come:1 one-time:1 lingering:2 flat:4 drugs:2 94:1 posted:1 showed:1 below:1 growth:1 risks:1 were:2 published:1 cents:1 certain:1 share:2 sales:3 diving:2 compared:1 same:1 inventory:1 income:2 stock:1 product:2 kinds:1 may:1 arthritis:1 buyback:1 billion:4 reimbursement:2 largely:4 biotechnology:1 corporate:1 latest:1
stock_AMGN r_down	revenue:3 cents:3 polled:1 share:3 period:1 widened:1 year:1 's:2 25:1 $:7 11.7:1 28:1 due:1 research:1 year-ago:1 expected:1 net:1 development:1 earlier:1 first-quarter:1 company:1 million:5 fell:1 loss:2 lower:1 32:1 average:1 analysts:1
stock_AMGN r_down	because:2 letter:2 companies:4 move:2 some:2 assumptions:2 experts:2 signed:2 have:2 parties:2 fine:2 makers:2 fifth:1 out:2 leaders:2 renewed:2 end:2 would:2 credit:4 profit:2 expired:2 legislation:2 research:2 write:2 confident:2 'll:2 details:1 certain:2 print:2 weeks:2 has:2 might:2 pan:2 development:2 's:1 urging:2 extend:2 read:2 tax:4 forecasts:3 members:2 not:2 off:2 beginning:1 84:2 recent:2 ago:2 both:2 made:2 wise:2 ahead:2 yet:2 allows:2 drug:4 n't:2 federal:2 costs:2 2007:2 2008:4 restored:2
stock_AMGN r_down	15:1 drugs:1 amid:1 promising:1 sales:2 slowing:1 two:1 regulators:1 rejection:1 slash:1 cholesterol:1 medicine:1 force:1 its:1
stock_AMGN r_up	expects:1 ended:1 year:2 its:1 said:1 $:1 profit:1 5.9:1 current:1 earnings:1 net:1 posted:1 billion:1 company:1 rise:1 slump:1 but:1 recent:1 fiscal:1 purchase:1 31:1 8.8:1 following:1 biotechnology:1
stock_AMGN r_down	biotech:1 already:1 cancer:2 ``:1 '':1 colon:1 types:1 its:1 tumor:1 said:1 headline:1 marketed:1 feature:1 least:1 3:1 treatment:1 new:1 treat:1 development:1 meets:1 product:2 's:1 drugs:1 involving:1 uses:1 breast:1 president:1 aiming:1 approved:1 expand:1 me:1 many:1 30:1 up:1 flagship:1 those:1 lung:1 studies:2
stock_AMGN r_up	said:2 name:1 ahead:2 head-to-head:1 pitting:2 rival:2 study:2 brand:1 drug:4 produced:1 against:2 denosumab:2 under:1 out:2 its:2 came:2 osteoporosis:2
stock_AMGN r_up	biotech:1 major:1 pharmaceutical:1 investors:1 lines:1 into:1 results:1 billions:1 produced:1 against:1 second:1 trading:1 higher:3 after-hours:1 seek:1 its:2 plans:1 pouring:1 giant:1 said:1 considered:1 profit:1 detail:1 shares:2 yet:1 needed:1 clinical:1 denosumab:2 under:1 genetically:1 new:1 has:1 boost:1 sent:1 more:1 development:1 product:2 's:1 gains:2 get:1 drugs:1 pitting:1 brand:1 after:1 but:1 early:1 most:1 engineered:1 compound:1 regulatory:1 approval:1 stocks:3 than:1 name:1 building:1 pipeline:1 ahead:1 effective:1 --:1 rival:1 study:4 companies:1 up:2 drug:2 turn:1 edge:3 came:1 promising:1 biotechnology:1 osteoporosis:1 shows:1 out:1 industry:1 bone:1 head-to-head:1
stock_AMGN r_up	majority:1 them:2 said:1 risk:2 nationwide:2 their:1 over:2 45:2 worried:2 n't:1 most:3 health:2 survey:2 despite:2 not:1 found:2 age:1 bone:2
stock_AMGN r_down	sector:3 increasingly:1 money:1 results:1 session:1 radio:1 seats:1 contributions:3 its:3 decade:2 superior:1 group:2 presidency:1 candidates:2 denosumab:1 congressional:1 gains:1 during:1 presidential:1 regarding:1 like:1 --:1 suppliers:1 55:1 donations:3 bone:1 election:2 year:1 7th:1 makers:1 said:1 federal:2 health:4 new:1 injections:1 according:3 drug:1 trial:2 figures:1 options:1 first:2 major:2 letters:1 campaign:2 determine:1 parties:2 watchdog:2 two:2 station:1 call:1 collected:1 meeting:1 treatment:1 becoming:1 removes:1 but:1 gap:2 doctors:2 than:2 women:1 look:2 showed:1 cancers:1 were:1 more:2 nurses:1 certain:1 have:1 hospitals:1 45:1 detail:1 majority:2 which:1 place:1 insurers:1 's:5 may:1 includes:1 running:1 channeling:2 significant:2 device:1 cycle:2 mineral:1 6th:1 medical:1 time:2 professional:1 head-to-head:1
stock_AMGN r_up	prevent:1 letters:1 cancer:1 1.5:1 increasingly:1 certain:2 into:1 filed:1 some:1 price:2 radio:1 determine:1 such:1 repurchased:1 adjustment:1 completion:1 said:3 $:1 working:1 pay:1 initial:1 seems:1 shares:1 drugs:1 station:1 call:1 treatment:1 place:1 entered:1 document:1 company:1 pact:1 's:3 may:2 share:1 becoming:1 million:1 but:1 doctors:1 repurchase:1 article:1 look:2 billion:1 purchase:1 transaction:2 like:1 --:1 cells:1 required:1 receive:1 accelerated:1 cancers:1 common:1 published:1 following:1 gene:1 options:1
stock_AMGN r_up	advisory:2 says:1 proposed:1 people:1 bleeding:1 some:1 chronic:1 likes:1 committee:1 vote:1 counts:1 its:1 short-term:1 low:1 use:1 said:1 exists:1 outside:1 immune:1 recommended:1 clinical:1 treat:1 which:1 treatment:1 profile:1 's:2 drugs:1 blood:1 condition:1 panel:1 17:1 --:1 approve:1 trades:1 drug:1 upside:1 studies:1 options:1 involves:1 favorable:1
stock_AMGN r_up	biotech:3 work:1 help:2 cancer:6 exclusive:1 drugs:2 some:1 tests:1 likely:2 identify:2 benefit:1 specialists:3 blockbuster:1 market:1 conference:3 pharmaceutical:3 said:1 based:1 two:1 research:1 firm:1 their:1 genetic:1 has:1 meeting:3 week:3 ends:3 used:1 's:2 may:1 agreement:1 but:1 drug:1 updates:3 doctors:1 five-day:3 narrow:1 most:1 --:1 annual:3 companies:3 signed:1 specific:1 patients:2 status:1 can:1 distribution:1 providing:3 studies:3
stock_AMGN r_up	development:1 said:1 's:3 adults:1 cancers:1 --:1 arthritis:1 possible:1 young:1 disease:1 drugs:1 other:1 link:1 treat:1 between:1 investigating:1 lymphoma:1 children:1
stock_AMGN r_up	group:1 risk:1 cancer:1 whether:1 heighten:1 arthritis:1 disease:1 drugs:1 adolescents:1 investigating:1 's:1 children:1
stock_AMGN r_down	development:1 show:1 --:1 studies:1 arthritis:1 drug:1 patients:1 under:1 rheumatoid:1 unit:1 late-stage:1
stock_AMGN r_down	advance:1 stocks:3 although:1 modestly:1 rheumatoid:1 into:3 arthritis:1 negative:3 shares:1 its:1 drug:1 favorable:1 broader:1 news:1 follow:1 territory:3 new:1 wander:2 market:1
stock_AMGN r_up	sue:1 elect:1 improved:1 candidate:1 may:1 warned:1 company:1 according:1 drug:1 patent:1 version:1 designed:1 factor:1 infringement:1 's:1 relating:1 filing:1 treatment:1
stock_AMGN r_up	deaths:1 stronger:1 labels:1 warning:1 including:1 drug:1 children:2 death:1 beef:1 note:1 potential:1 include:1 can:1 wants:2 used:2 's:4 warnings:1 may:1 said:1 moderate:1 lead:1 --:1 infections:2 up:1 labeling:1 severe:1 risks:1 result:1
stock_AMGN r_down	psoriasis:2 's:4 say:2 can:2 --:1 severe:1 disease:2 patients:2 recommended:2 treat:2 skin:2 approval:2 moderate:1 children:2 expand:2 panel:2
stock_AMGN r_up	say:1 experts:1 skin:1 children:1 information:1 said:1 recommended:1 comments:1 increase:1 outside:1 concerns:1 treat:1 meeting:1 stock:1 psoriasis:1 's:3 price:1 but:1 tuberculosis:1 risks:1 approval:1 appears:1 expand:1 panel:2 like:1 effective:1 --:1 medical:1 infections:1 disease:1 drug:2 whether:1 patients:1 can:1 serious:1
stock_AMGN r_up	named:1 old:1 years:1 pharmaceutical:1 chief:1 1:1 until:1 ...:2 affairs:1 company:1 succeed:1 president:1 effective:1 vice:1 --:1 54:1 medical:2 55:1 remain:1 officer:1 consultant:1 31:1
stock_AMGN r_up	pipeline:1 's:1 company:1 trades:1 but:1 discount:1 strong:1 stock:1
stock_AMGN r_up	control:1 pharmaceutical:1 's:1 spending:1 industry:1 took:1 according:1 lobbying:1 2007:1 report:1 watchdog:1 group:1
stock_AMGN r_down	financial:1 cancer:2 mirroring:1 anti-anemia:1 curb:1 have:1 makers:1 blow:1 use:1 medications:1 their:1 health:1 used:2 's:1 warnings:2 drugs:2 authority:1 backed:2 such:1 --:1 stronger:2 drug:1 regulator:1 patients:2 dealt:1 following:1 efforts:2 similar:1
stock_AMGN r_up	biotech:2 targets:1 investors:1 presence:2 previously:1 expanding:1 collaboration:1 n't:1 simply:1 something:1 committed:2 research:2 pills:2 roots:1 really:1 looking:2 certainly:1 said:2 giant:1 rather:1 pay:1 had:2 near:1 been:2 its:7 chemical:2 pioneer:1 potential:1 developed:2 new:1 increasing:2 company:1 therapies:2 implied:1 development:2 ``:2 selling:2 's:5 drugs:2 sold:2 published:2 story:1 willing:1 lucrative:2 lows:1 not:1 article:1 expand:2 '':2 has:2 off:1 developing:2 --:2 many:1 could:1 disease:1 drug:1 traditional:2 record:1 surrendering:1 p.m.:1 shares:1 time:2 biologic:2 previous:1 promising:1 bet:1
stock_AMGN r_up	250,000:2
stock_AMGN r_up	200,000:2
stock_AMGN r_down	says:1 cancer:3 issued:1 into:2 move:1 results:1 disease:1 spinal:1 hormone:1 made:1 its:3 osteoporosis:1 containing:1 said:1 candidate:2 positive:1 decision:1 negative:2 shares:1 fight:1 treatment:4 territory:2 denosumab:2 fractures:1 rise:1 's:2 undergoing:3 shored:1 helps:1 men:3 approving:1 reported:1 strength:1 blood:1 key:1 press:1 news:2 stocks:3 prostate:3 after:1 common:1 treating:1 loss:2 has:1 lead:1 --:2 study:1 up:1 drug:3 morning:1 n't:1 bone:3 error:1 release:1 higher:1 reduced:1 experimental:1
stock_AMGN r_up	sector:3 financial:1 trend:1 trade:1 see:1 session:1 reports:1 amp:2 whose:1 raise:1 shares:1 their:1 earnings:1 biggest:2 issue:1 higher:1 gaining:2 's:3 bellwethers:1 after:1 forecasts:1 expected:1 favorable:1 active:1 stoke:2 stocks:3 second-quarter:1 declining:2 largely:1 companies:1 drug:2 2008:1
stock_AMGN r_down	adjusted:1 cents:1 certain:1 health-care:1 estimates:1 sales:4 past:2 currency:2 earnings:2 rising:1 3.3:1 have:1 3.1:1 compared:1 its:2 1.17:1 strength:2 $:5 would:1 earned:1 profit:2 moderately:1 expectations:1 same:1 second-quarter:1 rates:2 low:2 income:1 net:1 edging:1 higher:1 's:2 said:1 climbs:2 dollar:2 company:1 largest:1 most:2 edges:1 favorable:2 world:1 analyst:2 billion:2 1.05:1 reported:2 --:1 medical:2 1.18:1 devices:2 charges:1 products:2 2007:1 share:3 quarter:1 consumer:2 maker:1 medical-device:2
stock_AMGN r_up	financial:1 consider:1 investors:1 less:1 developed:1 energy:1 health-care:3 some:1 highly:1 risks:1 value:1 want:1 such:1 rally:1 market:3 before:1 partners:1 said:1 threats:1 $:1 44:1 since:1 had:1 two:1 delicate:1 successful:1 500:1 earnings:1 which:1 quarterly:1 surprise:1 decades:1 company:1 momentum:2 closed:1 independent:1 over:1 full:1 's:5 sick:1 relationship:1 may:1 bid:1 weak:2 possible:2 but:1 took:1 gain:1 ownership:1 others:1 sustained:1 stocks:3 than:2 billion:1 have:1 sectors:1 --:2 collective:1 reports:1 banking:1 values:1 today:1 policies:1 time:1 biotechnology:1 higher:2 changes:1 first:1
stock_AMGN r_up	heart:1 woes:1 show:1 health-care:1 nutritional:1 sales:2 helped:1 economic:1 devices:1 broader:1 its:1 conference:1 said:1 profit:1 patients:1 call:1 interview:1 '08:2 has:1 company:1 stock:1 diversified:1 partly:1 combination:1 weakness:1 price:1 rise:1 continuing:1 results:1 shields:1 half:1 strong:1 data:1 second-quarter:1 arthritis:1 posted:1 both:1 branded:1 industry:1 well:1 drug:2 34:3 affecting:1 trial:1 range:1 products:2 more:1 rheumatoid:1
stock_AMGN r_down	drug-benefit:1 results:1 ended:1 including:1 shares:1 its:4 giant:1 1.12:1 $:3 crimped:2 treatment:1 various:1 has:1 modestly:2 hit:1 increased:2 early:1 heightened:1 --:2 popular:2 deadline:1 quarter:1 better-than-expected:1 heavy:1 heartburn:2 competition:7 challenges:1 growth:1 trading:1 83:1 makers:1 profit:4 decision:1 comments:1 forecast:2 safety:1 international:1 net:1 reported:3 restructuring:6 offset:1 regulatory:1 improved:1 pressure:1 30:1 reports:1 executives:1 raised:1 period:1 down:1 raises:1 miss:1 due:2 2:1 6:2 midday:1 but:2 scrutiny:1 part:2 prices:1 second-quarter:3 posted:1 weighed:1 up:1 while:1 were:1 medication:2 cents:2 share:2 sales:1 helped:1 full-year:2 drug:2 compared:1 generic:7 agency:1 same:1 87:1 earnings:2 income:1 's:3 plans:1 blood:1 approving:1 billion:2 lower:2 charges:1 well:1 disease:1 face:1 costs:2 2007:1 1.20:1 profits:1
stock_AMGN r_up	fractures:2 give:1 joints:1 reduce:1 results:1 highly:1 spinal:1 session:2 trading:3 reports:1 pain:1 reducing:1 its:2 causes:1 osteoporosis:2 said:1 gainers:1 lead:2 positive:1 late:1 potential:1 pivotal:1 treatment:1 destroy:1 upbeat:1 company:1 can:1 hip:1 tests:1 evening:2 's:2 risk:1 got:1 jumps:2 after:1 but:1 anticipated:1 did:1 reported:1 key:1 new:1 news:1 injection:1 data:1 appears:1 arthritis:1 women:1 treating:1 10:2 chronic:1 effective:1 success:1 developing:1 --:1 paces:1 study:1 disease:1 drug:3 n't:1 trial:1 patients:2 massive:1 found:1 rheumatoid:1 bone:1
stock_AMGN r_up	sector:1 all:1 deck:2 reinvigorate:1 focus:2 trade:1 session:1 7.7:4 article:1 its:12 osteoporosis:5 whose:1 giant:1 candidate:4 rose:1 guidance:1 expectations:1 passage:1 program:2 denosumab:3 quarterly:2 8:3 secondary:1 kick:2 real:2 seized:1 risk:2 far:1 results:3 flattish:1 cutting:1 updates:1 anemia:3 treating:1 loss:2 success:6 --:4 12th:1 drop:3 companies:1 skewed:1 three-year:1 further:1 bone:3 better-than-expected:1 week:2 financial:1 prompted:1 posts:2 250,000:2 estimates:1 back:1 see:1 growth:2 exceeded:1 close:1 out:1 lead:3 profit:3 per:1 forecast:2 52-week:1 behind:2 safety:1 new:1 boost:1 housing:2 fractures:3 beleaguered:1 await:1 led:1 acquisition-related:1 reported:1 regulators:2 key:3 active:1 news:1 major:2 both:1 met:1 study:8 double-digit:1 drug:8 trial:2 massive:1 published:1 pivotal:1 ease:1 comes:1 raised:1 revenue:1 primary:1 seizure:1 two:2 regulatory:1 approval:1 reducing:2 decline:1 hip:1 positive:1 adjusted:1 due:2 much:2 passed:1 expected:1 warns:1 treatment:2 sending:1 drugs:2 company:1 removes:2 but:3 hoped:1 failure:2 goals:1 valuation:1 second-quarter:4 endpoint:1 bill:2 bellwether:1 n't:2 patients:2 were:2 following:1 more:1 spotlight:2 dropped:1 biotech:1 60.30:2 investors:1 well:1 measure:2 share:1 sales:3 high:1 reports:1 rally:1 accounting:1 gains:2 information:1 overcoming:1 topped:1 shares:2 lifts:2 stagnant:1 earnings:3 which:1 income:1 performance:1 outlook:1 stock:5 profile:1 's:17 price:1 after:4 chance:1 fell:1 biotechnology:1 data:4 concerns:1 off:3 especially:1 largely:1 charges:1 futures:4 steady:3 federal:2 costs:1 clean:1 banks:2 comparisons:1 2008:2 playing:1
stock_AMGN r_up	sector:1 saying:1 reinvigorate:1 over:2 raised:4 trade:2 prices:5 attempts:1 session:4 including:1 higher:8 its:4 rescue:1 before:2 whose:2 giant:2 $:5 candidate:1 rose:2 guidance:1 it’s:1 expectations:1 send:1 second-quarter:3 advisories:2 denosumab:1 under:2 quarterly:1 achieve:1 hit:1 definitive:1 government:1 far:1 weakness:1 rise:2 pave:2 results:1 fall:2 during:1 quarters:1 net:2 anemia:2 1.02:1 like:1 success:1 --:1 issue:1 drop:3 companies:4 retailers:1 lose:1 worries:1 economy:1 7.7:2 financial:2 prompted:1 eclipse:1 declines:2 30:1 estimates:1 back:1 sign:1 see:2 economic:2 trading:1 exceeded:1 led:1 87:1 declined:1 2.4:1 said:1 mortgage:1 profit:3 recorded:1 shares:5 future:1 select:1 crude:1 new:1 falling:1 boost:1 beleaguered:1 million:1 transportation:1 ability:1 after-hours:1 drug:2 key:1 offset:1 active:2 brokerage:2 post:2 strong:1 declining:4 roundup:1 both:1 ahead:1 pressure:2 prior-year:1 study:1 losses:1 article:1 prior:1 regular:1 published:1 better-than-expected:1 slightly:1 comes:1 solidly:1 outlook:5 revenue:2 period:1 put:1 reported:1 rising:1 news:3 says:1 crisis:1 market:1 per:1 confidence:3 8.5:2 would:1 adjusted:1 faltering:1 two:1 mark:1 their:2 way:2 house:1 biggest:4 more:1 lowest:1 rallied:1 selling:1 big:1 faith:1 fire:1 company:3 stabilize:1 but:2 hoped:1 biotech:1 expected:2 lows:1 sharply:3 hopes:1 90:1 than:1 rebounding:1 conviction:1 solid:1 plunged:1 up:1 lead:1 international:1 while:3 growth:2 pending:1 spotlight:1 risky:1 firm:2 months:1 surprises:2 investors:1 cents:2 sense:1 share:3 sales:3 dropped:1 rally:1 close:2 sharp:2 turn:1 any:1 gains:2 compared:1 credit:1 overcoming:1 topped:1 brightened:1 drugs:2 stagnant:1 earnings:3 which:1 income:3 performance:1 stepped:1 stock:4 gaining:4 oil:7 's:15 financials:2 price:1 after:3 helping:1 fell:1 plan:1 stocks:13 data:2 pull:1 billion:4 lower:3 assets:2 tested:1 corporate:1 futures:3 stronger:1 sale:1 reports:2 cheer:1 edge:2 gain:1 biotechnology:2 2008:4 consumer:3 latest:2
stock_AMGN r_up	advisory:1 outlook:2 ordered:3 cancer:4 tumble:1 move:1 disappointing:1 financial:1 agents:1 committee:1 follow:1 blockbuster:1 issues:1 use:1 while:1 shares:1 forecast:1 their:3 statement:1 tumbles:2 usage:3 new:1 has:3 labels:3 drugs:4 sold:3 restricting:3 early:1 known:1 stocks:3 2008:1 after:1 anemia:3 made:1 limits:1 --:2 companies:1 patients:4 action:1 climb:3 changes:3 called:1
stock_AMGN r_up	use:1 last:1 cancer:1 --:1 restricted:1 decision:1 drop:1 request:1 treatments:1 patients:1 decided:1 payments:1 year:1 's:2 has:1 company:1 its:1 anemia:1
stock_AMGN r_up	pact:1 said:1 join:1 chose:1 experienced:1 board:1 investor:1 its:2 executives:1
stock_AMGN r_up	help:1 results:1 chronic:1 patient:1 often:1 system:1 immune:2 unable:1 low:1 destroy:1 treat:2 compensate:1 product:2 used:2 's:5 loss:1 number:1 blood:3 approval:1 approved:1 received:1 rare:2 disease:1 1,000:2 patients:3 components:1 believed:1 disorder:2 bone:1
stock_AMGN r_down	prospective:1 certain:1 period:1 have:1 apply:1 impact:1 n't:3 granted:1 had:1 drugs:1 waiting:1 take:1 under:1 acquirers:1 division:1 wo:1 sales:1 early:1 regulators:1 they:1 during:1 voting:1 prescription:1 assets:1 antitrust:1 securities:1 determined:1 products:1 advertising:1 action:1 termination:1 clearance:2 requires:1 researchers:1
stock_AMGN r_down	strengthened:1 labels:1 four:2 strongest:1 's:4 additional:2 agency:1 comments:1 details:1 more:1 wants:1 added:2 black-box:2 risk:2 warnings:2 drugs:2 arthritis:2 warn:2 regulators:2 --:2 infections:2 disease:2 serious:2
stock_AMGN r_down	arthritis:2 ordered:2 risk:2 warnings:2 drugs:2 infections:2 labels:2 stronger:2 disease:2 alert:2 four:2 patients:2 serious:2 's:2
stock_AMGN r_down	appear:1 rebound:1 beaten:1 companies:1 up:1 been:1 chief:1 looks:1 have:1 poised:1 investment:1 officer:1
stock_AMGN r_up	development:1 conference:1 health-care:1 --:1 partnership:1 agreement:1 drug:1 sign:1 may:1 not:1 immediately:1 its:1 osteoporosis:1
stock_AMGN r_up	infringed:2 royalties:1 related:3 drug:1 113:1 immediately:1 licenses:1 partner:1 seek:1 its:5 market:1 help:2 use:1 said:1 federal:2 granted:1 two:3 research:4 biotechnology:2 sustain:1 has:1 tool:2 development:1 foundation:2 used:2 's:1 may:1 company:2 upon:2 fund:1 allowing:1 filed:2 not:1 using:1 lawsuit:2 response:1 vaccine:2 third:1 university:2 alleging:2 companies:1 against:2 n't:2 enhance:2 osteoporosis:1 institutions:1 patents:3 making:2
stock_AMGN r_up	saying:1 major:1 gaining:2 investors:1 show:1 top:2 among:1 walk:1 assess:1 player:1 likely:1 actively:1 filing:1 measure:1 years:1 financial:1 its:3 market:1 osteoporosis:3 sell:1 most:1 strength:1 data:1 away:1 two:1 shares:1 risk:1 treatment:2 mid-stage:1 biggest:2 details:1 firms:1 women:1 might:1 sliding:1 68:3 denosumab:2 fractures:1 comparable:1 's:2 said:1 bid:1 after:1 treatments:1 new:1 slides:2 released:2 takeover:3 plan:1 doubts:2 news:1 stocks:6 continued:1 declining:2 improve:1 bankruptcy:1 has:1 crowded:1 --:1 spine:1 study:1 itself:1 drug:4 reduced:1 trial:1 protection:1 experimental:3 mixed:3 traded:1 maker:1 bone:3
stock_AMGN r_down	stock:1 major:2 financial:1 show:1 trend:1 reported:1 boosting:1 effectiveness:1 maladies:1 high:1 player:1 trends:2 trading:3 shares:1 broader:1 's:5 billion-dollar:1 its:1 market:2 osteoporosis:1 pharmaceutical:1 story:1 but:1 likely:1 new:1 treatment:1 comments:1 analyst:1 late:1 concerns:1 health:1 denosumab:2 details:1 firms:1 has:1 18-month:1 midday:2 gives:2 fractures:1 led:1 gains:3 physician:1 weakness:1 price:1 confer:2 bolsters:1 slides:1 reorganizes:1 important:1 updates:1 become:1 stocks:2 data:1 day:1 bank:2 case:1 early:3 lower:3 potential:1 central:2 success:1 third:1 released:1 --:2 industry:1 crowded:1 up:3 drug:3 reduced:1 banking:1 patients:1 could:1 bone:1 banks:2 study:2 gave:1 sank:1 experimental:1
stock_AMGN r_down	skin:3 patient:3 blockbuster:3 its:3 said:3 analyst:1 eighth:1 add:1 more:3 psoriasis:3 's:10 prices:1 beginning:1 than:3 treating:3 reaction:1 effective:3 study:3 disease:3 drug:6 stock:1 experimental:3
stock_AMGN r_down	treating:1 psoriasis:1 said:1 's:1 study:1 disease:1 drug:2 than:1 better:1 skin:1 its:1
stock_AMGN r_down	slid:1 financial:1 agreed:1 short-selling:1 buy:1 still:1 sell:1 stake:1 29:2 traders:1 few:1 bailout:1 way:1 even:1 oil:1 after:1 caps:1 plan:1 sweeping:1 stocks:3 bank:1 restrictions:1 short:1 59:2 plunged:1 spiked:1 small:1 found:1 left:1
stock_AMGN r_up	comment:1 said:2 alfa:2 study:2 marketed:2 drug:2 used:2 rates:2 reviewing:2 fourth:1 anemia:2 starting:1 treatment:2
stock_AMGN r_up	tumble:2 down:3 broader:1 pass:1 ailing:1 dives:1 market:1 previous:1 fails:1 provide:1 rout:2 legislation:1 bailout:2 voted:1 has:1 plunge:1 rebound:3 after:6 votes:2 crippled:1 news:1 stocks:6 day:1 day-ago:2 industry:2 bill:2 plunging:1 banking:2 relief:1 following:1 aid:1 resolution:1
stock_AMGN r_down	help:1 people:1 certain:1 injunction:1 course:1 portfolio:1 charting:1 's:1 its:1 market:1 said:1 court:1 federal:1 granted:1 investment:1 anyone:1 also:1 permanent:1 treatment:1 performance:1 has:1 stock:1 selling:1 jury:1 infringement:1 company:1 inflation:1 dismal:1 biotechnology:1 stocks:1 anemia:1 regarding:1 especially:1 many:1 up:1 keep:1 n't:2 patent:1 while:1 important:1 verdict:1 can:1 horizon:1 long-term:2 claims:1
stock_AMGN r_up	saying:1 own:1 old:1 investors:4 among:1 being:1 patent-infringement:1 '':1 because:1 sharp:2 tumultuous:1 doesn’t:1 its:2 assessing:1 court:2 federal:1 treatment:2 everything:1 upheld:1 don’t:1 test:2 verdict:1 you:1 stock:3 ``:1 selling:1 run:1 get:1 far:1 funds:2 sold:1 quarterly:2 said:1 know:1 they:2 stocks:1 mettle:2 anemia:2 regarding:1 patent:1 third:1 did:1 could:2 losses:2 attached:1 n't:2 --:1 so:1 ruling:1 infringement:1 claims:1 quarter:1
stock_AMGN r_down	get:1 implosion:2 one:1 maimed:2 history:1 experiences:1 battered:1 worst:1 sell-offs:1 stocks:3 market:3 stock:1
stock_AMGN r_up	sector:2 major:1 reverse:1 some:1 sales:1 competition:1 quarters:1 high:1 n't:1 growth:1 trading:3 news:1 wo:1 turn:2 seek:1 find:1 after:1 pharmaceutical:2 bullish:1 may:1 generic:1 beginning:1 benefit:2 been:1 crisis:1 late:1 their:1 much:1 dominated:1 expected:1 write-offs:1 has:1 note:1 development:1 flat:1 hover:1 pipelines:1 around:1 post:1 weakness:1 negative:1 weak:1 modest:1 takeover:1 recent:1 related:1 they:1 prices:1 comeback:1 line:1 stocks:7 shelter:1 day:1 ending:1 stage:1 session:1 territory:1 unlike:1 third:1 course:1 solid:1 companies:3 face:1 large:1 credit:1 while:1 continue:1 products:1 afternoon:5 promising:1 action:2 biotechnology:1 climb:2 quarter:1 south:2
stock_AMGN r_down	reaction:1 appeals:1 court:1 federal:1 issued:1 injunction:1 drug:2 keep:1 prevented:1 anti-anemia:1 affirmed:1 preliminary:1 judge:1 off:1 selling:1 fight:1 its:1 market:1
stock_AMGN r_up	appeals:1 court:1 drug:1 keep:1 anti-anemia:1 off:1 fight:1 its:1 market:1
stock_AMGN r_down	's:1 blue-chip:1 solid:1 earnings:1 foreign-exchange:1 sales:3 reports:1 third-quarter:1 rate:3 lift:2 growth:1 consumer-product:2 favorable:1 boosted:1 products:1 part:1 trade:1 consumer:1 its:1 shares:1 higher:2
stock_AMGN r_down	streak:1 financial:1 sales:1 challenges:1 economic:1 its:4 conference:1 pharmaceutical:1 stent:1 third-quarter:2 comments:1 increase:1 safety:1 call:1 which:1 performance:1 net:1 has:1 business:1 company:1 diversified:1 serve:1 reported:2 during:1 strong:1 continued:1 bigger:1 improved:1 launch:1 solid:1 rival:1 industry:1 uncertainty:1 51:3 drug:1 times:1 products:1 can:1 drug-coated:1 healthcare:1 model:1 profits:2
stock_AMGN r_down	decidedly:1 reversing:1 territory:1 positive:1 into:1 after:1 early:3 course:1 seesaw:3 session:1 action:3 stocks:3 starting:1 red:1
stock_AMGN r_up	confidence:1 ahead:3 investors:1 government:1 positive:1 global:1 stabilize:1 effect:1 finally:1 broader:3 cruise:2 action:1 stocks:3 markets:1 having:1 market:3 greater:1
stock_AMGN r_down	some:1 sales:3 slowing:1 high:2 have:1 year:1 seen:2 its:1 industrials:1 profit:3 best-selling:1 third-quarter:1 should:1 earnings:1 spike:1 expected:2 sluggish:2 product:1 bellwethers:1 reporting:2 outperformed:1 but:3 reflect:1 strength:1 demand:1 report:2 stocks:1 steep:1 display:1
stock_AMGN r_down	focus:4 trade:2 7.3:1 session:2 cuts:1 its:3 whose:2 grapples:1 expectations:1 late:1 program:1 disclosed:1 quarterly:1 increased:1 online:1 effects:1 glitches:1 companies:3 slide:2 worries:1 round:1 tepid:2 competition:2 slowdown:1 challenges:1 see:2 cost:1 delivered:1 profit:4 exceeding:1 shares:5 forecast:1 increase:1 new:1 net:1 sluggish:1 hefty:1 weak:1 reported:3 restructuring:2 active:2 manufacturing:1 vaccine:1 both:1 essentially:1 reports:5 sank:1 products:1 analysts:1 outlook:3 retailer:1 period:1 due:4 another:1 decline:1 raise:1 spending:1 top:2 third-quarter:3 confirming:1 growth:1 spike:2 taken:1 flat:4 drugs:1 company:2 year-ago:3 hurt:1 expected:2 economic:1 feeling:1 prompting:1 sales:5 again:1 weakened:1 generic:2 other:1 earnings:6 income:1 higher:1 surges:2 's:4 boosted:1 after:3 two:1 brands:1 such:1 tighter:1 acquisitions:1 largely:1 charges:3 roughly:1 2008:1 consumer:2
stock_AMGN r_up	all:2 unemployment:1 global:1 focus:2 ended:2 session:2 through:1 its:8 weekly:1 1.16:1 giant:4 $:7 rose:1 expectations:2 late:1 outlooks:1 systems:2 has:1 surprised:1 beat:2 rebound:1 rise:1 fall:2 bringing:2 anemia:2 treating:2 easily:2 7.3:3 --:3 companies:2 1.09:1 after-hours:1 including:3 economy:1 bone:2 financial:2 energy:1 prediction:1 growth:2 simmering:1 projections:2 year:1 said:1 pressured:1 profit:2 jumped:2 recorded:1 shares:2 volatile:1 simmer:2 navigating:1 net:2 previous:1 across:2 infrastructure:1 million:2 notable:1 agreement:1 following:1 key:2 franchise:2 article:1 declining:2 raise:3 cautious:1 prior-year:1 losses:1 brutal:1 regular:1 products:3 published:1 messaging:1 experimental:2 comment:1 among:1 outlook:2 benefited:1 revenue:2 period:1 third-quarter:3 down:1 crude-oil:1 names:1 another:1 news:1 compared:1 throughout:1 electronic:1 market:4 decline:2 jobless:1 osteoporosis:2 catalysts:1 next:1 much:1 stock:6 biggest:2 denosumab:2 mostly:1 season:1 company:5 but:2 sales:2 part:1 prices:1 analyst:1 those:1 begins:2 troubled:2 18:1 up:1 recession:5 trading:1 future:3 sent:1 were:1 squeezed:1 making:1 trim:2 biotech:3 months:1 prompting:3 cents:1 share:2 stressing:1 drug:2 moves:1 again:6 strength:3 5.4:1 provide:1 rout:1 fears:4 other:1 5:1 earnings:2 income:2 higher:1 gaining:2 extended:1 's:10 information:1 price:1 after:1 driver:2 fell:1 biotechnology:1 services:1 such:1 stocks:5 data:1 soared:1 recent:1 billion:1 sectors:1 older:1 futures:3 spent:1 '08:6 claims:1 2008:3 800:1
stock_AMGN r_up	sector:1 among:1 soars:2 companies:1 energy:3 month:1 down:1 seesaw:2 session:1 trading:3 rally:4 23:1 rose:1 shares:1 late:2 tumbles:2 several:1 stock:1 gains:2 seesaws:1 weak:1 chemicals:1 fell:1 prices:3 data:1 declining:1 plunges:1 mount:2 30:1 bellwether:1 drug:1 while:1 economic:1 afternoon:1 components:1 '03:2 maker:1 profits:1 weakest:1
stock_AMGN r_up	huge:1 lower:2 off:1 investors:1 lost:1 late-traded:2 equities:1 sales:2 driven:1 lifts:2 ground:1 day-session:1 rally:1 stocks:3 came:1 view:2
stock_AMGN r_down	biotech:1 broader:3 rocket:2 issued:1 move:1 soon:1 file:1 year:1 table:1 market:3 bankruptcy:1 pharmaceutical:2 rely:1 patent:1 selected:1 rally:3 lower:1 warms:1 potentially:1 listed:2 interest:1 big:1 expected:1 rates:1 firms:1 damaging:1 week:1 approvals:1 further:1 released:1 hopes:1 stocks:3 following:1 pipeline:1 companies:3 drug:1 patents:1 were:1 small:1 biotechnology:1 order:1 medical-device:1
stock_AMGN r_up	``:1 said:1 false:1 --:1 certain:1 disease:1 drug:1 '':1 patients:1 used:1 advertising:1 misleading:1 kidney:1
stock_AMGN r_down	says:2 money:1 cheap:2 we:1 '':2 manager:1 good:2 find:3 now:1 there:1 also:1 lot:1 ...:1 ``:2 buy:3 's:2 easy:3 very:1 but:3 prices:1 stocks:2 scary:3 --:1 companies:2 sale:1 while:1 think:1
stock_AMGN r_down	forced:1 selling:1 stabilization:1 recovery:3 investors:1 can:1 checklist:2 bonds:1 there:2 opportunity:1 have:1 signs:1 usually:1 's:3 convertible:1 markets:1 find:1 market:2 recent:1
stock_AMGN r_down	's:2 look:2 year:1 but:1 34:1 down:1 everything:1 stock-market:2 don’t:1 time:2 date:1 beyond:2 averages:3 tell:1 500:1
stock_AMGN r_up	gaining:2 whose:1 's:2 seeing:1 companies:1 shares:1 trade:1 active:1 session:1 biggest:2 stocks:2 declining:2
stock_AMGN r_up	weather:1 economic:1 can:1 storm:1
stock_AMGN r_down	advisory:1 adults:1 backing:1 orphan:1 $:2 chronic:1 hypertension:1 said:1 21:1 positive:1 review:2 1:2 immune:1 treatment:2 medicine:1 new:1 several:1 authorization:1 203:1 's:3 adult:1 active:1 amp:2 panel:1 --:1 medicines:1 days:1 drug:1 essential:1 regulator:1 receive:1 2007:1 time:1 opinion:1 began:1
stock_AMGN r_down	received:1 said:1 's:2 --:1 medical:1 advisors:1 drug:1 backing:1 treatment:1 new:1 rheumatoid:1 arthritis:1 drugmaker:1
stock_AMGN r_down	comment:1 setback:1 submit:1 year:1 its:2 plans:1 information:1 said:1 based:1 additional:1 least:1 next:1 delay:1 other:1 animal:1 new:2 suffered:1 which:1 arthritis:1 most:1 background:1 data:1 analyst:1 third:1 launch:1 --:1 18:1 months:1 drug:2 trial:1 severe:1 promising:1 quarter:1 rheumatoid:1 asked:1
stock_AMGN r_down	biotech:1 people:1 series:1 some:1 competition:1 years:5 growth:4 seen:4 scares:1 unit:1 category:4 information:1 copycat:1 said:4 consumers:1 area:4 generic:1 leading:4 make:1 long:1 immune:1 safety:1 potentially:1 market:1 new:5 receiving:1 division:4 's:4 flood:1 drugs:5 big:4 formed:4 much:1 lucrative:1 coming:4 recent:1 developing:4 --:5 versions:5 so:1 risks:1 scaring:1 biotechnology:4 top:1
stock_AMGN r_down	loss:1 charges:1 amid:1 expects:1 related:1 its:1 takeover:1 net:1 2008:1
stock_AMGN r_up	comment:1 ahead:1 now:1 because:1 followed:1 worst-performing:2 deal:1 sporting:1 alternatives:1 number:1 years:1 set:1 including:1 have:1 toys:1 shopping:1 drug-industry:2 its:1 out:1 said:1 1982:1 lead:2 sector:1 patent:1 positive:1 make:1 since:1 send:1 their:2 charge:2 firmly:1 longtime:2 under:1 probably:2 has:1 conditions:1 500:3 higher:1 them:1 turning:1 sixth:1 company:2 acquire:2 consolidation:2 cheaper:1 pressure:1 protection:1 could:1 coming:1 such:2 stocks:4 come:1 analyst:3 10:3 term:1 kids:1 consumers:1 best-:2 performers:1 technical:1 industry:3 lose:1 list:1 according:2 drug:1 large:2 near:1 products:1 cholesterol:1 biotechnology:2 2008:2 retail:1 top:2
stock_AMGN r_down	used:1 group:1 target:1 cancer:1 seeking:1 --:1 certain:1 two:1 disease:1 drugs:1 patients:1 growth:1 colon:1 treat:1 involved:1 approval:1 products:1 gene:1 type:1 makers:1
stock_AMGN r_down	all:1 right:2 investors:1 unemployment:1 national:2 health-care:1 through:1 ailing:1 families:1 its:2 impact:1 said:1 longstanding:1 reform:2 workers:1 administration:1 system:1 finally:2 health:2 has:1 collaboration:1 reviving:1 discovery:2 division:1 extended:1 's:1 company:1 failure:1 governments:1 service:1 success:1 sizes:1 --:1 well:1 drug:2 2010:1 recession:1 time:3 rising:1 2009:1 businesses:1
stock_AMGN r_down	biotech:1 cancer:1 prevent:1 its:1 osteoporosis:1 sell:1 giant:1 lead:1 treat:2 has:1 treatment:1 hormone:1 undergoing:1 seeking:1 marketing:1 therapy:1 breast:1 approval:1 prostate:1 women:1 applied:1 loss:1 pipeline:1 --:1 drug:2 patients:1 either:1 denosumab:1 bone:2
stock_AMGN r_down	saying:1 right:1 1.2:2 had:1 down:1 against:1 trading:1 dismissed:1 have:1 openness:1 contributions:1 its:2 improperly:1 decline:1 use:2 said:1 court:1 $:1 no:1 federal:1 political:1 two:1 shares:1 p.m.:1 only:1 2:3 percentage:1 seeks:1 ``:1 business:1 drugs:1 funds:1 giant:1 regulators:1 such:1 lawsuit:1 improve:1 case:1 '':1 longer:1 bring:1 --:1 drug:2 were:1 promoted:1 biotechnology:1 corporate:1 maker:1
stock_AMGN r_up	years:1 any:1 three:1 approved:1 new:1 struggling:1 layoffs:1 thousands:1 more:1 pipelines:1 greater:1 slight:1 drugs:1 scrutiny:1 regulators:1 consolation:1 than:1 --:1 industry:1 drug:1 prior:1 2008:1
stock_AMGN r_down	certain:1 years:1 any:1 24:1 20:1 22:1 three:1 approved:5 treatment:1 new:2 struggling:1 layoffs:1 thousands:1 more:2 pipelines:1 greater:1 slight:1 drugs:3 2005:1 leukemia:1 scrutiny:1 regulators:1 consolation:1 included:1 article:1 lymphoma:1 than:2 types:1 --:1 18:1 industry:1 drug:1 antidepressant:1 prior:1 2006:2 published:1 2008:2
stock_AMGN r_down	fourth-quarter:1 lines:1 some:1 unhedged:2 separating:1 if:2 bottom:1 bite:1 able:1 their:1 winners:1 role:1 take:1 which:1 big:1 out:1 earnings:2 play:1 's:1 dollar:3 pressure:2 hedge:1 exposure:1 could:3 companies:2 surge:1 losers:1 risks:2 were:1 overseas:1 left:2
stock_AMGN r_down	sector:1 biotech:1 major:1 smaller:1 tough:1 revenue:1 being:1 harder:1 some:2 up:1 heels:1 names:1 article:1 talks:1 targets:1 raise:1 crisis:1 needed:1 potential:1 new:1 turmoil:1 recommends:1 's:3 seeking:1 drugs:1 near-term:1 possible:1 eyed:1 such:1 hold:1 vaccine:1 purchase:1 companies:1 cash:1 drug:1 times:1 credit:1 can:1 published:1 makes:1 maker:2 acquisition:3
stock_AMGN r_up	operations:2 6:1 unexpected:1 help:1 supply:1 dealing:1 onslaught:1 years:2 five-:1 second:1 investment-grade:1 year:1 corner:1 market:2 faces:1 households:1 giant:1 maturities:1 $:11 due:2 totals:1 1:1 their:2 2:1 marketing:1 new:3 sold:1 750:2 's:2 around:1 get:1 funds:2 offered:2 million:2 they:2 alone:1 debt:2 raise:2 billion:5 10:2 15.5:1 --:2 notes:3 30:2 companies:2 foreign:1 deals:2 repay:2 were:1 banks:1 could:1 launched:1 bond:2
stock_AMGN r_down	operations:2 caused:1 agreed:1 fueling:1 years:1 its:3 announcement:1 giant:2 $:13 16.5:1 combine:1 treatment:1 has:1 them:1 get:1 weakness:1 updates:1 they:2 not:1 --:5 warned:1 notes:5 companies:3 deals:2 banking:1 speculation:1 quarter:1 tumors:1 wrote:1 bond:2 because:1 financial:1 second:2 even:1 swaps:1 pressured:1 worsen:1 since:1 research:2 bailout:1 market:2 medicine:1 new:2 business:2 marketing:2 sold:1 million:1 broken:1 alone:2 brokerage:2 debt:2 additional:1 industry:1 30:1 foreign:2 credit:4 gene:1 cancer:1 throughout:1 unit:1 raise:2 would:1 transfer:1 due:1 their:4 2:2 markets:2 more:1 firm:1 ``:1 750:1 funds:2 offered:2 tally:1 tested:1 highest:1 those:1 10:1 default:1 up:1 n't:3 patients:1 were:2 could:1 urging:1 control:1 costly:1 rumored:1 '':1 have:1 9.75:1 government:1 note:1 concerns:2 earnings:1 fourth:1 economy:1 poor:1 's:5 reach:1 levels:1 data:1 billion:6 15.5:1 effective:1 amid:1 sale:2 repay:2 banks:2 organization:1
stock_AMGN r_down	sector:1 fourth-quarter:2 investors:1 revenue:1 short:2 declines:2 health-care:2 sign:1 sales:4 marked:2 slowdown:2 helped:2 cost:2 economy:1 comments:1 cuts:2 throughout:1 its:3 decline:1 giant:2 also:2 profit:2 beginning:1 5th:1 expectations:2 one-time:2 forecast:2 increase:2 pharmaceuticals:2 add:1 details:2 which:2 issued:2 resilient:1 stock:2 pain:2 gains:2 earnings:2 price:2 toll:1 reported:2 fell:2 updates:2 background:2 offset:2 years:1 investor:1 reaction:1 2009:2 14:6 76:1 makes:2 medical:2 well:2 devices:2 recession:1 products:2 '09:4 more:1 consumer:2 taking:1 first:1
stock_AMGN r_up	bets:1 handily:1 though:1 beat:1 energy:1 health-care:1 overall:1 hurt:1 few:2 returns:1 retailers:1 our:1 discount:1 stocks:1 their:1
stock_AMGN r_down	secure:2 deal:2 less:2 looming:1 feeling:1 8217:2 patent:1 60:3 have:2 argue:1 talks:1 pain:1 blockbuster:1 its:1 market:2 help:1 even:2 use:2 generic:1 sheet:2 $:5 remains:2 mounting:1 acquire:1 presence:1 than:1 vaccines:1 needed:2 revenue:1 best:2 which:1 valued:1 2011:3 company:1 today:2 more:1 quarter:1 's:8 ability:2 drugs:1 bid:2 cholesterol:1 but:2 reported:2 levels:1 billion-plus:2 competition:1 appears:2 bigger:1 billion:1 represents:1 financing:2 balance:2 especially:1 whether:2 rival:1 clear:2 annual:1 drug:2 maker:1 n't:4 credit:2 s:2 2001:2 expiration:1 high-growth:1 choppy:2 could:2
stock_AMGN r_up	saying:1 deal:1 fourth-quarter:1 stronger:1 headwinds:1 dollar:1 8217:2 quarters:1 say:1 drug:1 68:4 its:1 pharmaceutical:1 giant:1 $:4 takeover:1 profit:1 surprises:2 only:1 advisories:2 earnings:1 net:1 economy:1 analysts:1 's:4 some:1 company:1 problems:1 but:1 hailed:1 partially:1 roundup:1 15:3 rival:1 companies:1 reports:1 s:2 future:1 solve:1 planned:1 rose:1 long-term:1 corporate:1 latest:1
stock_AMGN r_down	dollar:2 results:2 trade:2 session:1 economy:1 looks:2 its:9 whose:1 giant:3 cut:1 $:4 rose:3 than:1 better:1 denosumab:2 quarterly:2 earnings:2 rise:2 focus:2 despite:1 disappointed:2 anemia:6 stabilize:2 --:2 12th:1 companies:1 continue:2 after-hours:2 small:1 stock:1 bone:2 headwinds:2 back:1 see:1 economic:1 trading:2 expect:1 year:4 2.2:2 targets:2 out:1 embattled:2 profit:2 shares:7 forecast:2 misses:2 net:3 recently:2 operating:1 struggle:1 franchise:4 along:2 come:1 quarter:2 launch:2 eke:1 drug:4 analysts:1 maker:1 experimental:2 comment:1 fourth-quarter:5 outlook:3 revenue:6 active:1 throughout:1 miss:1 100:2 late:1 forward:2 flat:3 company:5 but:4 hurt:2 expected:1 gain:1 analyst:1 grew:2 15:15 up:2 flagship:2 while:1 result:2 biotech:1 investors:2 chip:1 sales:4 expenses:1 reports:3 close:2 weakened:2 able:1 other:1 details:2 fourth:2 income:3 disappoint:2 higher:1 's:14 price:1 after:4 fell:2 lifting:1 ago:2 later:2 stronger:2 '09:2 biotechnology:2 2009:6
stock_AMGN r_up	partnership:1 years:1 blockbuster:1 market:1 if:1 pay:1 make:1 next:1 few:1 intends:1 has:1 issue:1 them:1 drugs:1 big:1 agreement:1 governing:1 five:1 competing:1 off:1 --:1 could:2 companies:1 identified:1 drug:2
stock_AMGN r_up	deal:1 bugs:1 terms:1 sells:1 technology:1 its:1 unit:1 giant:1 rated:1 granted:1 their:1 potentially:1 systems:1 strike:1 has:1 markets:1 screen:1 disclosed:1 used:1 's:1 food:1 big:1 company:2 were:1 chemicals:1 said:1 borrowers:1 high-quality:1 license:1 --:1 dangerous:1 companies:1 according:1 n't:1 credit:1 products:1 diagnostics:1 easing:1 latest:1 corporate:1 issuers:1
stock_AMGN r_up	consolation:1 hard:1 year:1 mutual:1 other:1 health:1 take:1 '09:2 knowing:1 hit:1 funds:2 hurt:1 most:1 they:1 dearly:1 quite:1 types:1 care:1 last:1 --:1 invest:1 losses:1 n't:1 can:1 were:1
stock_AMGN r_up	consolation:1 hopeful:1 hard:1 although:1 year:2 hospitals:1 relatively:1 industries:1 uncertainties:1 mutual:1 hold:1 generally:1 shares:1 better:1 other:2 health:1 take:1 downturn:1 several:1 speaking:1 '09:2 knowing:1 hit:1 manufacturers:1 funds:3 published:1 hurt:1 most:1 they:1 dearly:1 article:1 quite:1 true:1 than:1 types:1 care:2 2009:1 last:1 --:1 invest:1 losses:1 companies:1 drug:1 n't:1 remain:1 can:1 were:1 biotechnology:1 more:1
stock_AMGN r_up	firm:1 pipeline:1 buy:1 $:1 agreed:1 million:1 drug:1 130:1 candidates:1 biotechnology:1
stock_AMGN r_down	oncology:1 its:2 unit:1 has:1 said:1 way:1 medicine:1 biosimilar:2 final:1 available:1 generics:1 important:1 paving:1 approval:1 drugmaker:1 received:1 made:1 third:1 --:1 drug:1 across:1 patients:1
stock_AMGN r_down	being:1 disease:1 have:1 unit:1 risk:1 marketed:1 diseases:1 shingles:1 other:1 treat:1 new:1 psoriasis:1 's:1 increased:1 may:1 arthritis:2 released:1 approved:1 developing:1 --:1 treated:1 study:1 according:1 patients:1 rheumatoid:1
stock_AMGN r_down	session:1 whose:1 infrastructure:1 's:1 $:1 received:1 company:1 after:1 companies:1 shares:1 trade:1 late:1 actively:1 trading:1 letter:1 -2:2 expected:1 tumbled:1 9.1:1 said:1
stock_AMGN r_up	'':2 amp:2 ``:2
stock_AMGN r_down	biotech:1 $:1 sold:1 million:1 shares:1 5:1
stock_AMGN r_down	set:1 's:1 faster:1 versions:1 generic:2 budget:1 up:1 drugs:2 hailed:1 biologic:1 proposal:1 pathway:1
stock_AMGN r_down	sector:2 accuses:1 less:2 health-care:1 3.6:2 drug:2 apply:2 blockbuster:3 hospitals:2 its:3 cut:2 $:2 illegal:3 trillion:2 proposal:2 has:2 company:3 across:2 sent:2 payments:2 pay:2 's:4 drugs:3 marketing:3 whistleblower:3 after:2 pressure:2 filed:2 prices:4 lawsuit:3 unidentified:2 insurers:2 prescription:2 budget:2 against:3 patients:2 seeks:2 healthcare:1 biotechnology:3 sank:2
stock_AMGN r_up	prospect:1 development:1 tough:1 proposed:1 expensive:1 may:1 generic:1 long:1 their:1 new:1 week:1 's:1 drugs:1 outlined:1 but:1 biologic:1 inevitable:1 last:1 versions:1 budget:1 faces:1 road:1
stock_AMGN r_down	ratio:1 longer:1 no:1 positive:1 57:2 says:1 risk/reward:1
stock_AMGN r_up	47:2 $:2
stock_AMGN r_up	biotech:1 right:1 tough:1 buyer:1 tag:1 makers:1 market:1 leverage:1 generic:1 demonstrates:1 copies:1 fight:1 higher:1 's:1 ability:1 opening:1 price:1 faces:1 produce:1 biologic:1 regulatory:1 path:1 especially:1 assets:1 --:1 medicines:1 bill:1 drug:1 downtrodden:1 otherwise:1
stock_AMGN r_up	biotech:2 right:1 prompt:1 deal:1 health-care:1 tag:1 seen:1 its:1 market:1 if:1 even:1 remaking:1 leverage:1 remains:1 demonstrates:1 time:1 higher:1 's:1 ability:1 hefty:1 price:1 published:1 additional:1 buyer:1 article:1 valuation:1 especially:1 acquisitions:1 assets:1 --:1 industry:1 face:1 large:1 itself:1 downtrodden:1 changes:1 otherwise:1
stock_AMGN r_down	giants:1 pharmaceutical:1 buy:1 longer:1 investors:1 biotech:1 dollars:1 no:1 companies:2 spent:1 billions:1 lately:1 behind:1 other:1 drug:1 have:1 small:1 leaving:1 find:1 can:1
stock_AMGN r_up	biotech:1 dries:2 investors:1 billions:1 spent:1 have:1 find:1 pharmaceutical:1 no:1 lately:1 behind:1 other:1 giants:1 buy:1 longer:1 dollars:1 companies:2 up:2 drug:1 leaving:1 can:1 small:1 biotechnology:2 start-ups:2
stock_AMGN r_down	mainly:1 elderly:1 years:1 brain:1 schizophrenia:1 thinks:1 if:1 asthma:1 would:1 area:1 research:2 fatal:1 treatment:1 dozens:1 more:1 's:5 diseases:1 drugs:1 strikes:1 most:1 important:1 condition:1 he:1 advance:1 land:1 acquiring:1 target:1 ahead:1 --:2 many:1 proud:1 disease:1 range:1 yields:1 efforts:1 experimental:1
stock_AMGN r_down	mainly:2 elderly:2 years:2 brain:2 schizophrenia:2 thinks:2 if:2 asthma:2 would:2 area:2 research:4 fatal:2 treatment:2 dozens:2 more:2 's:10 diseases:2 drugs:2 strikes:2 most:2 important:2 article:1 condition:2 he:2 advance:2 land:2 acquiring:2 target:2 ahead:2 --:4 many:2 proud:2 disease:2 range:2 yields:2 published:1 efforts:2 experimental:2
stock_AMGN r_up	's:1 favorites:1
stock_AMGN r_up	heart:1 raised:1 futures:1 key:1 rating:1 trend:2 sag:1 sales:1 billions:1 see:1 already:1 have:1 's:1 clinical:1 market:1 if:1 giant:1 upgrade:1 asthma:1 would:1 trial:1 federal:1 equities:1 shares:1 better:1 their:1 citing:1 other:1 treat:1 which:1 under:1 new:2 conditions:1 company:1 stock:1 week:1 product:1 rise:1 declined:1 upcoming:1 government:1 drugs:1 breaks:2 arthritis:1 overweight:1 focus:3 neutral:1 they:1 8:1 oncology:1 stocks:1 data:1 than:1 after:1 drop:1 consumer:1 dollars:1 register:1 proposals:1 up:1 spending:1 profit:1 while:1 're:1 analysts:1 jumped:1 real:1 biotechnology:1 downward:2 higher:1 warning:1 options:1 denosumab:1
stock_AMGN r_down	acquiring:1 people:1 considered:1 amid:1 away:1 but:1 price:1 matter:1 say:1 concerns:1 familiar:1 backed:1 over:1
stock_AMGN r_down	major:1 deal:1 people:1 over:1 global:1 cheap:3 held:1 decided:1 discussions:1 issues:1 funding:1 make:1 access:1 their:1 splash:1 price:1 's:2 advantage:2 familiar:1 company:1 but:1 reason:1 preliminary:1 not:1 concerns:1 acquisitions:1 financing:2 acquiring:1 pursue:1 companies:1 according:1 matter:1 starting:1 other:1 mergers:1
stock_AMGN r_down	first-quarter:1 investors:1 17:1 shocked:1 --:1 after:1 shares:1 maker:1 drug:1 much:1 three-year:1 low:1 high-growth:1 warning:1 setting:1 fell:1 earnings:1
stock_AMGN r_up	financial:1 trend:1 health-care:2 reaffirms:2 sales:1 heavyweight:1 broader:1 reaffirmed:1 its:1 giant:2 shares:2 forecast:3 expected:1 posting:1 than:1 market’s:1 after:3 despite:1 downward:1 buck:1 lower:1 quarter:1 industry:1 climb:2 2009:1 slightly:1 first:1
stock_AMGN r_down	said:1 first-quarter:1 rose:1 were:1 overall:1 sales:1 53:3 expectations:1 short:1 but:1 income:1 's:2 net:1 its:1
stock_AMGN r_down	stocks:3 issued:1 into:2 were:1 continuing:1 negative:2 markets:1 credit:1 warning:1 broader:1 fall:1 territory:2 flee:2 reacts:1 market:1
stock_AMGN r_down	whose:1 companies:1 focus:2 shares:1 trade:1 active:1 see:1 session:1 expected:1
stock_AMGN r_up	biotech:1 because:1 revenue:1 being:1 money:1 into:2 year:1 focus:2 competition:1 years:1 held:1 see:1 session:1 drug:1 7.4:1 view:1 ailing:1 's:1 medication:1 its:2 market:1 decline:1 whose:1 giant:1 said:1 profit:2 expectations:1 shares:1 research:1 slips:2 earnings:1 7:1 late:1 expected:1 downturn:1 net:1 meetings:1 today:1 economy:2 firm:1 global:1 first-quarter:2 increased:1 pharmaceutical:1 drugs:1 income:1 sales:4 reported:2 cut:5 active:1 amp:2 trade:1 than:1 2009:1 target:2 influential:1 could:1 annual:1 companies:2 50:1 contract:1 maker:1 --:1 amount:1 fell:1 economic:1 deterioration:1 time:1 more:1 spent:1 reduced:1 first:1
stock_AMGN r_up	sector:2 biotech:1 followed:1 saying:1 caused:1 into:1 fights:1 quarters:1 high:1 embraced:1 reports:2 broader:1 blockbuster:1 market:1 $:1 disorders:1 surprises:2 three:1 shares:1 forms:1 advisories:2 potential:1 earnings:2 boost:2 higher:1 recommends:1 's:1 arthritis:1 early:1 stocks:1 approved:1 buying:1 roundup:1 companies:1 drug:3 future:1 latest:1 corporate:1 50s:1 better-than-expected:1
stock_AMGN r_up	revenue:1 sales:1 affirms:2 partly:1 impact:1 earnings:2 income:1 net:1 boost:1 virtually:1 flat:3 's:1 exchange:1 rises:1 first-quarter:1 target:2 excluding:1 foreign:1 while:1 overseas:1 2009:2 comes:1
stock_AMGN r_up	jobs:1 their:1 giving:1 company:1 insurance:1 drugs:1 patients:1 health:1 lose:1 away:1
stock_AMGN r_down	biotech:1 emerging:1 help:1 people:1 expanding:1 health-care:1 encouraging:1 makers:1 overhaul:1 system:1 boost:1 tests:1 's:2 get:1 afford:1 handful:1 treatments:1 programs:1 amid:1 medicines:1 companies:1 prolonged:1 reports:1 recession:1 efforts:1
stock_AMGN r_down	rose:1 all:1
stock_AMGN r_up	biotech:1 emerging:1 cancer:1 results:1 sign:1 renewed:1 broader:1 market:1 bankruptcy:1 upgrade:2 $:1 positive:2 two:1 concerns:1 run:1 140:1 drugs:1 jumps:2 million:1 slump:2 part:1 stocks:3 developments:1 doldrums:1 lower:1 license:1 industry:1 slumps:1 deals:1 edge:1 experimental:1
stock_AMGN r_down	members:1 process:1 over:1 hearing:1 innovative:1 still:1 debate:1 living:1 throughout:1 develop:1 matter:1 generic:2 create:1 comments:1 chemical:1 encourage:1 complex:1 details:1 new:1 development:1 traditional:1 drugs:2 incentives:1 made:1 biologic:1 background:1 party:1 report:1 approval:1 desire:1 providing:1 faster:1 unlike:1 --:1 medicines:2 lines:1 biologics:1 n't:2 whether:1 while:1 crossed:1 balance:1
stock_AMGN r_up	biotech:1 cancer:1 insight:1 soon:1 see:1 growth:1 giant:1 additional:1 provide:1 projected:1 denosumab:1 expected:1 's:1 use:1 but:1 approval:1 data:1 wide:1 --:1 could:1 drive:1 drug:2 whether:1 patients:1 future:1 bone:1 experimental:1
stock_AMGN r_up	temporarily:1 deal:1 fall:1 halting:1 trading:2 another:1 upgrade:1 pharma:1 there:1 due:1 production:1 sparking:1 plant:1 gains:2 business:1 climbs:1 company:1 after:1 falls:2 newspaper:1 contamination:1 report:1 news:1 analyst:1 recent:1 mega:1 hunt:1 drug:1 while:1 mixed:2 speculation:1 works:1
stock_AMGN r_down	advisory:3 all:1 because:1 hoping:1 proposed:2 almost:1 move:1 site:1 transform:1 likely:1 committee:1 its:4 developer:1 said:2 posting:1 osteoporosis:1 review:4 agency:1 three:1 been:1 name:1 chemical:1 health:1 denosumab:3 which:1 under:1 expected:1 new:2 has:1 decades:1 brand:1 stock:1 's:2 around:1 business:1 get:1 drugs:2 brings:1 sold:1 but:1 approval:1 entity:1 panel:2 13:3 would:2 --:2 drug:3 considered:1 small:1 meet:1 panels:1 first:1
stock_AMGN r_up	summer:1 partnership:1 talks:1 its:1 if:1 would:1 pivotal:1 new:1 surprised:1 's:1 after:1 takeover:1 preparing:1 data:1 he:1 aggressively:1 --:1 later:1 drug:1 n't:1 obesity:1 comes:1
stock_AMGN r_up	10:1 cautious:2 investing:2 maybe:1 midyear:2 ideas:3 highlighted:1 too:1 were:1 careful:1 2009:3 investment:1
stock_AMGN r_down	funding:1 receive:1 topics:1 up:1 should:1 priority:1 health:1 100:1 has:1 come:1 thinks:1
stock_AMGN r_up	health-care:1 cost:1 have:1 prevail:1 its:1 whose:1 said:1 would:1 make:1 patients:1 should:1 spread:1 denosumab:1 has:1 's:1 assured:1 drugs:1 outperformed:1 breast-cancer:1 treating:1 industry:1 bill:1 unnecessary:1 drug:2 savings:1 tumors:1 bone:2
stock_AMGN r_up	undervalued:1 focus:2 trade:2 session:3 6.1:1 its:1 issues:1 osteoporosis:1 whose:3 giant:3 22:1 rose:5 29:1 than:2 better:2 denosumab:1 premarket:1 8:1 day’s:1 gains:2 get:3 possible:1 results:4 despite:1 report:2 continued:2 day:2 aluminum:3 lost:2 level:1 --:2 companies:3 herald:1 works:1 bone:3 says:1 see:4 actively:3 trading:4 year:1 close:2 2.7:1 declined:2 out:3 said:1 while:1 shares:5 1.75:1 3:2 7:1 can:3 await:3 jobs:2 key:1 news:1 100:2 rut:3 additional:1 gained:1 last:2 35:1 surge:1 trial:4 levels:3 climb:2 slightly:1 experimental:1 late-stage:2 major:1 point:1 awaited:1 one:2 down:2 reached:2 market:4 885:1 positive:1 long:1 start:1 stock:7 's:12 9.1:1 500:5 more:1 lowest:3 flat:1 season:1 company:2 wake:2 lows:4 worked:1 highest:1 surged:1 second-quarter:1 15:2 16:1 up:2 near:5 economic:2 lingering:1 were:6 biotech:3 investors:1 two-month:2 disappointing:2 drug:4 1:1 if:3 5.1:1 4.1:1 goal:1 prior:3 traders:4 earnings:1 which:1 higher:2 week:2 added:1 edged:1 may:1 after:3 bone-drug:2 fell:2 stocks:5 lifting:1 recent:3 futures:11 jitters:2 points:14 meander:1
stock_AMGN r_down	undervalued:1 ending:1 ended:3 6.5:1 session:1 7.5:1 its:2 issues:1 weekly:2 whose:1 rose:4 had:3 late:1 add:1 going:1 denosumab:1 include:1 details:1 gains:1 government:1 possible:1 early:1 putting:1 despite:1 loss:3 level:1 --:3 companies:1 morning:1 bad:3 late-session:1 higher:1 bone:1 gaining:2 significantly:1 some:2 actively:1 trading:2 year:1 said:1 decision:1 shares:1 forecast:3 falling:1 available:1 kicked:3 were:2 news:1 100:2 strong:2 declining:2 gained:3 last:1 taking:1 drug:4 cheering:1 amount:1 analysts:3 mixed:4 experimental:1 comment:1 among:2 point:1 68:1 respect:1 market:3 jobless:2 positive:1 initial:1 selloff:1 long:1 start:2 development:3 biggest:2 rates:1 markets:2 9.1:1 500:3 more:1 ``:1 season:3 company:1 but:2 biotech:1 prices:2 highest:1 second-quarter:3 15:1 n't:3 below:1 lingering:1 promising:3 following:2 1.5:1 figure:1 sales:1 sense:1 42:1 1:1 earnings:3 9:3 600,000:1 stock:4 week:1 added:2 's:6 highs:1 after:4 fell:3 moving:1 stocks:3 data:1 lifting:1 recent:1 off:5 futures:7 points:8 push:1 claims:2 latest:1
stock_AMGN r_down	sector:1 biotech:1 investors:1 trend:1 some:1 expenses:1 second:1 growth:1 signs:1 hit:1 makers:1 expensive:1 may:1 spending:1 expectations:1 pressures:1 earnings:2 expected:1 struggling:1 economy:1 controlled:1 drugs:1 report:1 last:1 look:1 solid:1 many:1 vulnerability:1 companies:1 drive:1 drug:1 large:1 more:1 continue:1 meet:1 quarter:2 consumer:1 order:1
stock_AMGN r_up	amendment:4 represent:2 major:2 competition:2 years:2 committee:3 vote:3 makers:2 living:2 would:2 generic:2 late:2 pharmaceuticals:2 which:2 gives:2 manufacturers:2 drugs:4 biologic:2 segment:2 approved:2 reaction:1 protect:2 12:2 --:6 cells:2 drug:2 victory:2 growing:2 biotechnology:2 industry:4
stock_AMGN r_up	reduce:1 investors:1 testing:1 turned:1 sales:3 competition:2 3.6:3 currency:2 cost:1 higher:1 cuts:1 unfavorable:2 declined:1 out:1 would:1 trial:1 generic:2 treatment:1 than:1 better:1 track:1 potential:1 rates:2 4:1 expected:1 chemotherapy:1 net:1 difficult:1 product:1 safe:1 's:3 drugs:1 some:1 duration:1 knew:1 results:1 effect:1 but:1 hurt:2 fell:1 nearly:1 approval:1 second-quarter:1 tighter:2 helped:1 prescription:1 effective:1 showed:1 side:1 spending:2 profit:1 severe:1 products:1 quarter:1 consumer:2 maker:1 remains:1
stock_AMGN r_up	biotech:1 raised:1 letters:1 estimates:1 one:1 bring:1 have:2 no:1 generic:1 top:2 patients:1 grim:1 better:1 only:1 complex:1 call:1 has:1 pathway:1 told:1 crash:1 creating:1 cheaper:1 meaning:2 biologic:1 letter:2 than:1 versions:1 --:1 macro:2 medicines:1 bill:2 macroeconomic:1 bad:1 future:1 tech:2 vision:1
stock_AMGN r_up	comment:1 over:1 years:1 four:1 its:2 kidney:2 dialysis:3 everything:1 legislation:1 drugs:3 treatment:1 which:2 under:1 2011:1 flat:1 used:1 undergoing:1 rules:2 price:1 but:1 unveil:2 most:2 beginning:1 change:2 prominent:2 reimbursement:2 made:2 would:1 --:2 required:1 separately:1 patients:1 expecting:2 2008:1 changes:1 mean:1
stock_AMGN r_up	office:1 lobbying:2 marginal:1 health-care:1 up:1 past:1 overhaul:1 would:1 patent:1 agency:1 three:1 increase:1 only:1 take:1 struggling:1 head:1 's:1 time:1 problems:1 choice:1 reported:1 despite:1 budget:1 post:1 organizations:1 applications:1 industry:1 months:1 companies:1 drive:1 activity:1
stock_AMGN r_up	comment:1 streak:2 companies:1 headwinds:1 sales:3 competition:1 expectations:3 helped:3 full-year:1 cost:3 rising:2 cuts:3 unfavorable:1 makers:2 information:1 generic:1 additional:1 their:1 profit:2 top:3 exceeding:2 its:1 economy:1 rates:1 earnings:4 boost:2 higher:4 topping:1 increased:1 drugs:2 weak:1 cheaper:1 reported:3 prices:1 continued:2 second-quarter:3 faced:1 purchase:1 industry:2 posts:1 hikes:1 costs:2 products:2 stock:1 profits:1 view:1
stock_AMGN r_up	cancer:1 focus:2 trade:1 unexpectedly:1 authorities:1 see:1 session:1 its:1 whose:1 group:1 shares:3 reject:1 expected:1 's:1 after:3 slump:2 chemicals:1 active:1 rejection:2 drop:1 companies:1 drug:2
stock_AMGN r_down	biotech:1 outlook:1 focus:2 trade:1 see:1 session:1 its:1 whose:1 $:1 pay:1 shares:1 brighter:1 denosumab:1 expected:1 royalties:1 drugs:1 offered:1 million:1 sales:1 120:1 key:1 active:1 companies:1 efforts:1 2009:1 better-than-expected:1
stock_AMGN r_up	saying:1 remarkable:4 over:1 results:5 quarters:1 6.7:1 ended:2 session:1 40:10 surpass:1 during:1 forecast:5 its:7 ground:4 adding:2 giant:2 terms:2 $:6 surprises:2 guidance:2 revenue:6 had:2 expectations:3 send:2 late:1 brighter:2 lifts:2 denosumab:2 quarterly:1 details:1 3.8:2 take:2 sinking:1 do:1 gains:1 get:2 rebound:1 rise:4 wave:1 early:1 interview:2 nearly:1 background:1 despite:2 2:2 bit:1 items:2 continued:1 pharmaceutical:2 drugmaker:1 --:2 drop:2 '':3 skewed:2 slide:3 settle:1 lose:2 small:2 raised:2 higher:6 reduced:2 bone:2 2.25:1 deal:4 posts:1 energy:4 some:2 back:2 bounce:1 up:2 see:1 actively:1 trading:7 expected:2 year:3 close:1 declined:2 said:3 shares:8 diverge:1 companies:2 3:1 run:5 7:1 crude:1 firms:1 previous:2 strategist:1 announced:2 we:1 recently:1 2.9:1 whose:1 after-hours:2 confidence:1 stellar:1 reported:2 key:2 others:1 100:3 substantial:2 change:1 stage:1 roundup:1 hours:1 quarter:4 32:1 latest:1 allows:2 reports:4 plus:2 afternoon:1 rose:3 mixed:4 climb:2 better-than-expected:2 4.95:1 maker:2 comes:1 first:2 yearly:2 among:1 outlook:2 slipped:1 point:2 previously:1 offset:2 period:1 due:1 world’s:1 rising:4 raises:1 another:3 throughout:1 market:1 conference:1 decline:3 little:1 additional:1 second:1 major:1 housing:4 comments:1 negative:1 advisories:2 much:1 call:1 new-home:2 taken:1 's:9 gained:1 500:6 more:1 firm:1 flat:1 ``:3 releases:1 drugs:2 offered:2 1.9:1 8.25:1 part:1 gain:2 prices:1 longer-term:1 second-quarter:6 10:1 hearings:4 15:3 19:1 clients:1 batch:3 experimental:2 while:2 future:5 benchmarks:1 were:1 spotlight:4 unusual:2 biotech:1 climbed:1 sees:2 investors:1 health-care:1 share:2 sales:4 helped:3 bias:1 drug:6 if:1 sell:2 information:1 u.s:2 end:3 recovery:2 5.6:1 variety:1 generic:1 same:1 note:1 also:4 high:2 edge:3 earnings:19 largest:1 disappointing:2 company:2 stock:8 topping:2 analysts:2 edged:2 though:1 price:1 after:8 action:1 fell:6 stocks:11 data:4 recent:1 lower:5 off:1 charges:1 corporate:1 lift:1 futures:12 commodities:1 46:1 points:16 profits:2 comparisons:2 2009:9 consumer:1 paced:1 updates:1
stock_AMGN r_down	cancer:2 growth:1 lung:3 its:1 best:1 these:1 use:2 said:1 working:1 provide:1 genetic:1 factor:1 test:1 occurs:1 them:1 company:1 diagnostic:1 early:1 approved:1 10:1 15:1 --:1 tumors:1 drug:3 sensitive:1 patients:2 cancers:1 works:1 makes:1
stock_AMGN r_up	climate:1 months:1 legislation:1 ended:1 lobbying:1 boosted:1 amid:1 oil-and-gas:1 companies:1 three:1 their:1 flurry:1 30:1 action:1 during:1 health-care:1 makers:1 congressional:1
stock_AMGN r_up	results:3 month:2 7.5:1 integrity:1 children:3 adding:1 group:1 $:2 expectations:1 late:1 only:1 spread:2 denosumab:2 factor:1 fatal:1 risk:4 they:1 compound:2 lymphoma:2 disappointed:1 like:2 --:3 medicines:1 after-hours:1 popular:1 found:1 bone:3 because:1 warns:1 related:1 up:1 second:2 said:3 since:1 shares:1 increase:1 52-week:1 3:2 new:1 preserve:1 arthritis:1 ability:1 superior:1 reported:1 regulators:1 cancers:2 strong:1 last:1 33:1 study:3 drug:4 tumor:1 trial:1 positive:1 adolescents:3 late-stage:1 already:1 cancer:4 down:1 promise:1 use:2 additional:1 best-selling:1 there:2 been:1 touting:1 more:1 drugs:5 company:1 boxed:1 released:1 known:1 than:1 those:1 has:1 showed:1 developing:1 strongest:1 value:1 patients:1 complications:2 can:2 were:1 similar:2 could:1 1.6:1 associated:2 infections:1 high:2 warning:4 bones:1 blockbuster:1 increased:2 information:1 agency:1 preventing:2 other:2 pivotal:1 which:3 stock:1 added:1 's:12 warnings:2 after:1 blockers:1 but:1 data:1 class:1 ago:1 off:1 stronger:1 serious:1 starting:1 latest:1
stock_AMGN r_down	cancer:1 growth:1 its:2 remains:1 positive:1 next:1 denosumab:1 struggling:1 meeting:1 week:1 's:3 driver:1 but:1 reported:1 focused:1 regulatory:1 news:1 --:1 drug:2 future:1 experimental:1 bone:1
stock_AMGN r_up	proposed:2 soars:2 around:1 reducing:1 its:1 risk:3 said:2 positive:1 shares:1 increase:2 clinical:1 new:2 osteoporosis:2 type:2 fractures:1 flat:1 sinks:2 company:1 after:1 but:1 released:1 line:1 stocks:1 data:1 soared:1 increasing:1 mineral:1 effective:1 --:1 could:2 infections:2 drug:5 serious:2 studies:2 bone:1
stock_AMGN r_down	use:1 unanimously:1 treat:1 proposed:1 --:1 drug:1 women:1 denosumab:1 backed:1 osteoporosis:1 panel:1
stock_AMGN r_down	advisory:1 pointing:1 trade:2 session:2 shares:4 broader:2 follow:2 its:1 ground:2 whose:1 economists:1 candidate:1 headline:1 28:1 fared:1 94:1 add:1 production:1 denosumab:2 scheduled:1 inflation:1 lost:1 companies:1 lose:2 release:1 choppy:1 bone:1 set:1 actively:2 trading:1 index:3 said:1 broad:1 review:1 comments:1 enough:1 new:1 available:1 full:1 opening:1 a.m:1 reported:1 news:1 100:1 panel:1 ahead:1 disregard:1 according:1 drug:4 a.m.:2 analysts:1 published:1 slightly:1 experimental:1 industrial:1 slipped:1 point:1 down:2 market:3 1.2:1 expected:2 meeting:1 500:2 flat:2 ``:1 tandem:1 prices:1 analyst:1 10:1 n't:2 while:1 were:4 spotlight:1 biotech:1 slip:1 investors:1 soars:2 0.1:1 '':1 have:1 weaken:1 1:1 edge:1 survey:1 several:1 stock:2 's:3 track:1 price:2 await:1 stay:1 fell:1 stocks:6 data:2 lower:3 off:2 futures:4 well:1 points:5 south:2 consumer:2 latest:1
stock_AMGN r_down	biotech:1 because:1 limited:2 copies:1 topic:1 cost:1 have:1 close:1 struggles:1 market:2 their:3 generic:1 defend:1 biosimilars:1 able:1 complex:1 traction:1 may:2 hot:1 version:1 which:1 more:1 drugs:4 possible:1 but:1 biologic:2 effects:1 they:1 turf:1 exact:1 gained:1 reveal:1 --:1 hint:1 n't:2 savings:1 threat:1 worries:1 lucrative:1
stock_AMGN r_up	list:1 added:1 trading:1 its:1 short-term:1
stock_AMGN r_down	cancer:1 show:1 brought:1 paper:1 its:1 market:1 said:2 develop:1 working:1 no:1 spending:1 had:1 makers:1 appears:1 kidney:1 test:1 new:1 diabetes:1 more:1 's:1 company:1 diagnostic:2 effects:1 significant:1 services:1 data:1 than:1 anemia:2 --:1 medicines:1 companies:1 disease:1 drug:3 n't:2 trial:1 patients:1 accounted:1 2006:1
stock_AMGN r_up	biotech:4 annual:1 show:2 0.1:1 sales:2 slowing:2 helped:2 held:1 improvements:2 rising:2 dropped:1 2.2:1 rally:3 along:2 orders:2 adding:1 confidence:2 strong:2 group:1 lead:3 rose:2 point:1 3:1 shares:1 add:1 points:8 volatile:2 new-home:2 6:1 durable-goods:2 500:3 stock:2 available:1 north:1 around:1 may:2 highs:1 1.9:1 takeover:1 30:1 prices:1 nudge:2 100:2 stocks:2 data:3 2:1 lower:1 14:1 ahead:2 futures:6 up:1 while:2 fell:2 3.5:1 were:1 falls:2 speculation:1 higher:1 consumer:2 latest:1
stock_AMGN r_down	biotech:1 story:1 producer:1 also:1 generic:1 wins:3 allowed:1 28:1 identified:1 drug:2 loses:3 produced:1 drugs:1 finally:1 published:1 known:1 market:1 if:1
stock_AMGN r_up	blind:1 ``:1 get:1 media:1 over:1 use:1 there’s:1 month:1 '':1 excuse:1 worst:1 don’t:1 stocks:2 discussion:1 out:1
stock_AMGN r_down	biotech:1 soon:1 exclusivity:1 moves:1 market:2 if:1 medications:2 end:1 generic:1 finally:1 forward:1 plans:1 biologic:2 coming:2 come:1 endless:1 versions:2 could:1 days:1 biologics:1 allow:1 industry:1
stock_AMGN r_up	set:1 help:2 win:2 back:3 baskets:1 according:2 autumn:1 buy:2 through:1 determine:2 several:1 out:3 sell:2 resurgence:2 winter:2 should:3 health:2 buying:1 which:4 recommend:1 beating:2 might:4 happened:2 analysts:2 sold:1 team:1 broke:2 fall:1 authorities:2 stocks:5 those:2 task:1 look:2 flu:4 pandemic:2 experience:1 swine:2 lose:2 first:2
stock_AMGN r_up	biotech:1 fails:1 's:2 get:1 lift:1 much:1 favorable:1 piece:1 stock:1
stock_AMGN r_down	comment:2 appeals:3 injunction:3 some:3 held:3 infringes:3 drug:1 its:1 court:3 patent:3 investigational:1 permanent:3 treatment:3 ruled:3 announced:1 five-year:1 selling:3 's:3 drugs:1 lift:3 background:1 data:1 anemia:3 --:3 barring:3 n't:6 federal:3 promising:1 claims:3
stock_AMGN r_up	among:1 oncology:1 says:1 cancer:1 independent:1 rate:1 colon:1 its:1 conference:1 pharmaceutical:1 bottom:1 data:1 survival:1 minimal:1 division:1 's:3 company:1 key:1 line:1 weekend:1 impact:1 --:1 study:1 see:1 drug:1 patients:1 learn:1 starting:1
stock_AMGN r_up	sector:1 biotech:3 force:1 significant:1 sign:1 some:2 sales:2 one:1 product:1 hiring:1 have:2 year:2 seem:2 glance:1 market:4 wonder:2 index:2 stocks:4 recovery:1 would:1 indicate:1 efficient:1 generally:1 only:1 strategy:1 their:2 finally:4 treatment:1 which:1 expected:1 thriving:1 if:2 harrowing:2 recovered:5 more:1 such:1 's:1 gains:2 though:2 may:3 rebound:1 earlier:2 but:1 primary:1 tracks:1 osteoporosis:1 they:1 fall:2 not:1 downturn:1 broader:1 hold:2 flexible:1 cliff:2 also:1 regulatory:1 off:2 builds:1 ahead:1 launch:1 --:1 could:1 companies:1 've:1 mobile:1 approval:1 allow:1 climb:1 denosumab:1 care:1 first:1
stock_AMGN r_up	0.9:1 biotech:1 major:1 1.7:1 cancer:2 health-care:1 results:1 produced:1 including:1 skin:1 versus:1 multiple:1 surgery:1 suffer:1 giant:1 said:1 compression:1 rose:1 radiation:1 denosumab:1 statement:1 under:1 recent:1 events:1 treat:1 fractures:1 's:1 premarket:1 infusion:1 delayed:1 reported:1 breast:1 not:1 prostate:1 $:2 off:1 solid:1 study:1 months:2 myeloma:1 against:1 trial:1 patients:2 action:1 tumors:1 bone:3
stock_AMGN r_down	said:1 's:3 showed:1 cancer:1 people:1 positive:1 results:1 delayed:1 late-stage:1 better:1 trial:1 compared:1 treatment:1 denosumab:1 deterioration:1 latest:1 test:1 effectiveness:1 its:1 advanced:1 breast:1
stock_AMGN r_down	proved:1 investors:1 results:1 three:1 lived:2 colon:3 long:1 have:1 portfolio:2 earlier:1 longer:2 its:1 market:1 seemed:1 pharmaceutical:2 compared:2 cancer:4 their:1 rose:1 won’t:1 since:1 detail:1 been:2 shares:3 failed:1 rates:1 treatment:1 which:1 chemotherapy:2 improve:1 survival:1 sent:1 economy:1 independent:2 after:2 's:1 said:1 company:3 diversified:2 truly:1 most:1 feels:1 fell:1 key:1 half:1 stocks:2 data:1 day:1 standard:1 like:1 punctuate:2 remember:1 showed:3 --:2 study:4 months:2 up:1 drug:2 patients:3 3.5:1 so:1 afternoon:1 rollercoaster:1 published:1 added:1
stock_AMGN r_up	1.6:1 significantly:1 cancer:1 appeared:1 '':1 giant:1 compared:1 also:1 combined:1 statement:2 chemotherapy:1 treatment:1 ``:1 's:1 survival:1 reported:1 said:2 progress:1 alone:1 improved:1 months:1 median:1 trial:1 biotechnology:1
stock_AMGN r_up	gained:1 heavy:1 rumors:1 --:1 company:1 eyeing:1 volume:1 takeover:1 swirl:1 biotechnology:1 continued:1
stock_AMGN r_up	biotech:1 beneficial:1 cancer:1 supporting:1 companies:1 1.8:1 1.9:1 setback:2 ended:1 actively:1 promise:1 higher:1 its:2 whose:1 confirmed:1 painful:1 group:1 syndrome:1 1.3:1 stocks:1 payload:1 500:1 test:3 new:1 has:1 might:1 announced:1 accuracy:1 independent:1 's:1 company:1 after:1 but:1 prenatal:1 sting:1 hold:1 data:1 plunged:1 up:3 bee:1 session:1 can:1 shares:1 after-hours:1 trading:1 plunges:2 investigators:1
stock_AMGN r_down	drugs:1 biotech:1 generic:1 regardless:1 provides:1 --:1 into:1 legislation:1 expects:1 experience:1 whether:1 benefit:1 planned:1 entering:1 path:1 entry:1 biosimilar:1 its:1 market:1
stock_AMGN r_down	likes:1
stock_AMGN r_up	control:1 biotech:1 months:1 revenue:1 expenses:1 ended:1 growth:1 makers:1 takes:1 three:1 earnings:1 expected:1 economy:1 hit:1 report:1 many:1 30:1 companies:1 drug:1 large:1 while:1 continue:1
stock_AMGN r_up	over:1 focus:2 years:1 its:3 ground:1 giant:1 upgrade:1 $:5 rose:1 should:1 denosumab:2 premarket:1 2013:1 results:1 early:1 updates:1 sank:1 view:1 profile:1 lifted:1 right:1 our:1 2.5:1 total:1 sentiment:1 shares:3 osteoporosis:1 we:2 sinks:2 broker:1 sink:1 approval:1 estimate:1 ahead:1 launch:2 drug:2 action:2 climb:3 slightly:1 upgraded:1 61:1 63:1 respect:1 writing:1 market:1 stocks:4 next:1 clinical:2 today:1 treatment:2 ``:4 buy:1 releases:1 company:2 serve:1 released:1 neutral:1 lift:1 catalyst:1 highest:1 analyst:1 helped:1 target:1 cap:1 up:3 while:1 pending:1 revenues:1 1.3:1 '':4 earnings:1 which:1 several:1 stock:1 worldwide:1 product:1 's:2 price:1 after:2 mixed:2 said:1 70:1 wave:1 data:2 recent:1 billion:2 futures:1 biotechnology:1 model:1 gain:1
stock_AMGN r_up	biotech:1 because:1 want:1 investors:1 game-changer:1 years:1 expect:1 have:1 osteoporosis:1 record:1 analyze:1 decision:1 had:1 three:1 deadlines:1 day:1 potential:1 safety:1 denosumab:2 possibly:1 expected:1 new:1 gets:1 more:1 's:3 missing:1 may:2 company:1 notable:1 delayed:1 but:1 like:1 most:1 they:1 approved:1 wait:1 has:1 longer:1 launch:1 --:1 many:1 industry:1 months:1 drug:2 19:1 time:1 history:1
stock_AMGN r_down	decides:1 eye:1 whether:1 company:1 kept:1 's:1 traders:1 drug:1 close:1 approve:1 osteoporosis:1
stock_AMGN r_down	executive:1 session:1 including:1 questions:1 its:5 osteoporosis:4 whose:1 treatment:3 updated:1 gains:2 background:2 not:2 term:1 --:3 companies:1 six-month:1 slide:2 lose:1 denosumab:4 respond:1 because:1 says:1 actively:1 trading:1 year:1 said:1 adds:1 decision:3 crucial:1 4:1 shares:2 research:1 3:1 provides:1 new:1 ground:1 sliding:1 seeks:3 supporting:1 step:1 although:1 meet:1 approval:4 received:1 drug:4 prior:1 mixed:1 requests:2 approve:1 maker:2 comment:2 unclear:1 down:1 throughout:1 long:1 next:1 statement:1 until:2 500:1 more:4 ``:1 complete:1 company:4 delayed:2 but:2 gain:1 analyst:1 whether:1 up:1 near:1 were:1 making:1 biotech:1 delaying:1 two-month:1 '':1 10,000:1 seen:1 occur:1 information:4 end:1 agency:2 able:1 application:1 take:1 answer:1 stock:2 development:1 's:3 plans:1 though:1 may:1 price:2 after:1 letter:1 president:1 stocks:2 response:1 recent:1 vice:1 considered:1 points:2 ultimate:1 requires:1 review:1
stock_AMGN r_down	focus:2 shares:1 trade:1 active:1 see:1 session:1 expected:1 those:1
stock_AMGN r_up	saying:1 outlook:3 tumble:1 marketplace:1 quarters:1 disappointing:1 trading:1 issues:1 points:3 disappoints:2 92:1 surprises:2 shares:4 late:1 advisories:2 earnings:1 closed:1 online:1 8:1 falling:1 sliding:1 500:1 gives:1 earlier:1 gains:1 whose:1 after:1 13:1 nearly:1 downturn:1 active:1 stocks:1 declining:1 roundup:1 10:1 lower:1 drop:2 companies:2 up:1 reports:1 future:1 corporate:1 late-day:1 latest:1
stock_AMGN r_down	sector:1 proposed:1 over:1 top:1 results:3 trade:1 6.5:1 session:1 comments:1 cuts:3 its:8 24:9 whose:1 wraps:1 $:3 rose:1 revenue:3 expectations:5 concerns:1 denosumab:1 turnaround:1 details:1 modestly:1 around:1 beat:1 big:1 rise:2 focus:3 report:1 day:3 easily:2 clouds:2 impressive:1 --:2 57:1 companies:1 taxes:1 morning:1 slide:1 late-session:1 gears:2 after-hours:1 higher:3 bone:1 prompted:2 back:2 surrounding:1 see:1 cost:2 third-quarter:4 margins:1 2.7:1 declined:2 blue:1 said:1 profit:3 jumped:1 shares:3 forecast:1 does:1 health:2 closed:1 beating:2 recently:1 attention:1 broker:1 reported:2 members:1 downgrade:1 news:2 100:1 strong:4 sending:1 prospects:1 shift:2 reports:2 remains:1 products:2 analysts:1 other:1 experimental:1 major:2 point:1 negative:1 active:1 another:1 open:1 raise:2 spending:1 caught:1 due:1 expected:1 territory:1 500:2 more:1 wants:1 flat:1 spiral:1 company:3 lows:1 doubts:1 line:1 analyst:1 14:1 likely:1 n't:1 information:1 while:1 projections:2 weaker:1 investors:1 chip:1 share:1 sales:2 expenses:1 helped:1 full-year:1 drug:6 slip:2 rally:1 1:1 gains:1 again:3 end:1 weakened:1 treatment:1 delay:4 also:1 potential:1 earnings:10 swirl:1 performance:1 outlook:1 pan:1 stock:5 's:6 dime:1 boosted:1 price:2 after:2 falls:2 reflect:1 most:3 flurry:1 fell:3 driven:2 stocks:3 lower:3 deluge:2 amid:1 futures:6 maker:3 points:3 affirmed:1 time:1 banks:1 2009:2 profits:1
stock_AMGN r_down	's:1 than:1 reports:1 surge:1 helped:1 points:1 earnings:1 another:1 10000:2 100:1 more:1 round:1 paced:1 better-than-expected:1
stock_AMGN r_down	major:1 slipped:2 1.3:1 0.2:1 0.6:1 down:1 132:1 16:1 actively:3 trading:4 makers:1 declined:1 points:12 whose:4 giant:1 $:1 animal:1 rose:5 45:1 third-quarter:2 shares:4 its:1 lost:1 2:1 5:1 earnings:2 interest:1 several:1 500:4 more:1 11:1 health-care:1 's:6 increased:2 pharmaceutical:2 company:1 after:1 4.7:1 after-hour:1 early:1 released:1 fell:1 active:1 93:1 stocks:5 than:1 gained:2 10:1 14:1 tripled:1 reported:1 climbed:2 companies:4 sale:1 reports:1 session:3 due:1 were:3 mixed:3
stock_AMGN r_down	sees:1 bears:1 correction:1 bulls:1 melt-up:1 's:1 now:1 quality:1 called:1 painful:1
stock_AMGN r_down	doctors:2 states:4 anemia-drug:2 provided:2 headline:1 had:1 p.m.:1 retreats:2 source:1 citing:1 other:2 statement:1 suit:2 ``:1 sued:2 's:1 incentives:2 prescribe:2 reported:1 filed:2 '':1 15:2 14:2 alleging:2 published:1
stock_AMGN r_down	15:1 behind:1 drop:1 's:2 recent:1
stock_AMGN r_up	biotech:1 help:1 cancer:2 over:1 some:1 sales:1 have:1 its:1 data:1 initial:1 fears:1 shares:1 failed:1 treatment:1 snags:1 taken:1 weeks:1 beating:1 advanced:1 stock:1 regain:1 faced:1 's:3 survival:1 overall:1 but:2 anticipated:1 regulatory:1 news:1 believe:1 investor:2 retreat:2 recent:1 case:2 --:1 boost:1 study:1 drug:2 improve:1 patients:1 overreaction:2 status:1 can:1 could:1 investors’:1
stock_AMGN r_up	paying:2 pouring:2 right:2 's:2 investors:2 biotech:2 into:2 offer:2 results:2 stocks:2 high:2 mixed:2 bad:2 prices:2 news:2 firms:2 now:2 writes:2 best:2
stock_AMGN r_down	strong:1 biotech:2 major:1 because:1 1.2:2 ...:1 cents:1 topping:1 back:2 36:1 '':1 cost:1 another:1 cuts:1 its:5 market:1 24:1 11:1 giant:1 said:2 group:1 $:12 profit:1 jumped:1 zigzags:2 third-quarter:1 shares:2 1:1 add:1 much:1 5:3 authorized:1 premarket:1 under:1 has:2 remaining:1 authorization:1 stock:6 modestly:1 ``:1 buy:2 's:6 announcement:1 company:3 rise:3 confidence:1 zigzag:1 sales:1 helping:1 long-term:1 buyback:3 repurchase:2 news:1 stocks:3 expectations:1 additional:1 billion:6 easily:1 prospects:1 off:1 most:1 up:2 57:1 board:1 value:1 morning:1 n't:1 prior:1 products:1 amid:1 following:1 biotechnology:1 existing:1 plan:1
stock_AMGN r_up	quick:1 roundup:1 some:1 's:1 news:1
stock_AMGN r_up	cancer:1 tests:1 said:1 multiple:1 risk:1 showed:1 developing:1 related:1 advanced:1 23:1 drug:1 reduced:1 patients:1 compared:1 denosumab:1 events:1 's:1 its:1 bone:1 breast:1
stock_AMGN r_down	exclusive:1 global:1 session:4 whose:3 20:1 $:1 eligible:1 program:1 4:2 policy:1 11:1 get:1 big:1 early:1 milestone:1 day:1 companies:4 payments:1 deal:2 rate:1 actively:4 trading:4 's:2 declined:3 2.4:1 giving:1 jumped:1 assistance:1 shares:4 closed:1 falling:2 sliding:2 announced:1 million:1 notable:1 upfront:1 losing:1 declining:2 stage:1 last:1 climbed:1 trial:1 mixed:1 traded:1 among:1 60:1 market:1 would:1 due:1 2:3 interest:1 6:1 biggest:2 500:4 treatment:1 company:1 strike:1 deliberations:1 rights:2 18:1 up:1 were:1 making:1 glucose:1 spotlight:1 1.3:1 dropped:2 moves:1 49:1 government:1 40:1 other:1 becoming:1 stock:2 gaining:2 begin:1 edged:1 after:2 includes:1 fell:2 stocks:7 diabetes:1 lower:3 futures:1 repay:1 points:12 banks:1 oral:1
stock_AMGN r_down	gaining:2 whose:1 moves:1 's:3 notable:1 companies:1 some:1 shares:1 market:1 biggest:2 making:1 stocks:2 declining:2 stock:1
stock_AMGN r_up	biotech:1 all:1 consider:1 formerly:1 betting:1 states:1 single:1 prostate-cancer:1 its:2 if:1 late:1 given:1 said:3 additional:1 candidate:1 osteoporosis:1 positive:1 member:1 clinical:1 denosumab:1 before:1 has:1 authorization:2 treatment:1 requested:1 's:2 marketing:2 giant:1 approving:1 known:1 approved:1 loss:1 would:1 receive:1 drug:3 patients:1 future:1 trials:1 opinion:1 bone:2
stock_AMGN r_up	major:2 there:1 's:1 deal:2 --:1 becomes:2 health-care:2 seems:1 player:2 another:1 oracle:1
stock_AMGN r_up	aided:1 cents:1 session:1 its:1 developer:1 given:1 $:1 candidate:1 rose:1 aftermarket:1 comments:1 also:1 which:1 6:2 falling:1 has:1 today:1 stock:1 ...:1 gains:1 possible:1 regular:1 during:1 analyst:1 54:1 up:1 drug:1 acquisition:1
stock_AMGN r_up	sector:2 investors:2 injunction:1 focus:2 36:1 helped:2 infringes:1 economic:2 trading:2 drug:2 tallying:2 market:2 points:6 4.5:1 said:1 adds:1 23:1 provide:2 positive:2 support:2 there:1 materials:2 preventing:1 few:1 potential:2 stock:2 fourth:2 expected:2 8:1 entered:1 anemia:1 markets:2 500:2 more:2 rise:2 's:1 gains:4 million:2 here:1 permanent:1 court:1 key:2 report:2 4.1:1 100:2 stocks:2 data:2 day:2 those:2 ruled:1 gained:2 medicine:1 third:2 straight:2 futures:2 stronger:2 up:5 pacing:2 maker:1 selling:1 while:2 session:2 5.4:1 were:6 overseas:2 higher:2 its:1 housing:2 patents:1
stock_AMGN r_down	advisory:2 key:1 doses:2 focus:2 trade:1 chronic:2 see:1 session:1 comments:1 another:2 year:2 patient:2 kidney:2 might:2 25:3 use:2 said:4 monitoring:2 top:2 agency:2 shares:1 also:2 26:3 convene:2 expected:2 new:1 improve:2 meeting:2 store:1 more:2 division:2 's:5 though:1 drugs:3 sixth:1 online:2 reach:1 evaluation:2 regulators:1 compared:1 blood:2 they:2 active:1 article:2 outcomes:2 approved:1 those:1 panel:2 treating:2 lower:2 several:1 were:1 shelves:1 --:3 similar:2 medicines:1 disease:2 drug:2 n't:1 did:1 patients:2 officials:4 products:2 planned:2 published:2 2008:3 2009:3 starting:1 frequent:2
stock_AMGN r_down	slips:2 's:1 look:1 woes:2 drugs:1 two:1 safety:1 mixed:2 stocks:2
stock_AMGN r_down	'':2 its:2 previous:2 information:1 said:1 end:1 $:10 headline:1 guidance:1 submit:1 p.m.:1 also:1 version:1 low:1 correct:1 announced:1 earnings:1 ``:2 's:2 plans:1 views:1 very:1 company:1 reported:1 response:1 additional:1 short:1 standalone:1 --:1 follows:1 request:1 drug:1 a.m.:1 bone:1 published:1 2009:6 4.95:3 order:1 experimental:1
stock_AMGN r_up	saying:1 supply:1 quarters:1 year:2 its:1 no:1 surprises:3 make:1 there:1 shocked:1 advisories:2 clinical:1 treatment:1 which:1 earnings:1 wants:1 sure:1 company:1 upon:1 regulatory:1 approval:1 now:1 come:1 roundup:1 lupus:1 last:1 success:1 --:1 could:1 later:1 companies:1 reports:1 future:1 providing:1 corporate:1 experimental:1 latest:1
stock_AMGN r_down	sure:2 advantage:1 scammers:3 federal:1 seeking:1 government:1 anxious:1 warning:1 relief:3 not:2 you:2 donate:3 effort:1 take:1
stock_AMGN r_up	sector:2 biotech:1 smaller:1 health-care:1 likely:1 pharmaceutical:1 get:1 predictions:1 opportunities:1 writing:1 access:1 instead:1 checks:1 huge:1 drugs:1 brings:1 but:1 stay:1 focused:1 acquisitions:1 cautious:1 --:1 companies:1 large:1 remain:1 usual:1
stock_AMGN r_down	biotech:1 fourth-quarter:1 health-care:1 say:1 growth:1 projections:1 further:1 aggressive:1 should:1 makers:1 management:1 group:1 reform:1 provide:1 guidance:1 there:1 conservative:1 few:1 encourage:1 earnings:1 might:1 2010:1 around:1 may:1 incentives:1 early:2 report:1 strong:1 analyst:1 cautious:1 uncertainty:1 drug:1 teams:1 large:1 so:1
stock_AMGN r_down	whose:1 companies:1 focus:2 shares:1 active:1 see:1 trading:1 expected:1
stock_AMGN r_down	fourth-quarter:1 rebounded:1 says:1 billion:2 revenue:1 cents:1 best:1 estimates:2 sales:3 ninth:1 disappointing:1 including:1 drug:2 reports:1 substantially:1 its:2 declined:1 osteoporosis:1 information:1 giant:1 said:2 $:4 3.85:1 profit:3 data:1 agency:1 had:1 mixed:1 comments:1 should:1 1:1 also:1 clinical:1 5:1 denosumab:1 which:1 income:1 chemotherapy:1 net:1 sluggish:3 2010:1 3.8:1 stock:1 requested:1 analysts:1 's:1 sinks:2 opportunities:1 announcement:1 share:1 company:2 after:2 but:1 hours:1 reported:1 sink:1 ...:1 trading:1 early:1 stocks:3 beginning:1 grow:1 missed:1 buybacks:1 both:1 short:1 1.05:1 candidate:1 --:1 shy:1 drop:1 well:1 submitted:1 provide:1 while:1 bone:1 shares:1 following:1 rising:1 per:1 approve:1 mid-stage:1 experimental:1
stock_AMGN r_up	saying:1 over:2 focus:3 quarters:1 session:1 higher:3 its:4 osteoporosis:2 giant:1 $:3 lackluster:1 surprises:2 had:2 expectations:2 should:2 16.6:1 only:1 advisories:2 denosumab:2 2010:2 ...:1 big:1 slate:2 income:2 world:4 trade:1 regarding:1 --:2 shy:1 companies:1 morning:1 worries:2 economy:2 bone:2 posts:1 see:1 growth:3 year:1 substantially:2 close:1 declined:2 said:5 profit:7 once-hot:1 shares:1 forecast:1 increase:1 health:2 above:1 net:2 sluggish:1 slight:1 reported:6 step:1 key:3 active:1 article:1 roundup:1 both:2 pipeline:1 ahead:1 getting:2 regulators:1 drug:5 products:1 analysts:1 rose:2 approve:2 experimental:2 fourth-quarter:5 revenue:4 down:1 61:1 market:2 additional:1 remains:1 due:3 approved:1 expected:1 billion:2 mostly:1 company:3 but:4 those:1 submitted:3 future:2 limit:2 were:1 published:1 biotech:1 weaker:1 cents:1 sales:2 disappointing:2 reports:3 moves:2 information:2 agency:2 1:1 also:3 earnings:5 which:2 largest:2 9:1 performance:1 stock:2 requested:3 's:9 after:2 forecasts:1 fell:2 such:1 data:1 grow:2 fiscal:2 short:1 third:2 largely:1 slightly:4 futures:2 corporate:1 profits:1 latest:1
stock_AMGN r_up	'10:1 's:1 increased:1 area:1 --:1 companies:1 could:1 bottom:1 lines:1 agreement:1 signed:1 treatments:1 drug:1 treatment:1 faces:1 such:1 promote:1 competition:1 help:1
stock_AMGN r_up	sell:1 customers:1 cautious:1 selective:1 season:1 showing:1 despite:1 companies:1 results:1 sign:1 improving:1 remain:1 other:1 businesses:1 earnings:1 many:1 mixed:1 economy:1
stock_AMGN r_down	months:1 financial:1 1.1:1 predicting:1 people:1 caused:1 share:1 trading:1 dropped:1 market:1 said:1 $:1 driving:1 six:1 had:1 three:1 shares:3 also:1 6:1 performance:1 sluggish:1 company:1 congressional:1 stock:1 buy:1 's:3 cars:1 advice:1 were:1 stop:1 neutral:1 fell:2 advised:1 along:1 stocks:1 downgraded:1 he:2 lower:1 --:1 involved:1 could:1 drop:1 recall:1 testimony:1 steep:1
stock_AMGN r_down	sector:1 activists:1 's:1 like:1 increasingly:1 --:1 industry:1 under:1 companies:1 sign:1 traditional:1 maturity:1 microscope:1 shareholder:1 act:1 want:1 coming:1 businesses:1 more:1
stock_AMGN r_down	chances:1 over:1 four:1 bring:1 its:2 osteoporosis:1 whose:1 27:1 $:2 rose:5 groundwork:1 denosumab:2 government:1 continues:2 early:4 increases:1 report:1 continued:1 secondary:1 59:1 success:1 --:1 dig:2 laying:1 depositary:1 after-hours:1 worries:1 tightening:1 stock:4 bone:3 prevent:1 companies:1 sub-10,000:2 actively:1 trading:2 year:1 close:2 2.7:1 out:2 even:1 said:1 federal:2 since:4 remain:2 shares:3 health:1 closed:2 falling:2 agencies:2 drug:4 regulatory:1 approval:1 100:1 gained:1 last:1 recovering:4 met:1 region:2 35:1 credit:1 traded:1 experimental:2 first:4 cancer:1 point:1 primary:1 market:1 industrials:1 area:2 three:1 mark:4 clinical:1 storm:2 patients:1 500:3 sessions:1 finished:4 goals:1 14:1 pitting:1 finances:1 below:4 complications:1 were:3 0.9:1 biotech:1 slid:1 later:1 10000:3 156:1 well:1 0.2:1 against:1 weighed:1 10,000:1 dropped:1 recover:2 5.7:1 trials:1 snow:2 same:1 while:1 1:1 awaits:1 higher:1 begin:1 added:1 's:5 after:6 helping:1 stocks:2 weekend:2 third:2 futures:8 stronger:4 points:5 time:5
stock_AMGN r_down	upbeat:1 now:1
stock_AMGN r_up	information:1 used:2 additional:1 cancer:2 --:2 treat:2 undergoing:2 companies:2 said:2 drugs:2 patients:2 involving:2 plan:2 fourth:1 chemotherapy:2 new:2 anemia:2 starting:1 approved:2 unit:2 risk:2
stock_AMGN r_down	among:2 associated:2 less:1 year:1 elderly:1 likely:1 pass:1 says:1 use:1 death:2 dialysis:1 patients:2 new:1 higher:1 risk:2 drugs:1 but:1 nothing:1 meaningful:1 anemia:3 lower:1 --:1 study:1 according:1 severe:2 iron:1 were:2
stock_AMGN r_up	seem:1 compared:1 says:1 500:1 shares:1
stock_AMGN r_up	managers:1 deal:1 borrowing:1 through:1 +80:2 appetite:1 rated:1 $:5 lead:1 two:1 1:1 parts:1 take:1 new:1 low:1 advantage:1 bonds:1 familiar:1 offered:1 after:1 priced:1 they:1 debt:1 investor:1 day:1 billion:3 12:2 follows:1 companies:1 according:1 person:1 costs:1 were:1
stock_AMGN r_up	among:1 highly:1 offerings:1 manager:1 investment-grade:1 provided:1 rated:1 based:1 $:1 bonds:1 capital:1 new:1 firms:1 stage:1 markets:2 more:1 terms:1 information:1 offered:1 took:1 issuance:1 syndicate:1 robust:1 than:1 recent:1 billion:1 12:1 center:1 --:1 companies:1 credit:1 were:1 following:1 corporate:1 round:1
stock_AMGN r_down	most:1 says:1 risk:1
stock_AMGN r_up	sector:1 tracking:2 overhaul:2 controversial:1 industry:1 funds:2 approves:1 health-care:3 dramatically:1 vote:2 see:2 exchange-traded:1 bill:2 best-performing:1 action:2 got:1 stocks:2 boost:1 approved:1 after:4
stock_AMGN r_down	shareholders:3 rewards:2 return:1 40:1 announces:1 income:1 cash:1 new:1 35:1 part:1 plan:1 pay:1 dividend:3 net:1 ever:1 its:2 first:3
stock_AMGN r_down	biotech:1 1.7:1 growth:1 year:1 total:2 its:1 market:1 giant:1 $:7 4.2:1 rose:1 incentive:1 denosumab:1 3.8:1 stock:1 salary:1 's:1 option:1 million:5 4.7:1 includes:1 focused:1 plan:1 11:3 15.3:1 last:1 getting:1 package:1 compensation:3 future:1 awards:2 2009:2
stock_AMGN r_up	large:1 because:1 longer:1 no:1 --:1 deals:1 company:1 within:1 looking:1 diagnostics:1 ready:1 expand:1 he:1
stock_AMGN r_down	biotech:1 tough:1 key:1 companies:1 results:1 year:1 's:1 should:1 makers:1 next:1 expected:2 easier:1 week:1 begin:1 first-quarter:1 benefiting:1 price:1 reporting:1 period:1 increases:1 year-over-year:1 last:1 many:1 stronger:1 drug:1 face:1 large:1 continue:1 products:1 comparisons:1
stock_AMGN r_down	saying:1 sales:3 quarters:1 see:1 session:1 first-quarter:1 its:1 whose:1 profit:3 surprises:2 due:1 shares:1 advisories:2 earnings:1 expected:1 boost:2 's:2 increased:1 drugs:1 focus:2 active:1 trade:1 roundup:1 largely:1 larger:1 companies:2 reports:2 future:1 corporate:1 latest:1
stock_AMGN r_down	whose:1 companies:1 focus:2 shares:1 trade:1 active:1 see:1 session:1 expected:1
stock_AMGN r_up	all:1 over:1 results:4 years:1 bring:2 revision:1 its:5 previous:3 impact:1 whose:1 giant:2 overhaul:2 $:4 flood:1 rose:4 had:1 expectations:1 denosumab:1 2010:8 details:2 anticipated:1 preparing:1 fallout:2 anemia:1 --:4 warned:2 companies:1 after-hours:1 economy:1 bone:1 financial:1 requested:1 estimates:2 see:1 actively:1 trading:1 further:1 declined:1 blue:1 said:2 missed:1 reform:2 profit:2 marketed:1 while:1 shares:1 forecast:1 state:1 boost:1 recently:1 million:2 reported:2 key:1 repurchase:1 news:1 first-quarter:4 gained:1 projected:1 quarter:1 benefits:1 getting:1 annual:1 drug:2 mixed:1 maker:1 comes:1 comment:2 cancer:1 revenue:1 down:1 likes:1 another:1 250:1 market:1 additional:2 would:2 per-share:1 few:1 much:1 stock:1 6:1 500:1 more:1 drugs:2 reduce:1 company:2 but:2 analyst:1 15:9 14:1 submitted:1 patients:2 were:2 biotech:2 1.6:1 1.7:1 investors:1 chip:1 health-care:4 share:1 sales:1 helped:1 warning:1 unlikely:1 information:1 end:3 1:1 also:2 earnings:2 higher:1 200:1 's:3 after:2 includes:1 fell:1 coverage:1 such:1 stocks:1 billion:1 lower:3 futures:1 well:1 points:2
stock_AMGN r_down	benefited:1 focus:2 trade:1 see:1 session:1 committee:1 investment:1 market:1 whose:1 housing:1 shares:1 their:1 expected:1 stock:1 's:1 collapse:1 drift:1 questioning:1 active:1 continued:1 bank:1 futures:1 companies:1 faces:1 spotlight:1
stock_AMGN r_up	pharmaceutical:1 improved:1 versions:1 drugs:1 big:1 becoming:1 developing:1 aim:1 industry:1 biotech:1 take:1 biotechnology:1 maker:1 latest:1
stock_AMGN r_up	emerging:2 least:1 investors:1 clinical:1 37:1 testing:1 expects:1 now:1 down:1 ended:2 actively:1 rising:1 biologics:1 file:3 year:3 its:3 3.9:1 index:2 said:3 2012:1 $:2 review:1 comments:1 two:1 shares:2 research:1 1:1 field:2 points:2 economy:1 under:1 late:1 new:3 falling:1 has:3 biologic:3 company:2 500:1 stock:1 development:3 executives:2 's:2 plans:3 touted:1 whose:1 analysts:1 price:1 were:2 but:3 applications:3 takeover:1 five:4 plan:1 follow-on:3 stocks:1 stab:2 analyst:1 recent:1 billion:1 reaction:1 pipeline:1 off:1 four:1 newly:1 --:2 meeting:1 study:1 companies:1 drug:7 maker:1 project:1 adding:1 scrapping:1 session:1 risks:2 after-hours:1 mixed:1 trading:2 stages:1 other:1 first:2
stock_AMGN r_up	development:1 product:1 's:1 developing:1 --:1 boosted:1 company:1 discontinue:1 treatment:1 shares:1 plan:1 small:1 biotechnology:1 similar:1 anemia:1
stock_AMGN r_up	futures:6 point:2 series:2 over:3 successfully:2 retailer:1 held:1 6.5:1 growth:2 's:1 home-improvement:1 market:3 ground:2 24:1 5.1:2 giant:2 stocks:2 much:2 4.2:1 rose:4 tube:2 able:2 traders:1 concerns:2 earnings:1 financials:2 7:1 into:2 500:2 stock:2 tumbled:2 oil:4 edged:1 releases:2 very:2 hang:1 after:2 leaking:2 but:2 wave:1 broken:2 fell:1 half:1 100:2 debt:2 continued:1 advanced:2 gained:2 insert:2 ahead:2 --:4 climbed:3 steady:1 pipe:2 points:4 economic:2 were:2 worries:2 tightening:2 higher:1 mergers:1
stock_AMGN r_down	among:2 cancer:2 investors:2 makers:1 conference:2 information:1 additional:1 more:2 4,000:2 released:3 moving:2 key:2 beginning:1 than:2 ahead:2 --:2 study:2 companies:1 drug:1 were:2 biotechnology:1 16th:1
stock_AMGN r_down	copycat:1 arthritis:1 's:2 cancer:1 --:1 sold:1 testing:1 drug:1 version:1 begun:1 has:1 rheumatoid:1
stock_AMGN r_down	cancer:1 developed:1 within:1 60:1 its:1 market:1 before:3 index:2 two:1 indexes:1 comparing:1 treat:1 international:1 biosimilar:1 day:1 stock:1 arthritis:1 kinds:1 company:1 rise:3 stocks:3 approved:1 last:1 country:1 drug:1 trial:1 patients:1 rheumatoid:1
stock_AMGN r_down	money:1 health-care:1 actively:1 trading:1 dropped:1 partner:1 blockbuster:1 declined:1 osteoporosis:1 whose:1 said:1 overhaul:1 $:2 44:1 shares:1 points:3 5:1 's:3 500:1 more:1 worldwide:1 product:1 recently:1 marketing:1 13:1 fell:1 premature:1 approval:2 stocks:1 potential:1 treating:1 lower:1 consequences:1 --:1 bill:1 companies:1 disease:1 drug:2 session:1 bone:3 obesity:1 scans:1 traded:1 granted:1 experimental:1 first:1
stock_AMGN r_up	sector:1 all:1 global:1 session:1 osteoporosis:4 rundown:1 whose:1 26:1 pharma:1 rose:2 potential:1 loophole:1 gains:1 broadly:1 overdone:1 early:1 stays:1 unique:1 projects:1 treating:1 tobacco:1 --:2 companies:2 bone:2 worldwide:1 declines:1 energy:1 116:1 trading:1 year:1 recently:1 2.6:2 declined:1 said:1 gainers:1 decision:2 outpacing:1 shares:3 research:1 surprise:2 led:1 reaching:1 marketing:1 key:1 approval:4 declining:2 $:1 received:2 months:2 drug:3 traded:1 comes:2 first:1 comment:1 major:1 downside:1 market:1 industrials:1 hospital:1 two:2 their:1 2:1 treat:2 biggest:2 500:1 more:1 both:1 company:1 expected:2 gain:2 than:3 women:2 13:1 growth:1 benchmarks:1 plunges:2 biotech:1 investors:1 almost:2 tax:1 sales:1 tag:1 dropped:1 partner:1 seen:1 blockbuster:1 viewed:1 granted:1 shorter:1 maintain:1 stock:1 gaining:2 product:1 's:12 price:1 earlier:2 fell:1 actively:1 such:1 stocks:4 recent:1 billion:1 lower:1 disease:1 daily:1 points:3 experimental:1 decliners:1 prevention:1
stock_AMGN r_down	1.6:2 1.7:1 financial:1 1.3:2 energy:1 moved:1 economies:1 helped:1 session:2 trading:2 measure:1 led:1 gains:1 whose:2 strong:1 actively:2 46:1 rose:3 selloff:1 shares:2 late:1 also:1 2:1 500:2 higher:3 's:4 increased:1 0.5:1 lift:1 stocks:3 concerns:1 jump:1 sectors:1 19:1 climbed:2 companies:2 up:2 morning:1 while:1 points:3 were:2 following:1 easing:1 overseas:1
stock_AMGN r_down	rating:1 oncology:1 help:1 global:1 results:1 trade:1 6.6:1 session:2 its:3 osteoporosis:2 adding:1 upgrade:1 group:1 $:1 rose:4 had:1 program:1 hit:2 risk:1 survival:4 overall:2 were:1 nearly:1 report:1 awaiting:1 --:2 vibrant:1 companies:2 53:1 activity:1 small:1 found:1 stock:1 upward:1 lifted:1 significantly:1 tepid:1 energy:1 crushing:1 some:1 growth:3 trading:1 112:1 2.3:1 operation:1 employment:1 2.6:2 out:1 said:2 decision:1 shares:1 research:1 3:1 closed:1 medicine:1 new:1 increasing:1 jobs:1 whose:1 after-hours:1 stem:1 pressure:1 key:1 alone:1 approval:3 100:1 likelihood:1 received:1 prospects:1 choppy:1 improved:1 most:1 country:2 could:1 months:4 according:1 drug:3 creates:1 improves:1 figures:1 analysts:1 published:1 antibody:1 maker:1 comes:1 outlook:1 cancer:3 near-term:1 one:2 looms:1 article:1 pharmaceutical:1 use:1 major:1 monthly:1 positive:1 three:2 treat:1 expected:1 chemotherapy:2 meeting:1 500:2 fiscal:1 head:1 company:1 pancreatic:1 oil:1 sales:2 released:1 prices:1 longer-term:1 squeeze:1 than:1 women:1 grew:1 showed:1 markets:1 spill:1 patients:1 actively:1 benchmarks:1 promising:1 following:1 study:3 strengthens:1 annual:1 almost:1 ``:4 '':4 say:1 climbed:1 bones:1 seen:1 counting:1 car:1 compared:1 six:1 other:1 higher:1 added:1 's:14 plans:1 earlier:1 treatments:1 director:1 extending:1 two:1 retreating:1 stocks:2 approved:1 billion:1 lower:2 revive:1 sectors:1 failure:1 traded:1 medical:1 futures:3 points:4 push:1
stock_AMGN r_down	week:1 cancer:5 certain:4 delaying:1 reduce:1 added:2 colon:4 another:1 fail:2 after:2 osteoporosis:2 shown:1 group:4 just:1 marketed:2 approved:4 better:1 other:1 treat:3 finding:2 clinical:2 events:1 fractures:2 earlier:1 's:4 risk:1 extend:2 drugs:2 survival:2 men:1 treatments:2 involving:2 background:1 chemotherapy:4 article:2 prostate:1 than:1 advanced:1 women:2 surprising:2 showed:2 --:3 study:2 drug:5 n't:2 did:2 patients:4 published:2 called:2 researchers:2
stock_AMGN r_up	down:1 year:1 bones:1 watchdog:1 protein:1 regulate:1 its:1 increased:1 given:1 generic:1 due:1 targets:1 also:1 recommended:1 treat:1 which:1 newly:1 osteoporosis:1 denosumab:1 fractures:1 's:4 risk:1 helps:1 break:1 known:1 injection:1 cost-effectiveness:1 women:1 name:1 --:1 cells:1 drug:1 face:1 twice:1 bone:1 healthcare:1 called:2 launched:1
stock_AMGN r_up	1.1:1 moved:1 actively:2 trading:2 66:1 whose:2 rose:1 shares:2 1:2 points:3 5:2 500:2 higher:2 's:2 climbing:1 stocks:2 ahead:1 climbed:1 companies:2 up:2 session:2 traded:2
stock_AMGN r_down	actively:1 whose:1 lower:1 's:1 session:1 companies:1 shares:1 fell:2 trading:1 dropped:1 closed:1 after-hours:1 stocks:1 500:1 points:3
stock_AMGN r_up	biotech:1 such:1 handful:1 matter:1 auction:1 familiar:1 early-stage:1 up:1 two:2 person:1 according:1 heavyweights:1 likes:2 interest:1 others:2 drawn:1 sale:1 has:1 health-care:1
stock_AMGN r_down	biotech:3 selling:1 off:1 target:2 companies:1 some:1 price:2 early-stage:1 continuing:1 up:1 drug:1 sale:1 their:2 quest:1 cut:2 have:1 big:1 pipelines:1 's:2 set:1 sights:1
stock_AMGN r_down	actively:1 3.2:1 2.5:1 considering:1 whose:1 20:1 $:1 rose:1 4.8:1 shares:2 has:1 ever:1 sent:1 more:2 gained:2 company:1 report:1 acquiring:1 stocks:1 than:1 billion:1 valued:1 off:1 companies:1 according:1 trading:1 points:3 500:1 were:1 biting:1 higher:2 slightly:1
stock_AMGN r_up	biotech:1 named:1 financial:1 health-care:1 focus:1 have:1 makers:1 reform:1 away:1 same:1 pressures:1 role:1 earnings:1 across:1 division:1 may:1 price:1 after:1 coming:1 report:1 second-quarter:1 he:1 --:1 larger:1 drug:1 large:1 chief:1 officer:1 served:1 downward:1
stock_AMGN r_down	prevent:1 1.6:1 cancer:1 agreed:1 reduce:1 major:1 month:1 trading:1 exists:1 osteoporosis:1 given:1 said:1 $:1 no:1 provide:1 rose:1 review:2 priority:1 also:1 denosumab:2 treatment:2 fractures:1 risk:1 offer:1 drugs:1 advances:1 problems:1 one:1 approved:1 women:1 last:1 drug:1 patients:1 after-hours:1 called:1
stock_AMGN r_up	1.2:2 well:2 moved:1 expectations:2 7.2:1 3.7:1 62:1 actively:3 trading:3 dropped:2 34:1 market:2 bounced:2 whose:3 confidence:4 4.2:1 rose:10 generally:2 29:1 shares:3 points:15 earnings:4 closed:1 6:2 500:7 higher:5 week:2 added:1 beat:2 weakness:2 wave:2 6.4:1 released:2 economic:2 offset:2 100:2 stocks:5 analyst:2 recent:2 gained:1 disappointing:2 38:1 last:2 16:1 19:1 consumer:2 57:1 futures:6 companies:3 up:3 reports:4 face:2 --:4 session:3 3.8:1 retreating:2 after-hours:1 gauge:2 speculation:2 stock:2 traded:2
stock_AMGN r_down	week:2 index:2 quarterly:2 gains:2 investors:2 housing:2 later:2 weak:2 reports:2 sentiment:2 hopes:2 their:2 modest:2 through:2 earnings:2 pin:2 sifted:2 mixed:2 strong:2
stock_AMGN r_down	approached:1 deal:1 doing:1 company:1 reporting:1 much:1 has:1 worth:1
stock_AMGN r_up	pharma:1 's:3 like:1 deal:1 industry:1 company:1 top:1 up:2 one:1 deals:1 pair:1 overtures:1 stories:1 another:1 dealmaker:1 nothing:1 speculation:1 morning:1 casual:1 round:1 spice:1
stock_AMGN r_down	comment:1 saying:1 surprises:2 revenue:1 expectations:1 profit:1 sales:5 two:1 active:1 slowed:2 session:1 including:3 dropped:2 exceeded:1 throughout:1 its:3 partners:1 5.3:6 spending:2 leading:1 they:3 due:1 shares:1 analyst:1 makers:3 advisories:2 various:1 earnings:4 which:1 income:2 total:2 net:2 countries:3 drug:1 details:1 pay:3 product:2 expected:1 's:1 whose:1 boosted:1 company:1 watch:2 results:1 reported:2 cut:3 key:2 pinch:3 prices:3 quarters:1 second-quarter:2 roundup:1 both:1 lower:3 launch:2 charges:1 corporate:1 medicines:3 drop:2 companies:2 see:1 reports:4 preparation:2 --:2 future:1 products:3 payments:1 rose:2 trading:1 overseas:1 feeling:3 slightly:1 maker:1 latest:1
stock_AMGN r_up	8.50:1 1.6:1 set:1 600:1 revenue:1 sales:2 0.3:1 0.5:1 major:1 slid:1 trade:1 '':1 ended:1 second:1 growth:2 trading:1 dropped:1 range:1 its:2 declined:1 index:1 cents:1 5.3:3 end:1 $:3 would:1 topped:1 estimate:1 dropping:2 adjusted:1 expectations:1 40:1 forecast:1 late:1 flood:1 points:3 earnings:3 7:1 masking:1 firms:1 recent:1 500:1 low:1 billion:2 ``:1 below:1 's:2 said:2 mostly:1 opening:1 after-hours:1 results:1 tripled:1 following:1 fell:3 nearly:1 news:1 100:1 stocks:1 data:1 second-quarter:2 futures:2 session:1 15.1:1 lower:1 15.5:1 ahead:1 charges:1 up:1 losses:1 full-year:2 drug:1 morning:1 while:2 edge:1 economic:1 analysts:1 were:2 release:1 nerves:1 slightly:1 maker:1 affirmed:1
stock_AMGN r_down	background:1 through:1 human:1 find:1 $:2 rose:4 add:1 other:1 details:1 2010:1 2012:1 fourth:1 big:3 overall:1 expectation:1 updates:1 they:1 17th:1 products:2 follows:1 medicines:1 companies:2 've:1 cholesterol:2 including:3 jump:2 growth:3 year:2 pain:2 flagship:1 said:2 profit:2 contributed:1 comments:1 forecast:3 version:2 new:2 correct:1 15th:1 sixth:1 acquisition-related:1 reported:3 dividend:1 strong:2 vaccine:1 last:2 license:1 pressure:1 items:1 barely:1 drug:3 range:2 a.m.:1 published:1 maker:2 experimental:1 adjusted:1 revenue:4 68:2 throughout:1 pharmaceutical:1 top:3 due:2 been:1 hitting:1 9.5:3 ``:1 drugs:3 company:1 acquire:1 tested:1 second-quarter:2 pill:2 n't:2 while:1 applies:2 unusually:2 acquisition:1 prompting:1 sales:3 '':1 exclude:1 again:1 end:1 trials:1 also:1 implied:1 earnings:4 which:1 commentary:1 stock:1 's:9 boosted:1 price:1 most:2 billion:2 purchase:2 childhood:1 costs:1 biotechnology:1 its:7
stock_AMGN r_up	medication:1 prompting:1 process:1 tested:1 supplement:1 human:1 find:1 pharmaceutical:1 ingredients:1 trials:1 been:1 suit:1 new:1 wants:1 's:2 involuntary:1 big:1 acquire:1 pressure:1 effects:1 they:1 scary:1 license:1 clarify:1 medicines:1 barely:1 companies:2 've:1 n't:2 products:1 biotechnology:1 identifies:1 side:1 experimental:1
stock_AMGN r_down	actively:2 whose:2 lower:3 's:6 lost:1 session:2 1.8:1 companies:2 shares:2 2.8:1 fell:2 trading:2 declined:2 sharply:1 3.1:1 2.3:2 2:1 stocks:2 traded:2 500:2
stock_AMGN r_up	declines:1 global:1 slowdown:1 2.8:1 trading:1 signs:1 declined:1 whose:1 actively:1 broad:1 fears:1 shares:1 3:1 growth:1 2.5:1 closed:1 500:1 led:1 weakening:1 fell:1 sharply:1 stocks:2 session:1 lower:1 lost:1 companies:1 economic:1 heavyweights:1 after-hours:1
stock_AMGN r_down	rating:1 major:1 sales:1 makers:1 market:1 ratings:2 weakened:1 biosimilars:1 citing:1 race:1 potentially:1 expensive:1 which:1 take:1 fork:1 but:1 coverage:1 fall:2 regulatory:1 hold:1 valuation:1 analyst:2 uncertain:1 --:1 route:1 drug:1 face:1 initiate:1 nascent:1 enter:1 road:1
stock_AMGN r_down	likes:1
stock_AMGN r_up	keeping:1 sure:1 away:1 hunt:1 companies:1 should:1 fund:1 manager:1 anywhere:1 caution:1 making:1 portfolio:1 stocks:1 underappreciated:1 he:1
stock_AMGN r_down	keeping:1 sure:1 away:1 hunt:1 companies:1 should:1 fund:1 manager:1 anywhere:1 caution:1 making:1 portfolio:1 stocks:1 underappreciated:1 he:1
stock_AMGN r_up	corporate-bond:2 signs:1 market:3 approached:1 high-grade:2 $:3 rose:2 had:1 three:2 eagerly:3 rates:1 interest:1 consecutive:2 tapped:3 more:3 week:2 which:1 offering:3 may:1 after:2 lower:2 moving:1 lows:1 new:3 prices:2 debt:3 than:3 billion:3 13:3 last:2 --:1 amid:1 days:2 higher:1 corporate:1 bond:1
stock_AMGN r_up	available:1 fractures:1 said:1 's:6 increased:1 publicly:1 --:1 funded:1 patients:1 drug:1 recommended:1 made:1 denosumab:1 bone:1 risk:1 osteoporosis:1
stock_AMGN r_up	sell:1 unusual:1 raising:1 without:1 --:1 move:1 all:1 approved:1 while:1 itself:1 treatment:1 cash:1 making:1 newly:1 its:1 launching:1
stock_AMGN r_up	comment:1 saying:1 because:4 alfa:1 follows:1 certain:5 over:1 reduce:1 life:2 related:1 '':6 visible:4 say:1 including:1 perspective:1 have:1 therapy:1 11th:1 sells:1 fifth:1 previous:1 information:3 medications:1 additional:1 recalling:5 beginning:1 review:1 brand:1 been:1 why:1 drugs:5 vials:3 version:1 treat:1 which:2 under:2 a.m.:1 renal:1 markets:1 sold:3 failure:1 ``:6 used:1 's:1 may:5 shelf:2 company:2 published:1 corrected:1 but:1 much:1 glass:8 were:1 recalled:2 plan:1 they:3 chemotherapy:1 products:1 product:1 extremely:5 analyst:1 anemia:6 reaction:1 interaction:1 chronic:1 name:1 third:1 n't:1 --:3 recall:1 industry:1 barely:4 drug:1 noted:1 appear:1 lots:6 flakes:7 thin:5 contain:5 did:1 starting:1 maker:1 result:1
stock_AMGN r_down	treating:1 function:1 's:1 cancer:1 separate:1 --:1 suggest:1 drug:1 may:1 role:1 breast:1 useful:1 studies:1 its:1 osteoporosis:1
stock_AMGN r_up	sell:2 biotech:1 copycat:2 generic:1 's:6 launch:1 --:1 sold:1 delaying:1 drug:1 its:1 application:2 version:2 approve:2 any:1 declined:2 first:1
stock_AMGN r_down	respond:1 enable:1 smaller:1 goal:1 likely:1 much:1 mount:1 companies:1 patients:1 drug:2 only:1 2:2 studies:1 late-stage:1
stock_AMGN r_down	has:1 said:1 adults:1 progressive:1 --:1 inadequate:1 arthritis:1 drug:1 unable:1 therapy:1 treatment:1 recommend:1 active:1 been:1 previous:1 response:1 psoriatic:1
stock_AMGN r_up	slid:1 point:2 declined:1 6.7:1 actively:2 including:2 legal:1 committee:2 special:2 whose:2 rose:3 decision:1 less:1 negative:1 shares:3 1:1 5:1 board:2 500:2 higher:1 flat:3 's:4 evaluate:2 company:2 formed:2 slides:2 fell:1 fall:1 stocks:5 than:1 session:2 10:1 lower:1 54:1 companies:2 sale:2 drug:2 while:1 points:4 ruling:2 were:2 following:1 trading:3 slightly:1 options:2
stock_AMGN r_up	biotech:1 600:1 0.2:1 up:2 sleeping:1 hit:1 its:2 issues:1 index:1 compared:1 long:1 snag:1 hampered:1 potential:1 health:1 which:1 biggest:1 safety:1 include:1 pill:1 higher:1 independent:2 's:2 plans:1 company:2 preference:1 report:1 strategic:1 surged:1 care:1 11:1 has:1 last:1 --:1 could:1 sale:1 remain:1 stressed:1 following:1 stock:1 dip:1 drawing:1
stock_AMGN r_down	advisory:2 chronic:2 appropriate:1 another:2 kidney:2 cardiovascular:2 use:2 increase:1 strokes:1 concerns:2 's:2 drugs:3 advice:2 problems:2 ask:2 panel:2 whether:1 disease:2 face:2 --:1 patients:2 risks:1 similar:2 other:1
stock_AMGN r_up	biotech:1 being:2 eclipsed:1 chronic:1 numbers:1 watched:1 kidney:1 use:1 said:1 dialysis:1 agency:1 should:1 their:1 quarterly:1 performance:1 corporate:1 's:3 horizon:1 drugs:1 significant:1 not:1 developments:1 panel:1 --:1 many:1 companies:1 disease:1 large:1 patients:1 continue:1 allow:1 similar:1
stock_AMGN r_down	advisory:1 findings:1 certain:1 chronic:1 rate:1 doses:1 kidney:3 cardiovascular:1 information:1 use:3 said:1 cancer:1 dialysis:2 restricted:1 agency:2 had:1 should:3 looking:1 other:1 details:1 hormones:2 additional:1 panel:3 meeting:2 discuss:1 higher:1 's:4 combination:1 drugs:2 undergoing:1 lowered:1 therapy:1 breast:1 not:1 such:1 cases:1 than:1 those:1 women:2 renal:1 showed:1 --:4 similar:1 study:1 disease:2 n't:1 whether:2 patients:3 continue:1 allow:1 were:1 landmark:1 slightly:1 taking:2
stock_AMGN r_down	whose:1 companies:1 focus:1 shares:1 trade:1 active:1 see:1 session:1 expected:1
stock_AMGN r_up	all:1 over:2 move:2 dollar:2 focus:1 competitive:5 month:3 session:1 economy:1 shares:3 world:1 7.8:1 research:1 its:6 stock-index:2 now:1 20:3 rose:4 point:1 had:2 should:1 late:2 eager:1 potential:1 treatment:1 pursuing:1 quarterly:1 weeks:1 has:2 advanced:2 meetings:1 hope:2 take:1 do:2 evening:1 premium:1 finance:5 big:1 rise:2 results:1 nearly:1 they:1 fall:1 during:1 trade:2 bank:1 anemia:1 regarding:1 success:1 lost:1 --:2 shy:1 drop:1 '':1 did:1 7.1:1 steps:1 t:1 after-hours:1 done:1 higher:1 denosumab:1 bone:1 view:1 58:1 financial:1 pledge:3 eagerly:1 some:1 up:2 global:1 strongest:1 officials:4 trading:2 measure:1 further:2 little:1 nations:2 points:7 provided:1 said:2 opened:1 profit:4 avoid:4 comments:1 yet:1 new:1 across:1 red:1 degree:1 leg:1 confidence:1 use:1 reported:1 takeover:1 operating:1 key:1 approval:1 anticipated:1 half:1 gained:2 essentially:1 last:1 ahead:1 launch:1 reports:4 analysts:1 economies:1 action:1 maker:1 comes:1 permit:1 major:1 although:1 cancer:1 revenue:1 into:1 devaluation:1 pre-open:1 due:1 agreed:1 1.7:1 64:1 another:1 throughout:1 100:2 buoyed:1 leaders:1 unusual:1 much:1 additional:1 start:1 data:1 support:1 third-quarter:1 been:1 next:2 their:1 board:1 spread:1 expected:1 meeting:4 war:1 more:1 firm:1 flat:3 ``:1 general:1 offer:1 drugs:1 company:3 but:2 part:1 wake:2 hopes:1 central:1 trying:1 chatter:1 analyst:1 raising:1 11:4 3.6:1 made:1 look:1 55:1 straight:1 cash:1 value:1 final:1 n't:1 while:2 three:1 following:1 agree:1 numbers:1 bell:1 biotech:1 gathering:1 performer:1 investors:2 chip:1 sales:3 0.6:1 helped:2 currency:4 itself:2 drug:4 have:1 9.75:1 gains:2 sell:2 confab:1 built:1 equities:1 same:1 preventing:1 ministers:2 costs:1 details:1 stock:4 week:2 currencies:1 's:12 index:4 after:5 forecasts:1 extending:1 refrain:1 stocks:2 weekend:4 approved:1 lower:5 attempt:1 lift:2 futures:9 stimulate:1 without:1 relief:1 dominating:1 time:1 away:1
stock_AMGN r_down	saying:1 yen:1 dollar:1 focus:1 trade:2 known:2 through:1 thanks:2 consolidating:1 its:4 stock-index:2 ground:1 20:1 $:1 rose:5 less:1 had:1 expectations:4 than:1 advisories:2 denosumab:2 details:2 versus:1 gains:1 consolidation:1 results:3 background:1 during:2 bit:1 quarters:1 disappointed:2 --:2 drop:1 companies:1 works:1 round:2 set:1 house:1 reported:1 challenges:1 economic:3 exceeded:2 2.3:1 further:2 2.5:2 awaits:1 index:1 said:1 appear:1 profit:1 below:2 future:1 new:1 net:2 osteoporosis:4 strategist:1 full:2 little:1 drug:7 operating:4 key:4 100:2 strong:2 gained:1 essentially:2 quarter:2 last:1 ahead:2 launch:2 days:1 against:1 products:2 analysts:1 surprises:2 slightly:2 maker:2 first:2 comment:1 adjusted:1 slipped:2 revenue:2 confidence:2 decent:1 third-quarter:3 been:1 few:1 dropping:1 expected:1 euro:1 markets:1 500:2 more:2 roundup:1 ``:1 upcoming:1 company:5 but:1 catalyst:2 prices:1 analyst:2 11:12 15:1 while:2 individual:2 were:1 weaker:1 investors:2 flat:2 0.1:1 moved:1 sales:6 '':1 currency:1 single:1 dropped:2 slip:2 rally:1 consumer:2 also:2 costs:4 3.25:1 earnings:5 income:2 sidelines:2 greenback:1 stock:1 product:1 's:10 after:1 fell:5 data:5 recent:3 lower:3 amid:1 futures:9 reports:1 points:6 traded:1 corporate:3 came:2 latest:1
stock_AMGN r_down	fractures:1 available:1 said:1 's:8 option:1 --:1 certain:1 primary:1 increased:1 treatments:1 recommended:1 other:1 if:1 treatment:1 new:1 secondary:1 risk:1 women:1
stock_AMGN r_up	tide:1 over:1 said:1 envision:1 developing:1 --:1 industry:1 drug:1 next:1 n't:1 does:1 rising:1 diabetes:1 new:1 stem:1 medicines:1 decade:1 he:1
stock_AMGN r_down	operations:3 help:3 move:1 barbs:2 exclusivity:3 yet:1 cut:3 $:3 take:1 updated:2 seeking:1 asbestos:3 despite:3 not:2 world:3 loss:3 --:3 drop:3 did:1 cholesterol:3 because:3 acquired:3 trading:2 year:6 out:1 profit:3 jumped:3 comments:2 research:3 combative:1 day’s:1 pipeline:3 last:3 beef:3 double-digit:3 drug:6 trial:2 products:3 faces:3 undergo:1 maker:3 tone:1 revenue:1 strategic:1 down:1 dividend:1 68:3 conference:1 merger-related:3 third-quarter:3 rivals:2 call:1 percentage:3 billion:3 drugs:1 39:3 begins:2 publicly:1 versions:1 whether:1 rival:1 up:3 while:1 2012:6 sales:7 weighed:3 dropped:3 have:1 generic:1 trials:1 detail:1 other:3 details:2 largest:3 interview:1 pan:1 stock:3 's:10 separate:1 price:2 biologic:1 70:3 ago:3 purchase:3 charges:3 clear:1 proceedings:1 costs:3 diversify:3 its:9
stock_AMGN r_down	corrupt:1 operation:1 its:1 if:1 scoring:1 goal:1 federal:1 writes:1 than:1 biggest:1 more:1 big:1 award:1 intent:1 appears:1 las:1 look:3 aim:1 trial:2 bad:1 making:1 endorsed:1
stock_AMGN r_down	comment:2 biotech:2 background:1 stalked:1 being:1 share:1 back:1 challenges:1 course:1 have:1 led:1 buffeted:1 its:1 market:1 unusual:1 said:1 adds:1 patent:1 jumped:1 takeovers:1 had:1 been:1 their:1 participants:2 other:1 declined:1 which:1 largest:1 without:1 ordinary:1 rumors:1 company:3 cost-cutting:1 dialogue:2 's:4 statement:1 business:1 government:1 price:1 after:1 took:2 step:1 takeover:2 key:1 reforms:1 put:1 such:1 part:1 intensify:1 ``:1 arena:1 '':1 bid:1 announcing:1 programs:1 --:4 amid:1 industry:2 drug:1 until:1 remain:1 regular:2 analysts:1 healthcare:1 recently:1 speculation:2
stock_AMGN r_up	received:1 use:1 's:3 whose:1 cancer:1 prevent:1 solid:1 tumors:1 disease:1 drug:1 helping:1 patients:1 spread:1 complications:1 denosumab:1 approval:1 has:1 bone:3
stock_AMGN r_down	prevent:2 exceed:1 cancer:2 share:1 expects:1 month:1 against:1 aims:1 approval:2 rally:1 its:1 market:2 whose:2 use:1 end:1 $:1 makers:1 late:1 spread:2 denosumab:1 widely:1 new:1 has:2 all:1 hormone:1 's:3 rules:1 sold:1 sales:1 helping:2 important:1 therapy:1 key:1 timing:1 competitor:1 approved:1 billion:1 received:1 gets:1 launch:1 --:2 tumors:2 annual:1 disease:2 drug:5 solid:2 patients:2 1:1 complications:2 analysts:1 grab:1 changes:1 bone:6 expect:1
stock_AMGN r_down	peninsula:1 climbs:2 tensions:1 brewing:1 shares:1 slides:1 concerns:1 drug:2 broader:1 fall:2 climbing:1 stocks:2 market:1
stock_AMGN r_down	treating:1 disorder:1 product:1 said:1 's:6 injectable:1 chronic:1 --:1 certain:1 patients:1 bleeding:1 recommended:1 healthcare:1 immune:1 watchdog:1 cost-effectiveness:1 called:1
stock_AMGN r_up	customers:1 foot:1 business:1 tablet:1 --:1 crucial:1 computers:1 companies:1 sales:1 same:1 up:1 their:1 doctors:1 time:1 pitch:1 spruce:1 door:1 passing:1 giving:1 thousands:1 out:1
stock_AMGN r_up	firm:1 executive:1 shut:1 linking:1 down:1 year:1 investment:1 network:1 expert:1 next:1 pioneering:1 ``:1 's:1 business:1 government:1 funds:1 scrutiny:1 doctors:1 hedge:1 bank:1 '':1 heightened:1 amid:1 could:1 according:1 industry:1
stock_AMGN r_up	comment:1 biotech:1 background:1 do:1 executive:2 pioneering:1 shut:1 linking:1 '':2 want:1 type:1 next:1 any:1 investment:1 n't:2 said:2 network:1 would:1 government:1 event:1 interested:1 wants:1 details:1 which:2 largest:1 according:1 sidelines:1 2011:1 2012:1 firm:2 independent:1 ``:2 's:4 business:1 year:1 funds:1 company:2 here:1 stay:1 produce:1 shareholder:1 although:1 doctors:1 hedge:1 scrutiny:1 bank:1 heightened:1 down:1 peers:1 expert:1 --:1 deals:1 industry:2 headquarters:1 large:1 chief:1 amid:1 discussing:1 could:2 block:1 partnerships:1
stock_AMGN r_up	biotech:1 background:1 cancer:1 competition:1 years:1 helped:1 rising:1 throughout:1 open:1 its:3 issues:1 drugs:1 aging:1 use:1 blockbuster:1 4.2:1 prostate:1 delay:1 pressures:1 spread:1 details:1 which:1 new:1 has:1 numerous:1 stock:1 's:2 business:1 may:1 price:1 giant:1 reported:1 important:1 related:1 key:1 suite:1 regulatory:1 data:2 potential:1 recent:1 faced:1 --:1 months:1 up:1 drug:2 bone:2 late-stage:1
stock_AMGN r_up	sector:1 limited:1 all:1 results:1 years:1 not:1 session:4 looks:1 questions:1 dividend:1 its:9 issues:2 before:2 whose:2 giant:1 group:1 $:1 rose:10 had:2 should:1 spread:1 treatment:1 premarket:1 under:1 policy:5 suite:1 has:2 dramatically:1 earnings:2 gains:1 emergency:1 far:1 rise:2 related:1 report:2 2:1 room:1 name:1 --:3 numerous:1 future:1 companies:2 50:1 morning:1 heart:1 after-hours:3 found:1 went:1 higher:6 round:1 bone:5 heavy:1 ahead:1 because:1 committee:1 posts:1 some:1 competition:1 3.7:1 second:1 actively:2 trading:5 surface:1 year:1 close:1 've:1 await:1 encouraged:1 index:4 bones:1 said:2 opened:1 lead:3 profit:2 decision:6 schedule:1 remain:1 shares:2 p.m.:2 looking:1 pressures:1 health:1 various:1 closed:1 new:1 6.8:1 strategist:1 fractures:1 we:1 '':1 business:1 months:1 edge:2 sold:1 monetary:2 reported:1 lucrative:1 although:1 regulatory:1 article:1 100:2 change:1 care:1 gained:1 prospects:1 4.2:1 language:1 taking:2 30:1 drug:7 patients:1 trial:2 economic:3 published:1 improvement:1 retail:3 slightly:4 maker:1 late-stage:1 reduce:1 already:2 key:5 cancer:1 headed:1 spreading:1 safety:1 awaited:2 rising:1 raises:2 news:1 easy-money:1 open:1 along:1 use:2 fallen:1 their:1 8.9:1 prostate:1 top:1 due:2 stuck:1 clinical:1 statement:1 6:2 really:1 9.1:1 500:5 faced:1 ``:1 health-care:1 successful:1 0.5:1 company:1 but:2 1.9:1 quarterly:1 sting:1 than:1 those:1 women:1 11:1 helped:2 14:1 showed:1 performers:1 19:1 work:1 up:7 while:2 growth:3 were:5 study:2 control:1 biotech:1 climbed:3 investors:3 0.1:1 bigger-than-expected:2 0.3:1 0.2:3 moved:2 sales:3 0.7:1 0.6:1 disappointing:2 currency:1 lived:1 prostate-cancer:1 need:1 blockbuster:1 any:1 risk:1 drugs:1 aging:1 easing:1 4.3:1 sensitive:1 4.9:1 same:1 delay:1 shifts:1 potential:2 3.25:1 take:1 which:2 plus:1 you:1 sidelines:2 brand:1 stock:5 added:3 's:17 4.4:1 may:2 after:2 driver:1 treatments:1 visitors:1 meaning:1 important:1 uses:1 osteoporosis:1 significant:1 70:1 nothing:1 such:1 stocks:3 data:8 recent:1 off:1 longer:2 third:1 traded:2 futures:6 disease:1 without:1 retail-sales:2 points:13 so:1 47.98:2 time:3 quantitative:1 first:1
stock_AMGN r_down	1.1:1 moved:1 2.8:1 trading:1 easy-money:1 its:1 47.98:2 actively:1 48:1 rose:1 shares:1 improvement:1 stuck:1 closed:2 policy:1 500:1 higher:2 's:1 whose:1 stocks:1 data:1 session:1 showed:1 climbed:1 companies:1 up:1 points:3 economic:1 after-hours:1
stock_AMGN r_down	discontent:1 figure:2 tougher:1 year:1 soon:1 years:2 escaped:2 looks:1 during:1 types:1 's:1 yet:2 relatively:2 24:1 pharmaceutical:2 21:3 few:1 monthly:1 deserve:1 higher:1 its:2 better:1 drugs:3 potential:1 safety:1 treatment:1 factor:1 new:2 has:2 2010:7 18:1 shows:2 website:1 partly:1 25:1 may:1 got:1 delayed:1 but:2 number:1 modest:1 reflecting:1 low:2 demand:1 regulatory:1 approval:1 drought:2 blockbusters:1 approved:3 environment:1 recent:3 down:1 concerns:1 won:1 --:1 amid:1 could:1 drug:1 retirees:1 n't:2 reports:1 ongoing:1 2007:1 were:1 become:1 2008:3 2009:3 industry:2 others:1
stock_AMGN r_up	1.7:1 session:3 trading:3 7.7:1 declined:1 2.4:1 whose:3 20:1 22:2 rose:1 shares:3 points:8 9.8:1 closed:1 500:3 's:3 but:2 fell:2 stocks:3 gained:2 10:1 lower:1 lost:3 companies:3 actively:3 after-hours:1 mixed:2 traded:2
stock_AMGN r_down	biotech:1 named:2 autoimmune:1 being:1 developed:1 one:1 held:1 scientist:1 licensing:1 's:1 moves:1 its:2 result:1 $:3 lead:1 since:1 been:1 research:2 also:1 continue:1 treat:1 under:1 finding:1 new:1 entered:1 has:2 worth:1 500:1 development:3 head:2 recently:1 diseases:1 may:1 company:4 million:1 agreement:1 joined:1 restructuring:1 important:1 post:1 future:1 former:1 antibodies:1 --:1 changes:1 up:1 empty:1 '09:2 organization:1 efforts:1 2009:1 corporate:1 privately:1
stock_AMGN r_down	fourth-quarter:3 set:2 slipped:2 0.8:2 cents:1 declines:2 share:1 according:1 trading:2 dropped:4 losses:1 close:3 open:1 post:1 index:4 giant:2 sentiment:1 profit:1 blue-chip:2 40:1 earnings:2 sixth:2 expected:1 markets:4 500:2 stock:3 week:4 analysts:1 season:2 after:3 9.75:1 fell:2 last:2 100:2 posted:1 gained:2 off:2 ahead:1 aluminum:2 18:1 straight:2 futures:6 50:1 points:6 survey:1 kick:2 following:2 finishing:2 higher:2 souring:1
stock_AMGN r_down	biotech:1 adjusted:1 revenue:1 health-care:1 share:1 expects:3 related:1 middle:1 growth:2 projections:2 exclude:1 along:1 post:1 previous:1 24:1 giant:1 fee:1 $:2 would:1 reform:1 provide:1 expectations:2 per:1 p.m.:1 note:1 failed:1 version:1 earnings:6 stories:1 2011:6 2010:7 full:1 's:1 company:2 corrected:1 but:2 reported:1 said:2 report:2 line:1 first-quarter:1 below:1 --:1 follows:1 roughly:1 range:2 a.m.:1 slightly:1 its:1
stock_AMGN r_up	alliance:3 financial:1 deal:1 within:1 '':1 biologics:1 close:1 's:1 its:2 unit:2 sell:2 living:1 provide:1 copies:1 research:2 clinical:1 candidates:1 disclosed:2 which:1 provider:2 new:2 biosimilar:1 opposed:1 development:1 ``:1 terms:2 intended:1 drugs:4 formed:3 part:2 services:1 versions:2 --:1 cells:1 contract:2 n't:2 traditional:1 were:2 push:2 biotechnology:2
stock_AMGN r_down	investors:1 billions:1 drug:3 open:1 its:1 competition:1 weaken:1 overhaul:1 generic:1 make:1 health:1 too:1 save:1 excited:1 do:1 sure:1 's:1 get:1 but:1 designed:1 regulatory:1 approval:1 trying:1 provision:1 lupus:1 launch:1 --:1 dollars:1 companies:1 up:1 fighting:1 n't:1 expecting:1 biotechnology:1 medicines:1
stock_AMGN r_up	's:1 list:1 companies:1 50:3 cash:1 stockpiles:1 biggest:1 world:1
stock_AMGN r_down	biotech:1 fourth-quarter:1 into:1 focus:1 trade:1 report:1 see:1 session:1 year:1 makers:1 whose:1 profit:1 shares:1 next:1 looking:1 earnings:1 expected:1 new:1 week:1 begin:1 active:1 strong:1 insights:1 companies:1 drug:1 large:1 growth:1
stock_AMGN r_up	comment:1 fourth-quarter:4 cancer:2 biotech:2 agreed:2 upfront:1 focus:1 575:1 trade:1 held:2 see:1 session:1 privately:2 year:1 further:1 development:1 its:4 osteoporosis:2 conference:1 whose:1 slow:2 melanoma:1 $:7 profit:4 pay:1 acquire:1 initial:2 regulatory:1 shares:1 1:5 also:1 clinical:1 call:1 details:1 fourth:1 cash:1 expected:1 9.8:2 has:1 425:1 announced:1 achievements:1 ago:1 head:1 buy:2 earns:1 plans:1 tops:1 company:3 million:2 watch:1 new:2 sales:3 reported:2 said:2 related:1 despite:2 active:1 vaccine:1 additional:1 billion:5 10:1 grew:2 neck:1 --:1 companies:1 up:4 drug:2 milestone:1 reports:1 period:1 payments:1 quarter:1 maker:1 late-stage:1
stock_AMGN r_down	saying:1 fourth-quarter:2 over:1 milestone:1 years:1 held:1 session:5 spinoff:1 forecast:1 agrees:1 decade:1 developer:1 home-price:2 whose:3 some:1 slow:1 overhaul:1 $:15 22:1 merger:1 rose:5 had:1 bust:1 analyst:1 surprises:2 advisories:2 4:1 has:2 2011:2 beware:1 details:1 return:1 around:1 views:1 big:1 possible:1 grew:1 575:1 background:1 despite:1 quarters:1 cancer:2 lost:1 --:1 companies:4 5.25:1 morning:1 6.4:1 payments:1 after-hours:1 popular:1 mean:1 set:2 networkers:1 capitalists:1 related:1 cash:1 past:1 battle:1 actively:3 trading:4 3.3:1 year:2 close:3 makers:1 declined:3 3.9:1 index:4 said:1 giving:1 decision:1 since:2 shares:3 its:5 drug:1 health:1 consumer-confidence:2 closed:1 new:2 previous:2 425:1 achievements:1 risen:1 million:2 confidence:2 reported:1 upfront:1 regulatory:1 100:2 vaccine:1 roundup:2 39:1 31:1 heating:1 reports:2 a.m.:4 analysts:1 social:1 mixed:1 traded:2 first:1 8.50:1 adjusted:1 slipped:2 revenue:2 billions:1 agreed:1 raises:1 decline:1 high-profile:2 additional:1 osteoporosis:1 housing:2 initial:1 been:1 stuck:1 clinical:1 9.8:4 goes:1 500:5 more:1 gained:1 head:1 buy:2 privately:1 posting:2 drugs:2 estimates:1 company:6 fund:1 1.2:1 talks:1 prices:2 highest:2 than:1 15.5:1 11:1 10:3 made:1 word:1 up:4 below:1 future:1 could:1 venture:1 dollars:1 acquisition:1 0.9:2 biotech:1 1.7:1 lately:1 investors:2 0.1:1 share:2 sales:4 according:1 single:1 dropped:2 have:2 rally:2 increased:1 grown:1 melanoma:1 pay:1 investment:1 1:4 flood:2 5:1 earnings:6 largest:1 9:2 survey:1 stock:3 development:1 topping:1 's:11 though:1 may:1 after:2 most:1 meaning:1 fell:7 stocks:3 data:4 billion:5 15.1:1 lower:2 neck:1 released:4 corporate:1 futures:6 well:2 profit:1 points:14 biotechnology:2 2008:2 late-stage:1 consumer:2 blue-chip:2 profits:1 latest:1
stock_AMGN r_up	biotech:1 said:1 getting:1 --:1 pay:1 company:2 move:1 again:1 louder:1 evaluating:1 such:1 dividend:1 first:1
stock_AMGN r_down	still:1 biotech:1 unexpected:1 being:1 series:1 betting:1 supported:1 dollar:1 competition:1 sleeping:1 helped:1 been:1 comments:1 have:1 into:1 recover:1 its:1 viewed:1 blow:1 has:1 said:2 adds:1 winner:1 had:1 shares:1 traders:1 won:1 development:2 which:3 largest:1 medicine:1 safety:1 suffered:2 rumors:1 company:1 leader:2 stock:1 bets:1 setbacks:1 ``:2 's:2 big:1 week’s:1 after:1 but:1 takeover:3 latest:1 news:1 turned:1 potential:1 recent:1 '':2 blockbuster:1 target:1 --:1 hardly:1 trader:1 months:1 drug:1 pill:1 trial:1 analysts:1 speculation:1 grounds:1 profits:1 first:1
stock_AMGN r_down	's:2 would:2 just:2 around:2 were:2 insomnia:2 rumors:2 been:2 maker:2 project:2 takeover:2 drug:2 have:2 year:2 last:2 shows:2 its:2 acquisition:2 risky:2
stock_AMGN r_down	criticism:2 saying:2 consider:1 biotech:6 backing:2 executive:2 sale:3 pushed:1 4:1 battle:2 shrugged:2 its:2 unit:1 group:1 lead:2 no:1 surged:1 top:2 chief:2 investment:1 also:1 asking:1 chairman:3 interest:1 largest:6 boardroom:2 has:1 company:5 sent:1 more:1 firm:6 independent:3 attention:1 's:14 way:2 bid:1 after:1 drew:2 fund:2 takeover:3 shareholder:1 pave:2 letter:1 hopes:2 overhaul:2 brass:2 investor:4 than:1 received:1 off:2 --:3 should:1 could:4 board:3 comment:1 remain:2 leadership:1 hedge:1 launching:2 resign:1 amid:1 called:2 shakeup:2 election:1
stock_AMGN r_down	firm:2 challenging:1 just:1 biotech:1 conundrum:1 economic:1 slashing:1 jobs:1 counting:1 investment:1 pharmaceutical:1 renewed:1 no:1 spending:1 its:1 strategy:1 call:1 board:1 largest:1 has:1 giants:1 's:5 offer:1 labs:1 takeover:1 shake-up:1 plan:1 those:1 like:1 received:1 center:1 --:1 many:1 industry:1 underscores:1 drug:2 high-tech:1 closing:1
stock_AMGN r_down	complete:1 cancer:1 failure:1 drugs:1 make:1 six:1 companies:1 their:1 accelerated:1 officials:1 questioned:1 follow-up:1 conduct:1 approval:1 they:1 studies:1 exchange:1 promised:1
stock_AMGN r_down	biotech:3 months:2 managers:3 another:2 deal:1 summer:1 within:1 scene:2 ended:1 been:1 least:1 questions:2 further:1 portfolio:2 throughout:1 its:1 short-term:1 announcement:1 giant:2 said:1 cycling:1 $:1 space:2 began:1 since:1 comments:1 their:2 uncertainty:1 other:1 capital:2 investors:2 out:1 officially:1 stock:1 firm:2 's:2 fundamental:1 deploy:2 drugs:2 pursuing:1 eliminates:2 consolidation:1 early:1 fund:1 anticipation:1 invested:2 pursuit:1 acquiring:1 now:2 billion:1 regarding:1 last:1 --:2 industry:1 official:1 analysts:1 have:2 options:1 acquisition:1 raises:2
stock_AMGN r_down	biotech:1 named:1 year-end:1 financial:1 consider:1 proposed:1 reasons:1 well:1 executive:2 positioned:1 results:1 years:2 four:2 interim:1 value:1 stepping:1 approval:1 our:1 resigned:1 its:2 decided:1 '':1 said:3 based:1 form:1 basis:1 personal:1 sale:1 remain:1 per:1 strategy:1 strong:1 capital:1 mum:1 instead:1 has:1 until:1 more:1 firm:1 ...:1 ``:2 creation:1 's:2 than:1 believe:1 payment:1 forming:1 company:4 after:2 confidence:1 but:1 pressure:1 treasurer:1 base:1 shareholder:3 we:1 reserves:1 performance:1 ask:1 dividend:2 post:1 replace:1 him:1 recent:1 down:1 pipeline:1 above-average:1 --:1 annual:1 mid-:2 job:1 reports:1 touted:1 spending:1 chief:3 growth:1 officer:1 repayment:1 long-term:3 lucrative:1 contribution:1 share:1
stock_AMGN r_down	billion:1 appeals:1 court:1 $:3 patent-infringement:1 reversed:1 1.8:3 against:1 decision:1
stock_AMGN r_down	adviser:3 cautions:2 says:1 optimistic:1 over:1 overvalued:3 but:1 three:1 five:1 ‘slightly:2 outlook:1 years:1 he’s:1 market:1 stock:1
stock_AMGN r_up	we:1 here:1 looking:1 ugly:1 're:1 performance:1 you:1
stock_AMGN r_down	comment:1 all:2 tap:2 hoping:2 being:2 into:2 coming:2 sales:1 competition:2 one:2 four:1 second:2 including:2 reducing:2 its:2 market:2 help:2 throughout:1 generic:2 six:2 projected:1 research:2 symptoms:2 drugs:2 details:1 which:2 newly:2 main:2 painful:2 's:2 reaction:1 may:2 company:1 arthritis:2 met:2 important:2 lucrative:2 goals:2 key:2 offset:2 years:2 analyst:1 condition:2 loss:2 pipeline:2 include:1 success:2 reported:2 --:2 studies:2 drug:7 trial:4 rheumatoid:2 called:2 late-stage:4
stock_AMGN r_down	biotech:2 lupus:1 large-cap:1 buck:1 declines:1 drop:1 shares:2 drug:1 against:1 broader:1 rallies:2 fuel:1 downturn:1 makers:1 market:1 treatment:1
stock_AMGN r_up	sector:2 biotech:2 says:1 products:1 positive:1 top:1 up:1 unchanged:1 one:1 remain:1 rates:1 market:1 close:2 analyst:1 boosts:2
stock_AMGN r_up	firm:1 major:1 's:1 six:1 redefine:1 should:1 accelerated:1 board:2 members:1 new:1 naming:1 strategy:1 efforts:1 shakeup:1
stock_AMGN r_down	sector:1 ...:1 one-year:1 right:1 's:2 look:1 we:2 big:1 bill:1 anniversary:1 past:1 'd:3 health:2 have:1 year:1 overhaul:1 has:1 treated:1 care:2
stock_AMGN r_down	firm:1 biotech:2 said:1 's:2 business:1 proposed:1 fixing:1 one:1 focus:1 but:1 sale:1 potential:1 board:1 members:1 largest:1 strategic:1 still:1 options:1 possible:1
stock_AMGN r_down	strongly:1 saying:1 shareholders:1 pushing:1 overhaul:1 plans:1 no:1 offered:1 rebuffed:1 sale:1 strategy:1 board:1 letter:1 quick:1 instead:1 investor:1 viable:1 sent:1 out:1
stock_AMGN r_up	said:1 late-stage:1 overall:1 survival:1 watch:1 courtesy:1 lung-cancer:1 morning:1 failed:1 hot:1 treatment:1 our:1 stocks:1 friends:1 study:1 experimental:1 improve:1
stock_AMGN r_up	firm:1 's:1 ahead:1 proposed:1 largest:1 crucial:1 investors:1 month:1 cost:1 shareholder:1 board:1 members:1 cuts:1 letter:1 new:1 biotechnology:1 calling:1 meeting:1 sent:1 restructure:1
stock_AMGN r_up	gaining:1 heft:3 name:1 companies:1 add:2 tech:1 100:3 expense:1 rebalance:2
stock_AMGN r_down	firm:1 named:1 join:1 company:1 attempt:1 deflect:1 investment:1 pressure:1 board:1 biotechnology:1 's:1 former:2
stock_AMGN r_down	biotech:1 shareholders:1 's:2 company:1 one:1 quell:1 growth:1 key:1 aiming:1 refocus:1 dispute:1
stock_AMGN r_down	firm:1 reshuffle:1 full:1 's:1 strategic:1 backing:1 win:1 rethink:1 strategy:1 investment:1 board:1 which:1 were:1 partly:1 efforts:1 hurt:1 investor:1 its:1 urging:1
stock_AMGN r_up	issued:1 results:5 years:1 held:1 session:1 including:1 its:4 osteoporosis:1 whose:1 rose:1 had:1 expectations:2 late:2 treatment:1 quarterly:1 has:1 momentum:1 earnings:1 scheduled:1 updated:1 increased:2 rules:1 continues:1 watch:4 report:2 continued:1 anemia:1 --:3 companies:3 large:1 after-hours:1 popular:1 quarter:3 noted:1 bone:1 exceed:1 financial:1 estimates:1 bounce:2 3.6:6 actively:1 trading:2 year:1 's:4 2.1:1 even:1 said:1 reform:1 profit:1 shares:5 closed:1 new:2 each:1 hours:1 operating:1 struggle:1 active:1 strong:2 beginning:1 gained:1 improved:1 drug:4 products:1 analysts:1 changes:1 maker:1 first:2 comment:1 seeing:1 adjusted:1 cancer:1 revenue:3 number:1 one:1 another:1 climbing:1 decline:1 '':2 fee:1 top:1 been:2 start:1 stock:1 500:1 ``:2 health-care:1 drugs:1 some:1 company:3 hurt:1 last:2 line:1 analyst:1 those:1 13th:1 include:1 showed:1 solid:1 launches:1 patients:1 growth:1 launched:1 1.4:1 1.5:1 associated:1 exceeded:1 sales:2 expenses:1 disappointing:1 dropped:1 have:1 technology:1 topped:1 also:1 details:1 widely:1 higher:5 product:1 added:1 first-quarter:2 though:2 price:1 after:3 driven:1 most:2 helped:1 fell:1 build:1 stocks:1 recent:2 reimbursement:1 off:1 bottom:1 well:1 drive:1 traditional:1 costs:1 biotechnology:1
stock_AMGN r_down	sector:3 operations:1 all:1 45:1 help:1 quarters:1 among:1 being:1 over:1 move:1 expects:2 years:2 prices:1 session:5 through:1 comments:1 6.1:1 its:16 succeeding:1 osteoporosis:1 one:1 whose:5 27:1 20:1 $:5 22:1 quarterly:2 rose:11 first-quarter:6 expectations:2 recommending:1 should:1 environment:1 production:1 systems:1 2015:5 smile:1 grow:1 regional:1 details:1 busy:1 updated:2 executive:1 saying:1 closed:1 than:1 rules:1 big:1 controls:1 watch:5 results:5 early:1 putting:1 additional:1 not:1 buyout:1 trade:2 continued:1 day:1 hired:1 anemia:1 roundup:1 increasing:1 disappointing:1 --:6 board:1 companies:6 50:1 53:1 officer:1 after-hours:3 including:1 higher:5 reduced:2 bone:1 shipments:1 cost:1 freight:1 declines:2 some:1 product:1 competition:2 group:1 3.6:4 owner:1 second:1 growth:5 trading:5 projections:3 year:3 our:1 2.1:1 insurance:1 emerges:2 said:8 profit:8 broad:1 review:1 loan-loss:1 patients:1 hepatitis:1 0.8:1 future:1 7:1 capital:1 new:3 net:1 beating:1 core:1 million:1 business:3 team:1 broker:1 costs:1 hours:1 reported:1 regulators:1 base:1 weaker-than-expected:1 multimedia:1 key:1 active:1 dividend:5 strong:2 beginning:1 panel:1 payout:1 conglomerate:1 pipeline:1 subdued:1 improved:2 tablet:1 computers:2 fourth-quarter:1 drug:5 trucking:1 regions:2 initiate:1 produce:1 products:3 analysts:2 treatment:1 usually:1 operating:1 retail:1 traded:2 maker:2 first:3 jumped:2 adjusted:2 own:1 fragrances:1 groups:1 cancer:1 revenue:3 launches:1 cosmetic:1 29:1 down:1 struggle:1 weather:1 names:1 another:2 lodging:1 operator:1 reached:1 market:1 decline:1 little:1 management:1 private-client:1 would:1 expected:2 create:1 two:3 adopted:1 next:1 advisories:2 teeth:1 9.4:1 recent:2 meeting:2 500:3 more:2 gained:3 ``:1 unanimously:1 drugs:2 estimates:2 company:13 gas:1 lower:3 but:2 hurt:1 markets:1 fuel:1 related:1 demand:4 hopes:1 last:3 95:1 second-quarter:4 he:1 helped:1 13:1 smartphones:1 14:1 showed:1 whether:1 18:1 see:3 aims:2 poison:1 record:4 while:1 actively:4 today:1 dispensing:1 were:1 report:1 3.2:1 changes:1 launched:1 dropped:1 detailed:3 biotech:3 promises:1 surprises:2 investors:2 exceeded:1 sales:4 expenses:1 '':1 quarter:1 financial:1 35:1 offsetting:1 saw:2 increased:2 5.5:1 4.2:1 generic:2 pay:3 make:1 offer:1 generally:1 severe:1 topped:1 shares:7 1:1 maintain:1 role:1 earnings:7 income:1 9:1 several:1 corporate:1 stock:2 week:1 topping:1 added:3 's:20 plans:3 though:1 price:2 after:4 update:2 analyst:1 most:1 courtesy:1 fell:2 driven:1 rejected:1 coming:3 president:1 oil:1 stocks:4 friends:1 payment:2 expand:1 winter:1 fiscal:3 reimbursement:1 posted:1 especially:1 slightly:1 well:2 traditional:1 reports:4 chief:2 points:9 allow:1 time:1 senior:1 consumer:1 veteran:1 latest:1
stock_AMGN r_up	cure:1 recommending:1 have:1 approval:1 should:1 market:1 shown:1 review:2 agency:1 28:1 two:1 hepatitis:1 next:1 recommended:1 rates:1 widely:1 expected:1 effectiveness:1 week:1 's:3 drugs:3 use:1 standard:1 regulators:1 therapy:1 liver:1 they:1 improving:1 article:1 strong:1 panel:1 --:1 disease:1 whether:1 patients:1 allow:1 published:1
stock_AMGN r_up	medication:1 bleeding:1 certain:1 agreed:1 chronic:1 directly:1 makers:1 regulator:1 use:1 said:1 goal:1 long:1 research:1 immune:1 potential:1 treatment:1 has:1 product:1 collaborate:1 's:8 delivering:1 backed:1 cost-effectiveness:1 treating:1 brain:1 --:1 drug:1 project:1 patients:1 healthcare:1 injectable:1 disorder:1 called:1 involves:1
stock_AMGN r_up	medication:1 certain:1 agreed:1 catheters:1 results:1 delivering:1 brain:2 through:1 aimed:1 directly:1 such:1 makers:2 packed:1 stocks:2 adds:1 network:1 disorders:1 spending:1 lets:1 tightly:1 research:1 only:1 potential:1 details:1 fourth:1 boost:1 implantable:1 treatment:1 collaborate:1 's:4 barrier:1 roster:1 collaboration:1 rise:2 sales:1 early:1 pumps:1 key:1 making:1 using:1 strong:1 beginning:1 projects:1 stage:1 pact:1 elusive:1 target:1 healthy:1 cells:1 disease:1 drug:3 project:1 attributes:1 involves:1
stock_AMGN r_up	rating:1 high-risk:1 over:1 focus:3 month:1 four:1 businesses:4 decisions:1 its:9 announcement:1 giant:3 anticipation:3 rose:3 expectations:1 program:1 stable:1 quarterly:1 announce:1 has:1 2011:1 details:1 animal:3 provisions:3 rise:1 anticipated:1 updates:1 background:1 half:1 report:1 years:1 pharmaceutical:4 --:10 12th:1 drop:3 fewer:1 did:1 cholesterol:3 bone:1 better-than-expected:3 shed:3 often:1 tepid:1 competition:1 growth:1 result:1 first-quarter:3 expects:1 investment:1 best:1 said:1 adds:1 profit:4 review:1 contributed:3 projected:1 comments:2 research:3 increase:1 health:6 above:1 new:2 ability:1 business:3 slight:3 continuing:1 reported:4 cut:1 dividend:2 debt:1 beginning:3 care:3 reaction:1 last:1 industry:1 brand-name:3 drug:6 credit:2 4th:1 graph:2 outlook:1 revenue:5 down:1 determine:1 throughout:1 quality:1 decline:3 next:1 few:1 which:1 reflects:1 partly:1 complete:1 slumping:1 drugs:1 share:1 company:5 but:1 hurt:1 analyst:1 posted:1 10:12 builds:3 challenge:1 edged:1 n't:1 maturity:1 while:5 launching:1 10th:1 biotech:1 tax:3 sales:4 helped:3 investment-grade:1 seen:1 blockbuster:3 any:1 increased:1 hone:3 ratings:1 pay:1 mix:1 earnings:3 fourth:1 several:3 stock:1 junk:1 's:14 though:1 price:1 buyback:1 levels:1 pair:1 such:3 lower:3 charges:1 amid:1 costs:3 consumer:3 came:1
stock_AMGN r_up	remedies:1 increase:1 ``:1 asthma:1 16:2 warns:1 equal:1 '':1 merging:1 health:1 rates:1 open:1 its:1 unit:1
stock_AMGN r_down	biotech:3 annual:1 investors:1 supported:1 share:1 2nd:1 hopes:1 including:2 sharp:1 trust:1 hedge:4 if:1 decline:1 shareholders:1 management:1 won:1 whom:1 general:1 top:2 six:1 had:4 been:1 fight:3 majority:2 potential:2 board:4 which:4 largest:3 new:1 meeting:1 price:1 details:1 firm:3 them:1 executive:1 's:10 triggered:1 company:4 pushing:2 reshuffle:2 replace:1 fund:4 4th:1 these:1 wanted:1 backed:4 chairman:1 brass:2 departure:1 former:1 oust:1 none:1 pushed:1 --:2 could:1 months:4 sale:4 pursue:1 directors:1 ones:1 pressed:3 defeat:1 quick:1 senior:1 its:3 8th:1
stock_AMGN r_up	payout:1 biotech:1 giant:1 's:1 first-ever:1 make:1 cheap:1 cash:1 regular:1 compelling:1 valuation:1 bet:1 stock:1
stock_AMGN r_up	1.1:1 slipped:1 one:1 down:1 7.3:1 actively:1 trading:1 been:1 open:1 blue:1 whose:1 $:4 sit:1 stake:1 had:1 shares:1 points:2 1.78:1 500:1 more:1 's:5 increased:1 watch:2 took:1 anticipated:1 fell:1 stocks:1 chips:1 than:1 stakes:1 screens:1 lower:1 retail:1 15:1 ahead:1 radar:1 companies:2 while:1 session:1 quarter:1 traded:2 investors’:1 first:1
stock_AMGN r_up	gained:1 whose:1 's:1 slipped:1 session:1 companies:1 shares:1 fell:1 trading:1 actively:1 closed:1 after-hours:1 mixed:1 69:1 stocks:1 500:1 points:1
stock_AMGN r_down	prevent:4 adults:1 cancer:2 opinions:1 caused:2 dose:2 recommending:1 have:1 injuries:2 market:4 osteoporosis:2 whose:2 given:2 said:3 melanoma:1 granting:1 also:2 positive:1 adopted:1 its:4 application:2 recommended:2 spread:2 treatment:5 under:4 has:2 brand:2 denosumab:2 's:6 intended:1 marketing:1 sold:2 prior:1 helping:2 regulators:2 therapy:1 approved:2 advanced:1 panel:2 treating:2 received:1 name:4 solid:4 tumors:4 disease:2 --:5 patients:4 complications:2 higher:2 approve:2 called:2 bone:8
stock_AMGN r_down	reasons:1 different:1 likes:1
stock_AMGN r_down	said:1 's:2 disorders:1 cancer:1 licensing:1 --:1 country:1 drug:1 denosumab:1 partner:1 new:1 along:1 bone:1 treatment:1
stock_AMGN r_down	trio:1 cancer:1 core:1 over:1 sales:2 one:1 13,000:1 against:1 year:1 its:1 pharmaceutical:1 said:1 $:1 million:2 trial:2 had:1 three:1 increase:1 3:2 clinical:1 which:2 test:1 280:1 meeting:1 betting:1 affordable:1 do:1 used:1 's:3 risk:1 drugs:1 company:1 arthritis:2 blockbusters:1 reflect:1 offsetting:1 biologic:1 hopes:1 stocks:1 data:1 loss:1 last:1 older:1 --:1 boost:1 annual:1 well:1 according:1 drug:3 n't:3 flagship:1 patients:2 products:1 rheumatoid:1 maker:1 patents:1 head-to-head:1
stock_AMGN r_down	slipped:2 cents:2 blood:2 primary:2 trading:2 duration:4 its:2 breast:2 cancer:2 said:4 goal:2 patients:2 shares:2 treatment:4 which:4 chemotherapy:2 white:2 recent:2 meeting:2 's:2 number:2 compared:2 effects:2 groups:2 others:2 taking:4 condition:2 $:2 both:2 17:2 --:6 markets:2 study:4 cells:2 drug:2 side:2 severe:4 depositary:2 similar:2 reduced:2 experimental:2 late-stage:2
stock_AMGN r_up	facing:1 's:1 cancer:1 --:1 breakthroughs:1 one:1 brought:1 while:1 costs:1 rising:1 updates:1 year:1 biggest:1 care:1 meeting:1 than:1 issues:1 more:1
stock_AMGN r_down	mostly:1 required:1 ones:1 green:1 model:1 antibody:1
stock_AMGN r_down	leaders:1 recommends:1 's:3 key:1 drugs:2 pay:1 two:1 coverage:1 opinion:1 change:1 anemia:1
stock_AMGN r_down	reveals:1 13:1 2009:1 run:1 $:1 earned:1 review:1 million:1 companies:1 employers:1 forms:1 other:1 members:1 jobs:1 side:1 250:1 total:1 they:1 former:1 congressional:1 staff:1
stock_AMGN r_down	certain:1 back:1 dosing:1 stroke:2 kidney:3 scale:1 increase:2 their:1 treatment:2 issued:2 new:2 warnings:2 drugs:3 after:2 doctors:1 such:2 anemia:3 suggested:2 kind:2 could:2 disease:2 patients:3 risks:2 studies:2 called:1
stock_AMGN r_up	help:2 over:1 its:2 issues:2 $:1 guidance:2 source:2 spread:2 denosumab:2 has:2 premium:1 risk:3 familiar:2 survival:2 125:1 10-year:1 advanced:2 --:2 notes:3 did:2 unsecured:1 bone:6 prevent:2 deal:2 competition:2 challenges:2 growth:2 pricing:2 pain:2 various:2 patient:2 risen:2 10-:2 million:1 reported:2 key:2 regulatory:2 debt:2 change:2 manufacturer:1 study:2 according:2 drug:5 suggests:1 cancer:4 spreading:4 five-:2 reducing:2 market:2 size:1 use:2 basis:3 least:1 rates:2 expected:1 500:1 offering:2 company:4 benchmark:1 delayed:2 priced:1 related:2 syndicate:2 known:2 95:1 applied:2 n't:2 patients:2 future:2 piece:3 have:2 also:2 three-part:2 five-year:1 145:1 's:9 though:2 preliminary:1 prostate:2 expand:2 third:1 considered:2 later:1 disease:2 points:3 biotechnology:1 senior:1
stock_AMGN r_up	emerging:1 over:2 expects:1 trade:2 session:2 including:1 innovative:1 find:1 whose:2 giant:2 $:15 rose:1 expectations:1 source:1 only:1 offers:1 candidates:1 notes:7 premarket:1 under:1 holiday:1 premium:1 risk:1 beat:1 familiar:2 rise:1 watch:1 results:1 120:1 putting:1 preparing:1 10-year:3 world:2 salmonella:1 --:4 medicines:1 companies:3 morning:1 small:1 quarter:1 high-yield:1 bond:1 deal:8 signs:1 back:1 second:2 actively:2 pricing:1 scrutinizing:1 said:1 shares:2 its:2 3:5 five-year:3 new:1 cash-strapped:1 barometer:1 sold:2 million:2 conglomerate:1 pressure:1 although:1 manufacturing:1 manufacturer:1 launch:1 industry:2 larger:1 according:3 drug:2 surge:1 credit:1 amount:1 footwear:1 passing:1 maker:1 first:3 fourth-quarter:1 industrial:1 one:1 down:1 hospice:1 market:1 debt:2 basis:3 data:1 top:1 there:1 long:1 their:1 expected:2 markets:2 4:1 billion:8 750:2 offering:2 company:2 syndicate:2 90:1 posted:1 14:1 up:1 n't:3 record:1 growth:1 were:2 already:1 piece:3 launched:1 biotech:1 unsecured:1 investors:1 providers:1 totaling:1 sales:2 slowing:1 winding:1 investment-grade:1 sprouts:1 orders:1 4.6:1 no:1 began:1 1:2 earnings:1 largest:1 three-part:2 stock:1 added:1 's:7 140:1 after:1 levels:1 such:1 stocks:1 weekend:1 class:1 fiscal:2 stress:1 third:3 sale:1 person:1 points:3 2007:1 apparel:1 biotechnology:2 senior:1 1.25:2
stock_AMGN r_down	1.7:1 1.1:1 1.2:1 1.3:1 certain:2 1.8:1 discovery:2 trade:2 down:2 actively:2 trading:2 broader:1 year:2 partner:2 work:2 any:2 declined:2 whose:2 cancer:2 debt:1 recently:2 deal:6 lead:5 4.2:2 addition:2 since:2 29:2 shares:2 research:2 1:1 start:2 concerns:1 while:2 market:2 premarket:2 clinical:2 struck:2 has:2 worth:2 500:2 stock:2 development:4 royalties:2 's:2 stages:2 company:4 million:4 upon:4 agreement:2 slides:1 job:1 fell:2 arrangement:2 execution:2 stocks:3 manufacturing:2 lower:3 milestones:2 lost:2 receive:4 drug-stocks:2 eligible:2 companies:2 up:4 drug:1 slide:2 session:2 products:2 therapies:2 were:2 further:2 situation:1 payments:2 traded:2 terms:2
stock_AMGN r_down	prevent:2 because:2 cancer:2 clinical:2 existing:2 spinal:2 year:2 bones:2 pain:2 exclusivity:2 its:2 market:2 use:2 additional:2 granted:2 benefit:2 also:4 spread:2 new:2 has:2 cord:2 therapies:2 shows:2 fractures:2 such:2 's:4 comparison:2 marketing:2 delayed:2 bone-drug:2 regulators:2 protection:2 significant:2 approval:2 data:2 compression:2 received:2 showed:2 drug:4 patients:2 complications:2 studies:2
stock_AMGN r_down	sector:1 help:1 sales:1 dollar:1 results:1 trends:1 another:1 should:1 full-year:1 crucial:1 next:1 outlooks:1 earnings:3 stable:1 boost:1 week:2 begin:1 's:2 price:1 includes:1 increases:1 updates:2 listening:1 report:1 during:1 along:1 strong:1 second-quarter:1 prescription:1 companies:2 batch:1 large:1 continue:1 expecting:1 biotechnology:1 overseas:1 quarter:1
stock_AMGN r_down	play:1 appear:1 less:1 issued:1 reality:1 blue-chips:1 others:1 new:1 debt:1 than:1 risky:1
stock_AMGN r_up	saying:1 over:1 move:4 domestic:1 results:4 quarters:1 session:1 headlines:1 still:1 its:10 whose:1 giant:2 $:10 surprises:2 28:6 expectations:8 send:1 analyst:2 advisories:2 quarterly:6 2011:4 details:2 updated:2 lack:1 increased:6 beat:4 continues:1 watch:4 early:1 long-anticipated:4 260:2 updates:2 2:1 trade:1 --:16 drop:4 companies:2 raised:2 higher:4 upper:2 declared:6 cost:2 deal:1 see:1 growth:1 mighty:1 year:2 further:1 2.7:8 gross:1 offsetting:2 sentiment:1 shares:1 forecast:2 current:2 progress:1 falling:1 shows:1 extend:1 marketing:2 million:2 seventh:2 reported:2 weaker-than-expected:1 offset:4 active:1 dividend:12 debt:3 beginning:4 roundup:1 reaction:2 quarter:2 getting:1 could:1 losses:1 reports:1 maker:2 first:10 comment:2 disclosure:2 major:2 projection:2 revenue:8 knocking:1 raises:4 throughout:2 your:1 decline:2 raise:1 per-share:2 much:1 expected:2 reflects:4 ceiling:2 first-ever:2 company:18 gain:4 sharply:1 second-quarter:5 posted:2 high:2 kind:1 up:1 maturity:4 future:1 limit:1 high-growth:4 spotlight:2 biotech:8 figure:1 cents:6 circus:1 share:8 expenses:2 13th:2 drug:2 close:1 again:1 damaged:1 end:4 also:2 5:2 earnings:8 stock:5 development:2 product:1 's:5 index:1 price:4 after:1 includes:1 fell:2 date:1 data:1 payment:2 billion:4 15.1:2 15.5:2 futures:1 costs:6 biotechnology:2 latest:1 corporate:1 came:2 once:4
stock_AMGN r_down	premium:1 widen:1 consider:1 deal:1 over:2 slowing:1 economic:1 investment-grade:1 year:3 wrap:1 further:1 still:1 its:1 market:1 relatively:1 even:1 debt:3 end:1 investors:1 widest:2 federal:1 much:1 government:1 spread:1 other:1 1.55:1 percentage:1 lingering:1 more:1 comparable:1 turning:1 risk:1 bonds:2 familiar:1 attention:1 points:1 levels:1 date:1 such:1 strong:1 threats:1 scrambles:1 performers:1 --:4 average:1 cap:1 up:1 securities:1 premiums:1 growth:1 indication:1 riskier:1 worries:1 corporate:3 bond:1
stock_AMGN r_up	estate:1 appeared:1 well:1 energy:2 sales:1 7.6:1 pharmaceutical:1 toy:1 3rd:1 stake:3 detail:1 passive:1 also:1 other:2 exit:1 which:2 new:2 real:1 company:1 number:1 reported:3 brokerage:1 investor:2 prominent:1 --:1 positions:1 companies:1 sale:1 cigarettes:2 9th:1 owns:1 10th:1 makes:2 maker:1 stakes:1
stock_AMGN r_down	among:1 real:1 estate:1 second:1 including:1 brokerage:1 saw:1 investment:1 whose:1 stake:1 their:1 other:1 those:1 which:1 new:1 approach:1 bets:1 funds:1 owns:1 reported:1 opposing:1 during:1 stocks:1 investor:1 bank:1 prominent:1 --:1 companies:1 cigarettes:1 were:1 mixed:1 quarter:1 makes:1 investments:1
stock_AMGN r_up	key:1 help:1 cancer:3 spreading:1 reduce:1 competition:1 helped:1 growth:1 rising:1 may:1 portfolio:1 blockbuster:1 open:1 its:3 issues:1 aging:1 use:1 said:1 4.2:1 profit:1 data:1 been:1 next:1 looking:1 pressures:1 spread:1 various:1 which:1 new:1 has:1 type:1 's:1 risk:1 drugs:1 company:1 reported:1 uses:1 related:1 decide:1 regulatory:1 aiming:1 prostate:2 potential:1 whether:1 numerous:1 months:1 up:1 drug:2 delay:1 faces:1 approve:1 bone:3 late-stage:1
stock_AMGN r_up	head:1 markets:1 tactics:1 assets:1 level:1 batten:1 today’s:1 writes:1 storms:2 hatches:3 valuable:1 keep:1 down:3 weather:1 weathering:1 same:1 choppy:1 true:1 market:2 extreme:1
stock_AMGN r_down	indications:1 cancer:3 revenue:1 being:2 sales:1 expenses:1 2.7:1 its:2 osteoporosis:2 use:1 said:1 4.1:1 two:1 second-quarter:1 increase:1 treatment:2 new:1 2010:1 earnings:1 men:1 giant:1 reported:1 fell:1 breast:1 biotechnology:1 approval:1 prostate:1 approved:1 women:2 loss:1 expanded:1 allows:1 drug:1 launched:1 making:1 higher:1 treated:2 bone:1 first:1
stock_AMGN r_down	findings:1 into:1 tax:1 argument:1 analysis:1 sense:1 if:1 little:1 would:2 flood:1 giving:1 avoid:1 their:2 holding:1 policy:1 public:1 shows:1 filings:1 back:1 most:1 change:1 paying:1 companies:1 cash:3 taxes:1 order:1 overseas:1 support:1 result:1
stock_AMGN r_up	biotech:1 increasing:1 's:1 fast-growing:1 lead:1 --:1 top:1 official:1 companies:1 mission:1 trade:1 access:1 explore:1 month:1 senior:1 next:1 market:1
stock_AMGN r_down	all:1 financial:1 being:1 some:2 back:1 1990s:1 find:1 decade:1 out:1 since:1 crisis:1 fans:1 short-term:1 edging:1 shut:1 after:1 but:1 favorites:1 such:1 debt:1 lost:1 markets:1 companies:1
stock_AMGN r_down	sector:1 biotech:1 companies:1 dollar:1 likely:1 any:1 market:1 again:1 third-quarter:1 looking:1 outlooks:1 earnings:1 firms:1 2011:1 2012:1 mostly:1 watching:1 weak:1 updates:2 significant:1 report:1 well:1 stronger:1 large:1 benefit:1 so:1 biotechnology:1 quarter:1
stock_AMGN r_up	development:1 says:1 cut:1 jobs:1 drugs:1 shift:1 company:1 maker:1 380:3 needed:1 restructures:1 which:1 organization:1 its:1 resources:1 late-stage:1
stock_AMGN r_up	program:1 '':1 63:3 dominating:1 another:1 headlines:1 3rd:1 p.m.:1 increase:1 version:1 earnings:1 corporate:1 stock:1 ``:1 good:1 's:1 upcoming:1 corrected:1 watch:2 early:1 repurchase:1 follows:1 reports:1 published:1 makes:1 acquisition:1 otherwise:1
stock_AMGN r_down	saying:1 global:1 quarters:1 four:1 session:2 headlines:1 its:6 litigation:1 whose:2 cut:1 $:4 rose:1 reserve:1 citing:1 program:2 board:1 2011:1 resources:1 very:2 big:1 watch:2 early:1 during:1 lost:2 --:1 companies:3 activity:1 quarter:1 expanded:1 force:1 leaders:1 second:1 actively:2 111:1 's:11 declined:2 2.4:1 said:2 profit:1 shares:3 1.75:1 repurchased:1 dominate:1 cost:1 full:1 recently:2 restructures:1 million:1 expansion:1 380:1 address:1 put:1 100:1 debt:1 roundup:1 shift:1 region:1 quiet:1 reports:2 credit:1 stock-buyback:1 swing:1 efforts:1 traded:3 surprises:2 outlook:1 slipped:1 point:2 awaited:1 third-quarter:1 102:1 63:3 total:1 crisis:1 advisories:2 charge:1 investors:2 prepare:1 negative:1 their:1 much:1 authorized:1 500:3 flat:1 ``:1 drugs:1 season:1 company:4 lowered:1 posted:1 10:2 jobs:1 work:1 up:1 n:1 while:2 future:1 ongoing:1 high-growth:1 trading:2 outcome:1 trader:1 1.1:2 stream:1 1.3:1 0.1:1 sales:1 days:1 '':1 investment-grade:1 unveiled:1 2.2:1 ratings:1 45:1 1:2 also:1 summit:1 5:1 earnings:4 sidelines:1 stock:2 development:1 edged:1 plans:1 digesting:1 buyback:1 fell:3 moving:1 plan:1 stocks:2 billion:4 lower:2 third:1 late-stage:1 futures:3 together:1 points:3 organization:1 latest:1 corporate:3 once:1
stock_AMGN r_up	actively:1 whose:1 lower:1 1.7:1 's:1 lost:1 session:1 companies:1 shares:1 fell:1 trading:1 declined:1 closed:1 after-hours:1 2.3:1 2:1 stocks:1 500:1
stock_AMGN r_up	among:1 30:1 says:1 have:1 cancer:4 summer:1 testing:1 due:1 put:1 against:1 2,500:1 's:3 cut:1 potential:1 trials:1 delays:1 only:1 been:1 research:1 also:1 waiting:1 clinical:2 treatment:1 which:1 supplier:1 has:1 more:1 affected:1 drugs:2 problems:1 but:1 not:1 hold:2 than:1 those:1 off:1 manufacturing:1 --:3 amid:1 many:1 list:1 drug:1 face:1 patients:2 ongoing:1 either:1 shortage:3 requests:1 studies:1 other:1 result:1
stock_AMGN r_up	help:4 being:1 move:1 actions:1 four:2 session:2 including:1 its:6 ground:1 rundown:1 whose:2 votes:1 $:12 rose:2 parts:1 cash:1 8:1 return:1 gains:1 bonds:1 conduct:1 13:1 they:1 own:1 continued:1 --:4 54:1 notes:1 companies:2 planning:1 common:1 launches:1 through:1 unsecured:1 noted:1 says:1 prompted:1 series:1 chunk:1 some:1 back:2 repurchases:4 modified:3 actively:2 trading:2 year:1 tender:5 declined:2 plans:1 said:2 threats:1 managing:1 since:1 shares:9 increase:1 late-session:1 between:2 new:3 firms:1 issue:3 public:1 shows:1 kicked:1 recently:2 shareholders:2 repurchase:1 dividend:1 debt:4 declining:2 21:1 first-ever:1 launch:1 auction:3 country:1 30:1 allows:1 days:1 reports:1 drama:1 fell:2 mixed:1 traded:2 maker:2 via:1 slipped:1 60:1 downgrade:1 1.7:1 trained:1 market:1 confidence:1 indicate:1 remains:1 two:1 their:2 gaze:1 biggest:2 500:4 acquisitions:1 ``:2 buy:2 offering:1 offer:4 offered:2 credit-rating:1 took:1 fund:6 bailout:1 highest:1 surged:1 10:2 television:1 pursue:1 wish:1 up:4 while:2 were:1 making:1 detailed:1 losses:1 outstanding:2 well:1 share:3 purposes:1 general:1 '':2 investment-grade:1 moves:2 any:1 sell:1 ratings:1 pay:1 1:1 other:1 costs:1 5:6 many:1 company:3 stock:3 gaining:3 added:1 's:4 allow:1 price:1 buyback:1 director:1 helped:1 74:1 funding:1 stocks:5 payment:1 euro:1 billion:4 lower:1 third:1 sizable:1 borrowing:1 roughly:2 daily:1 options:1 points:5 components:1 time:1 biotechnology:1 senior:2 corporate:1
stock_AMGN r_down	help:1 being:3 issued:1 four:1 ended:2 session:3 7.9:1 its:3 ground:1 whose:1 votes:3 monitored:3 $:7 22:1 rose:2 program:1 treatment:1 under:2 modestly:1 rescue:3 bonds:1 familiar:1 nearly:1 --:1 according:2 companies:1 planning:1 stopped:1 after-hours:1 unsecured:1 noted:3 because:1 deal:1 testing:1 jump:1 second:1 actively:1 trading:3 tender:1 85:1 threats:3 managing:3 announces:1 since:1 patients:2 shares:2 3:1 closed:3 provider:1 issue:1 shows:3 kicked:3 climbs:2 giant:1 agencies:1 focused:1 debt:2 downgraded:1 last:1 package:3 country:1 climbed:2 parts:1 surge:1 drama:3 trial:1 other:2 first:1 eyebrows:1 own:1 outcomes:1 rising:2 raises:1 size:1 confidence:3 remains:3 recruiting:1 two:1 their:3 clinical:1 low:2 6:1 recent:1 9.1:1 500:1 ``:3 offer:1 company:3 took:1 volume:2 fund:1 highest:1 surged:1 potential:1 television:3 clients:2 up:3 near:2 cancers:1 were:1 biotech:1 30:1 associated:1 ...:2 well:1 share:1 purposes:1 0.7:2 general:1 '':3 have:1 any:3 sell:1 ratings:1 tilt:2 discussion:2 reality:2 note:2 costs:4 5:2 commentary:1 events:3 higher:3 gaining:1 added:1 's:10 plans:1 highs:2 buyback:3 director:3 most:1 stocks:6 data:1 euro:1 billion:3 tracking:2 kept:2 borrowing:4 person:1 points:6 components:1 time:1 biotechnology:1 senior:1 corporate:1 latest:3
stock_AMGN r_down	development:1 shed:1 shot:1 1.1:1 cancer:1 certain:1 humans:1 play:1 used:1 actively:1 trading:1 roles:1 's:2 protein:1 involved:1 often:1 whose:1 23:1 shares:1 regulation:1 points:2 various:1 low:1 which:1 has:1 meeting:1 500:1 treat:1 body:1 product:2 145:1 recently:1 diseases:2 some:1 were:1 antibodies:1 fell:1 designed:2 known:1 93:1 stocks:1 potential:1 types:1 target:1 lower:2 showed:1 lost:1 antibody:1 study:1 annual:1 companies:1 specific:1 bad:2 session:1 can:1 cholesterol:2 action:1 autoimmune:1 traded:1 called:1 experimental:1 first:1
stock_AMGN r_down	said:1 office:1 supply:1 wo:1 share:1 into:1 retailer:1 buyback:1 its:1 n't:3 plan:1 go:1 further:1 aggressive:1 debt:1 order:1 more:1
stock_AMGN r_down	one-year:1 replacing:1 session:1 supply:2 end:1 regulatory:2 actively:1 agents:2 least:2 year:1 operator:2 recently:1 2.1:1 its:2 fifth:1 drugs:2 whose:1 needs:1 requirements:2 provide:1 44:1 comments:1 shares:1 1:1 discounts:1 points:3 2018:2 under:2 new:2 through:1 final:1 500:1 stock:1 gained:1 anti-anemia:2 's:5 clinics:3 expires:1 agreement:3 rebates:1 seven-year:2 updates:1 supplies:2 prices:1 90:3 disclosed:2 stocks:1 advanced:1 known:2 runs:2 lost:1 --:3 31:1 companies:1 drug:2 pact:1 trading:1 continue:2 stimulating:1 were:1 mixed:1 meet:3 2012:2 filing:2 7.6:1
stock_AMGN r_down	adviser:1 informed:1
stock_AMGN r_up	pharmaceutical:1 scientific:1 big:1 studying:1 medical:1 published:1 results:1 mounting:1 billions:1 research:2 n't:1 drug:1 companies:1 community:1 promising:1 new:1 ca:1 spends:1 therapies:1 shows:1
stock_AMGN r_up	limited:1 because:1 some:3 exist:1 daily:1 counts:1 still:1 benefits:1 rundown:1 said:1 requirements:1 no:1 restricted:1 though:1 moves:1 two:1 same:1 shares:1 safety:2 low:1 which:1 biggest:2 treat:1 gaining:2 's:2 both:3 drugs:3 distribution:2 treatments:1 market:1 blood:2 necessary:1 stocks:2 approved:1 condition:1 outweigh:1 restrictions:2 uncertain:1 longer:1 eased:1 experience:1 declining:2 ensure:1 risks:3 were:1 making:1 2008:1 stock:1 disorder:1 involves:1
stock_AMGN r_up	cited:1 ``:1 back:1 roughly:1 60:2 cost:1 tender:1 total:1 quality:1 makers:1 '':1 said:1 highlighting:1 $:3 pay:1 top:1 projected:1 shares:1 reliance:1 5:1 increasing:1 plant:1 buy:1 's:3 offer:1 big:1 posed:1 regulators:1 putting:1 contractors:1 end:1 manufacturing:1 effort:1 manufacturer:1 billion:1 challenges:1 troubled:1 auction:1 modified:1 drug:2 range:1 lapses:1 its:1
stock_AMGN r_up	biotech:1 's:1 auction:1 traders:1 savvy:1 rewarded:1
stock_AMGN r_up	sector:1 cautious:1 bullish:1 stocks:1 2012:2 several:1 he:1
stock_AMGN r_up	named:1 elect:1 prompting:2 retire:7 retires:1 businesses:2 year:3 tap:2 throughout:1 its:4 boosts:1 giant:2 said:4 end:1 also:1 since:2 29:7 research:2 chief:3 intends:1 longtime:2 details:1 company:2 leader:2 stock:1 head:2 executive:2 's:3 price:1 apparent:1 heir:1 next:2 succeed:2 operating:1 updates:1 background:1 position:1 dividend:1 president:1 after:1 he:2 last:1 --:3 board:1 2000:1 officer:1 mature:2 biotechnology:2 chairman:1 2012:7 steer:2
stock_AMGN r_up	trade:4 pops:1 session:6 tablets:1 7.5:1 headlines:1 its:1 whose:6 fronts:1 $:2 rose:6 workers:1 expectations:1 late:1 charge:1 quarterly:1 gave:1 three-day:1 watch:2 early:1 advanced:1 14.5:1 several:2 companies:6 morning:1 activity:1 stock:3 85:1 related:1 3.4:1 actively:6 trading:4 home:1 3.9:1 index:9 said:1 missed:1 blue-chip:1 shares:7 protections:1 closed:1 recently:2 downgrades:1 after-hours:2 losing:1 100:1 manufacturing:1 gained:2 institute:1 taking:1 climbed:4 experience:1 mixed:2 slightly:1 guidance:1 fourth-quarter:1 major:1 slipped:2 revenue:1 appeared:1 brush:1 66:1 unit:1 8.2:1 8.5:1 jobless:1 third-quarter:1 expected:3 proposal:1 pretax:1 500:1 mostly:1 company:1 but:1 spin:1 those:1 unsold:1 15:1 14:1 markets:2 edged:1 up:2 noncash:1 streak:1 1.6:1 30:1 1.1:1 investors:2 health-care:1 0.4:2 drug:1 tumbled:1 ratings:1 strength:1 pay:1 aside:1 topped:1 also:2 earnings:2 online:1 2.4:1 higher:2 's:9 after:2 forecasts:1 fell:1 71:1 claims:1 stocks:3 data:1 recent:1 fiscal:1 off:1 downbeat:1 traded:2 youths:1 futures:2 snapping:1 points:10 banks:1 weigh:1 corporate:1
stock_AMGN r_up	oncology:2 shot:4 agreed:2 resistance:1 trade:6 bring:2 session:5 its:6 previous:2 whose:5 giant:2 $:8 rose:5 revenue:2 28:2 expectations:2 capabilities:2 second-quarter:2 premarket:2 under:2 food:2 joint:2 they:2 ending:4 continued:4 medicines:2 companies:5 experience:4 officer:2 development:2 deal:8 estimates:2 actively:5 trading:1 expect:2 stronger-than-expected:2 2.2:1 margins:2 2.6:1 2.4:1 index:2 lead:2 shares:7 label:2 access:2 generics:2 provider:2 biosimilar:2 recently:1 commercial:2 bulls:2 hours:2 operating:2 manufacturing:2 both:4 39:4 2.8:2 many:4 climbed:1 outpace:2 leaving:4 products:4 traded:1 software:2 biologics:2 major:1 initial:2 rallied:1 slipped:2 point:3 had:2 another:1 cancer:2 8.7:2 pairing:2 third-quarter:2 long:4 fight:4 way:4 forward:4 touted:2 500:1 billion:4 complete:4 drugs:2 specialty:2 expected:4 sharply:1 line:2 than:2 challenge:2 work:2 patients:2 growth:2 quarters:2 distribution:2 acquisition:4 sales:2 dropped:2 have:1 nine-month:4 saw:4 sell:2 carriers:4 rather:2 47:2 potential:2 earnings:4 which:2 test:1 several:2 higher:3 breakdown:3 topping:2 added:1 's:23 after:2 fell:2 authorities:4 stocks:1 expand:2 recent:2 fiscal:4 antitrust:4 antibody:4 well:2 together:2 chief:2 costs:2
stock_AMGN r_up	major:1 own:1 biosimilars:1 player:1 likely:1 not:1 become:1 its:1
stock_AMGN r_down	says:1 global:1 rest:1 one:1 40:1 year:1 flying:1 least:1 poised:1 2012:1 buy:1 's:1 fell:1 turbulence:1 along:1 now:1 investor:1 than:1 industry:1 face:1 large:1 airline:1 time:1 more:2 looks:1
stock_AMGN r_down	followed:1 tough:1 lead:1 bonds:1 top:1 global:1 offerings:1 held:1 said:1 year:1 underwriter:1 's:2 stocks:1 its:1
stock_AMGN r_up	roundup:1 right:1 financial:1 help:1 business:1 morning:1 start:1 important:1 news:1 foot:1 's:1 you:1 your:1 day:1
stock_AMGN r_up	three-day:1 prospective:1 business:1 partners:1 300:1 over:1 period:1 team:1 than:1 more:1
stock_AMGN r_up	sector:1 based:1 cheap:1 metrics:1 including:1
stock_AMGN r_down	oncology:1 agreed:1 sales:1 looks:1 home:1 its:1 1.16:1 $:1 durable:1 platform:1 earnings:1 new:1 more:1 's:3 company:1 acquire:1 includes:1 biotechnology:1 expand:1 jobless:1 billion:1 goods:1 claims:1
stock_AMGN r_up	among:1 all:1 set:1 stepping:1 economists:1 saying:1 companies:2 1.8:1 sales:1 quarters:1 held:1 strongest:1 economic:1 businesses:1 thanks:1 have:2 talks:1 shopping:1 out:1 index:1 debt:1 spending:2 surprises:2 durable:1 since:1 informed:1 been:2 mark:1 blog:1 their:2 3:1 advisories:2 outlooks:1 too:1 expected:1 has:1 's:1 2010:1 day:1 earnings:1 adviser:1 recently:1 see:1 whose:1 auto:1 expansion:1 speak:1 goods:1 active:1 along:1 strong:1 data:1 grow:1 roundup:1 hits:1 holiday:1 showed:1 ahead:1 could:1 steady:1 up:2 reports:1 morning:1 stocks:1 future:1 rose:1 action:1 trading:1 corporate:1 think:1 latest:1
stock_AMGN r_up	billion:2 's:1 $:2 end:1 surge:1 1:1 decade:1 8:1 market:1
stock_AMGN r_down	prevent:1 use:1 group:1 cancer:1 seeking:1 men:1 other:1 spread:1 not:1 approval:1 has:1 prostate:1 responded:1 therapies:1
stock_AMGN r_up	gaining:2 rundown:1 moves:1 daily:1 sizable:1 market:1 shares:1 biggest:2 making:1 stocks:2 declining:2 stock:1
stock_AMGN r_down	advisory:1 use:1 cancer:1 federal:1 men:1 rejected:1 drug:1 spread:1 bone:1 not:1 bones:1 proposal:1 has:1 prostate:1 its:1 expand:1 panel:1
stock_AMGN r_down	has:1 ``:1 made:1 says:1 created:1 medicines:1 versions:1 shortcut:1 '':1 matter:1 complex:1 growth:1 expensive:1 biosimilar:1 market:1 first:1
stock_AMGN r_down	adviser:1 informed:1 ...:1
stock_AMGN r_up	pills:1 such:1 costly:1 cancer:1 rather:1 highlights:1 drug:1 fakes:1 simple:1 version:1 rising:1 threat:1 injectable:1 found:1 than:1 therapies:1 counterfeit:1
stock_AMGN r_down	among:1 3,000:3 away:1 major:1 40:1 indexes:1 clear:1 tech:1 points:1 nears:2 risks:1 fresh:1 outperformer:1 bubble:1 wings:2 signaling:1
stock_AMGN r_up	challenges:1 named:1 health-care:1 last:1 move:1 giant:1 should:1 past:1 few:1 finally:1 years:1
stock_AMGN r_up	case:1 's:1 cancer:1 involved:1 copies:1 drug:2 three:1 fakes:1 same:1 years:1 counterfeit:1 before:1
stock_AMGN r_down	suggested:1 do:1 prove:1 industry:1 companies:1 two:1 discoveries:1 need:1 ruling:1 new:1 jolted:1 biotechnology:1 more:1 really:1 their:1 patents:1 out:1
stock_AMGN r_up	set:1 's:1 trial:1 see:1 favorable:1 result:1
stock_AMGN r_up	week:1 early:1 giant:1 's:1 another:1 investors:1 trial:1 watch:2 results:1 drug:1 down:1 start:1 add:1 clinical:1 interest:1 headlines:1 appeal:1 corporate:1 stage:1
stock_AMGN r_up	treat:1 dialysis:1 drug:1 patients:1 adult:1 new:1 approved:1 anemia:1
stock_AMGN r_down	prospect:1 liberal:1 challenged:1 question:1 over:1 health-care:1 down:1 individual:1 seemed:1 overhaul:1 administration:1 conservative:2 health:1 split:1 justices:1 struck:1 ``:1 's:4 sharply:1 mandate:1 news:1 law:1 wings:1 raising:1 '':1 whether:1 could:1 morning:1 while:1 making:1 evenly:1
stock_AMGN r_up	adviser:1 informed:1
stock_AMGN r_down	session:1 's:3 deal:1 develop:1 companies:1 disease:1 shares:1 trade:1 actively:1 five:1 jointly:1 portfolio:1 expected:1 reached:1 treatments:1
stock_AMGN r_down	acquire:1 $:3 kidney:1 rights:1 giving:1 agreed:1 million:1 cash:1 315:3 disease:1 chronic:1 drug:2 maker:1 experimental:1 treat:1
stock_AMGN r_down	deal:1 its:1 stimulates:1 decision:1 cell:1 production:1 buying:1 new:1 red:1 hormone:1 's:2 company:1 blood:1 expand:1 $:3 billion:1 pipeline:1 success:1 medicines:1 drug:1 maker:1 credit:1 thin:1 1.26:3 bet:1
stock_AMGN r_up	confidence:1 set:1 's:3 off:1 highlights:1 slate:1 consumer:1 data:1 earnings:1 meeting:1 tap:1 corporate:1 tomorrow:1 kick:1
stock_AMGN r_up	session:1 buy:1 's:1 generic-drug:1 deal:1 people:1 700:1 company:1 million:1 companies:1 nearing:1 shares:1 trade:1 matter:1 actively:1 familiar:1 expected:1 according:1 roughly:1 $:1
stock_AMGN r_up	sector:1 dead:1 time:1 bullish:1 may:1 surprises:1 veteran:1 signs:1 some:1 been:2 surging:1 wrong:1 writes:1 tech:3 earnings:3 have:1 comeback:2 augur:2 has:1 rebound:1 market:1
stock_AMGN r_up	passenger:1 drop:1 's:2 reported:1 flight:1 leave:1 study:1 violence:1 drug:1 maker:1 n't:1 did:1 profit:1 damages:1 have:1 says:1 shows:1 children:1 exposure:1
stock_AMGN r_down	tumbled:1 product:1 generic:1 first-quarter:1 profit:1 amid:1 top:1 sales:1 drug:1 copies:1 19:1 competition:1 71:1 's:1 its:1 declined:1
stock_AMGN r_down	emerging:1 's:1 there:1 spot:1 least:1 one:1 bright:1 other:1 bleak:1 markets:1 landscape:1
stock_AMGN r_up	bondholders:2 colder:1 crisis:1 shareholders:1 been:1 their:1 returns:1 pretty:1 spring:1 has:1 friendly:1 poor:1 flex:1 muscles:1 far:1 shareholder:1 disappointed:1 climate:1 corporate:1 so:1 starting:1 mean:1
stock_AMGN r_down	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_AMGN r_up	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_AMGN r_down	hunts:1 bargains:2 safest:1 deals:1 middle:1 assets:1 stock:2 overbought:1 riskiest:1 hiding:2 best:1 bond:2
stock_AMGN r_up	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_AMGN r_down	upgraded:1 cancer:1 low-cost:1 joints:1 health-care:1 share:1 including:1 its:1 relatively:1 profitable:1 ratings:2 upgrade:1 over-the-counter:1 leading:1 make:1 six:1 range:1 artificial:1 production:1 criteria:1 short-term:2 markets:1 's:1 drugs:2 stable:1 medications:1 five:1 others:1 medical:1 changed:1 companies:2 large:1 while:1 products:1 model:1 notch:1 issuers:1
stock_AMGN r_up	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_AMGN r_down	said:1 primary:1 risk:1 failed:1 reducing:1 study:1 disease:1 suffering:1 drug:1 events:1 chronic:1 patients:1 endpoint:1 evaluating:1 meet:1 effectiveness:1 its:2 kidney:1 cardiovascular:1
stock_AMGN r_down	1.5:1 biotech:2 consider:2 played:1 companies:1 estimates:1 quarters:1 down:1 3.0:1 downplayed:1 2.0:1 2.5:1 said:1 based:1 two:2 per:1 current:1 concerns:2 safety:2 treat:2 income:1 =:5 used:2 's:2 drugs:2 share:1 company:2 operating:1 included:1 lawsuit:2 anemia:2 --:1 challenge:2 alleging:2 list:1 securities:2 survey:1 analysts:2
stock_AMGN r_up	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_AMGN r_up	's:3 advantage:1 health-care:1 priced:1 following:1 benefit:1 verdict:1 popular:1 court:1 options:1 movement:1
stock_AMGN r_down	meant:1 affordable:1 overhaul:1 challenging:1 federal:1 medicines:1 health:1 era:1 new:1 usher:1 provision:1
stock_AMGN r_down	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_AMGN r_down	even:1 they:1 uphold:1 largely:1 cuts:1 certainty:1 decision:1 health-care:1 some:1 drug:1 face:1 price:1 dollars:1 billions:1 though:1 fees:1 law:1 makers:1 gives:1
stock_AMGN r_up	hit:1 ranking:1 right:1 's:5 takes:1 billing:1 give:1 top:1 annual:1 behind:1 reputation:1 survey:1 our:1 once:1 more:1
stock_AMGN r_up	1.5:1 companies:1 estimates:1 sales:2 month:2 per:1 3.0:1 2.0:1 its:4 2.5:1 25:4 based:1 $:6 earned:2 one-time:2 current:1 2018:2 under:2 =:5 royalties:2 after:2 amended:2 exchange:2 share:1 million:2 agreement:2 operating:1 included:1 quarters:1 payment:2 license:2 rights:2 receive:4 list:1 income:1 drug:2 survey:1 analysts:2
stock_AMGN r_up	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_AMGN r_up	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_AMGN r_up	investors:2 some:2 results:2 competition:2 bring:2 likely:4 same:2 have:4 any:2 market:4 large:2 slow:2 also:2 watching:2 been:4 their:6 concerns:2 details:2 new:2 faring:2 pipelines:2 traditional:2 manufacturers:2 drugs:2 continues:2 treatments:2 sales:2 focused:2 report:2 intensify:2 second-quarter:2 expand:2 older:2 companies:4 trends:2 drug:4 facing:2 remain:2 strategies:2 efforts:2 acquisition:2
stock_AMGN r_up	151:2 development:2 cancer:2 60:2 including:2 reached:2 its:2 fee:2 develop:2 $:8 treat:4 which:2 entered:2 has:2 worldwide:2 terms:2 diseases:2 drugs:2 company:2 million:4 agreement:4 paid:2 focused:2 milestone:2 front:2 8.5:6 diabetes:2 developing:2 --:4 up:2 drug:4 patients:2 2009:2 called:2
stock_AMGN r_down	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_AMGN r_up	comment:1 adjusted:2 weaker:1 financial:1 investors:1 revenue:3 year:2 estimates:1 results:2 years:1 helped:1 full-year:1 growth:3 rising:1 exceeded:1 close:1 83:1 headlines:1 throughout:1 its:3 boosts:1 rundown:1 giant:1 blockbuster:1 details:1 pressured:1 23:1 profit:1 rose:2 watch:2 expectations:3 per-share:1 forecast:1 increase:1 drugs:1 16.5:1 other:2 earnings:5 interest:1 fuel:1 8:3 outlook:1 anemia:1 2012:5 's:5 beat:2 continuing:1 company:3 after-hours:1 overall:1 treatments:1 sales:4 early:1 reported:1 8.2:3 background:1 offset:1 estimate:1 range:1 second-quarter:2 recovery:1 billion:4 challenges:1 handily:2 third:1 --:3 up:1 drug:2 $:9 prior:2 trading:1 were:1 biotechnology:1 raised:2 stock:1 corporate:1 4.7:1
stock_AMGN r_up	saying:1 all:1 move:1 $:18 quarters:1 6.5:2 reclaiming:1 its:12 weekly:3 25:3 21:1 23:2 rose:14 headed:2 troubles:1 expectations:2 revenue:4 16.5:2 advisories:2 8:1 has:1 hope:2 2012:6 gains:5 10:1 beat:2 bid:2 anticipated:2 nearly:1 report:2 spur:2 advanced:2 anemia:2 58:1 stimulus:2 performing:1 companies:4 after-hours:2 raised:4 stock:4 round:2 billion:8 energy:1 estimates:2 slowdown:2 second:2 actively:3 trading:7 3.1:1 2.2:2 investment:2 best:1 index:5 said:2 confirm:2 since:1 while:4 shares:7 future:1 health:1 intraday:1 closed:1 strategist:2 sole:1 recently:2 pushing:1 monetary:4 bulls:2 hours:1 8.2:6 offset:2 estimate:2 debt:1 care:1 gained:2 prospects:2 quarter:2 central:1 central-bank:2 30:2 reports:2 prior:2 range:2 leading:2 turf:1 traded:2 reclaim:2 among:1 adjusted:2 0.8:2 awaited:2 13,000:5 weaker:2 market:2 intervention:2 pharmaceutical:2 industrials:1 would:1 positive:1 two:1 per-share:2 start:2 2:1 growth:2 expected:2 500:4 roundup:1 ``:2 drugs:2 company:8 but:1 sales:2 sharply:2 second-quarter:2 '':2 grew:1 anticipate:1 up:5 n't:1 near:2 economic:2 nine:1 were:6 3.2:1 0.9:1 1.5:1 1.6:1 climbed:1 surprises:2 investors:5 unchanged:2 year:4 0.5:1 1.9:3 high:1 laggard:1 curb:1 further:4 close:2 rally:1 spooked:2 moves:3 4.7:2 end:2 chief:2 topped:2 traders:2 other:2 earnings:11 outlook:2 higher:4 week:3 added:4 's:9 83:2 after:5 tops:2 treatments:2 forecasts:2 included:2 stocks:9 data:2 rallied:4 lower:2 sectors:1 futures:6 well:2 three-month:1 points:13 components:2 banks:1 latest:1 corporate:1 joining:1
stock_AMGN r_down	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_AMGN r_up	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_AMGN r_down	independent:1 pancreatic:1 cancer:1 trial:1 addition:1 review:1 after:1 three:1 unlikely:1 ended:1 interim:1 treatment:2 goals:1 meet:1 phase:1 study:2 type:1 its:1 panel:1
stock_AMGN r_up	pointing:1 ended:1 session:1 businesses:1 its:3 1:1 $:2 rose:2 revenue:1 expectations:1 4:1 8:1 has:1 fourth:1 seemingly:1 continued:1 advanced:1 loss:1 --:1 companies:1 write-down:1 stimulus:1 interim:1 after-hours:1 release:1 quarter:1 significantly:1 slowdown:1 economic:1 trading:2 said:1 actively:1 missed:1 review:1 shares:2 waiting:1 surprise:1 weak:1 reported:1 post:1 strong:1 panel:1 pancreatic:1 many:1 study:2 30:1 trial:1 range:1 analysts:1 narrow:1 traded:1 cancer:1 point:1 derivatives:1 little:1 publishing:1 addition:1 there:1 three:1 anyone:1 1.55:1 taken:1 9.7:1 type:1 500:1 more:1 fiscal:1 head:1 company:1 but:1 sales:1 expected:1 goals:1 second-quarter:1 those:1 case:1 while:1 growth:1 were:1 meet:1 toward:1 strengthening:1 investors:1 ``:1 '':1 unlikely:1 saw:1 suggest:1 treatment:2 traders:1 earnings:2 multibillion-dollar:1 stock:1 independent:1 's:3 may:1 after:3 most:1 fell:2 phase:1 data:2 billion:1 futures:3 overnight:1 points:2
stock_AMGN r_down	1.5:1 fourth-quarter:2 cancer:2 revenue:2 companies:1 estimates:1 doubled:2 quarters:1 higher:2 3.0:1 year:2 close:2 narrowed:2 2.0:1 its:2 2.5:1 per:1 drugs:2 5.3:2 8.5:2 $:4 expectations:2 shares:2 current:1 far:2 other:2 treat:4 income:1 survey:1 has:2 =:5 more:2 's:2 received:2 beat:2 share:1 company:6 million:2 agreement:2 reported:2 focused:2 milestone:2 included:1 develop:2 than:2 diabetes:2 fiscal:2 loss:2 developing:2 based:1 list:1 up:2 drug:4 patients:2 so:2 analysts:2 were:2 operating:1 stock:2
stock_AMGN r_down	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_AMGN r_down	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_AMGN r_up	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_AMGN r_up	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_AMGN r_down	tentatively:1 's:3 investors:1 facility:1 legality:1 mixed:1 euro-zone:1 start:1 bailout:1 ruling:1 expected:1 stocks:1 known:1 wait:1
stock_AMGN r_down	sterling:2 rated:2 advantage:2 increasingly:2 companies:2 taking:2 borrowing:2 relative:2 calm:2 2009:2 euro:2
stock_AMGN r_up	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_AMGN r_up	associated:1 previously:1 life:1 dose:1 '':1 its:1 osteoporosis:4 use:1 said:2 based:1 six:1 only:1 denosumab:1 which:1 new:2 has:1 issue:1 showing:1 more:1 fractures:1 ``:1 rise:1 led:1 offered:1 men:3 increases:1 compared:1 every:1 allowing:1 significant:1 injection:1 approved:2 women:2 increasing:1 study:1 months:1 disease:1 drug:1 indication:1 placebo:1 bone:1
stock_AMGN r_down	associated:1 previously:1 life:1 trade:2 '':1 session:2 led:1 its:1 osteoporosis:4 use:1 said:2 based:1 six:1 shares:2 only:1 denosumab:1 which:1 expected:2 new:2 has:1 issue:1 showing:1 more:1 fractures:1 ``:1 rise:1 's:2 offered:1 men:3 increases:1 compared:1 every:1 allowing:1 significant:1 injection:1 dose:1 approved:2 women:2 increasing:1 study:1 months:1 companies:2 disease:1 drug:1 actively:2 indication:1 placebo:1 bone:1
stock_AMGN r_up	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_AMGN r_up	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_AMGN r_down	superior:1 prospects:1 buy:1 puts:1 bonds:1 growth:1 plus:1 income:1 than:1 stock:1
stock_AMGN r_up	week:1 shut:1 last:1 distributed:1 year:1 moved:1 websites:1 pharmacy:1 down:1 drug:1 officials:1 owned:1 doctors:1 wholesaler:1 counterfeit:1
stock_AMGN r_down	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_AMGN r_up	health-care:2 gains:1 sectors:2 showing:1 rise:2 sales:1 reports:1 increase:1 also:1 market:1 lift:1 buoyed:2 investors:1 retail:1 data:1 bank:3 consider:1
stock_AMGN r_down	among:1 revenue:1 trend:3 results:1 trade:1 see:1 growth:1 raises:1 year-earlier:1 intermediate-term:1 contributed:1 third-quarter:1 shares:1 earnings:3 expected:1 downturn:1 company:1 speaking:1 more:1 's:2 week’s:1 watch:2 hurt:1 flag:1 newer:1 active:1 than:1 those:1 charges:1 shift:3 doubled:1 technical:2 session:1 products:1 were:1
stock_AMGN r_up	saying:1 issued:2 results:3 trade:3 session:3 through:1 still:1 year-earlier:2 its:6 cut:1 $:2 rose:2 than:3 going:1 money:2 quarterly:2 do:1 income:2 period:2 gloomy:1 they:2 international:2 now:1 loss:2 --:3 companies:5 doubled:2 consensus:1 quarter:1 says:1 estimates:1 likely:1 actively:3 year:2 out:2 index:1 said:2 contributed:2 shares:3 forecast:1 current:1 progress:2 net:2 run:1 closes:2 expansion:2 hours:2 reported:2 slow:1 operating:1 estimate:1 wait:1 roundup:1 many:2 reports:1 thing:1 products:2 advertising:2 social:2 expense:2 fourth-quarter:2 revenue:2 encouraging:2 one:1 decline:2 use:2 would:2 third-quarter:5 been:1 scenarios:1 advisories:2 growth:2 too:1 expected:3 markets:1 more:4 some:2 company:4 but:2 site:2 phone:2 newer:2 analyst:1 posted:2 13:2 14:2 88:2 devices:2 charges:2 below:1 future:1 were:2 quarters:1 making:2 problem:1 surprises:2 sales:2 high:1 have:5 'll:1 also:2 earnings:5 fourth:1 season:1 becoming:1 analysts:2 's:7 though:1 after:2 effect:1 react:1 hurt:2 data:2 longer:1 mobile:4 amid:2 clear:1 costs:2 so:1 profits:2 weigh:2 corporate:1 came:2 latest:1
stock_AMGN r_up	sales:1 high:1 all-time:1 have:1 high-profile:1 follow:1 slow:1 fourth:1 remains:1 been:1 forecast:1 their:1 outlooks:1 earnings:4 slash:1 suit:1 falter:2 500:1 more:1 worse:2 operating:1 grow:2 prospects:2 companies:1 analysts:1 quarter:1
stock_AMGN r_down	turning:1 divide:2 business:2 season:1 into:1 purse:1 loosening:1 their:1 while:1 tightens:1 earnings:2 seen:2 strings:1 consumers:1
stock_AMGN r_down	show:1 quarters:1 cardiovascular:1 20:1 justices:1 divergent:1 do:1 risk:1 views:1 anemia:1 --:2 medicines:1 list:1 securities:1 either:1 cholesterol:5 people:1 companies:1 successfully:1 estimates:1 3.0:1 2.0:1 ballot:1 2.5:1 n't:2 per:1 current:1 safety:1 new:1 cause:1 operating:1 based:1 estimate:1 lawsuit:1 attacks:1 levels:2 survey:1 analysts:2 experimental:1 1.5:1 biotech:1 ca:1 down:1 proceed:1 two:1 been:1 their:1 treat:1 way:1 which:1 lowering:1 successful:1 company:1 but:1 released:1 lowered:1 cases:1 case:1 fraud:1 developing:1 whether:1 challenge:1 tolerate:1 flagship:1 patients:1 can:1 called:1 heart:1 played:1 share:1 accept:1 high:1 have:2 increased:1 drugs:2 suggest:1 class-action:1 also:1 ideal:1 concerns:1 widely:1 income:1 =:5 used:1 's:1 strokes:1 most:1 involving:1 allowing:1 included:1 lower:1 statins:1 alleging:1 disease:1 researchers:1
stock_AMGN r_up	lower:1 drugs:1 suggest:1 successfully:1 released:1 involving:1 way:1 cholesterol:2 new:1 experimental:1
stock_AMGN r_up	1.5:1 cancer:1 list:1 estimates:1 lengthen:1 quarters:1 cease:1 3.0:1 fail:1 2.0:1 its:1 2.5:1 said:1 based:1 trials:1 per:1 current:1 clinical:1 treatment:1 income:1 =:5 development:1 share:1 after:1 lives:1 included:1 pancreatic:1 operating:1 companies:1 drug:1 patients:1 survey:1 analysts:2 become:1 latest:1
stock_AMGN r_up	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_AMGN r_down	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_AMGN r_down	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_AMGN r_up	1.5:1 function:1 population:3 3.0:1 deal:1 enhances:3 2.5:1 certain:3 agreed:5 find:3 updated:1 quarters:1 identify:3 per:1 genes:3 throughout:1 technology:1 targets:3 backseat:1 risk:5 adding:1 use:1 said:3 genetics:5 $:14 share:1 factors:5 personal:1 pay:1 links:3 diseases:11 research:1 access:3 companies:1 genetic:6 take:1 which:5 between:3 2.0:1 new:1 more:3 dozens:5 =:5 price:1 details:1 development:2 tests:1 acquire:5 's:5 plans:1 income:1 quote:1 company:2 million:6 giant:3 diagnostic:1 uses:3 all-cash:1 included:1 based:1 validate:3 efforts:3 improve:1 treat:3 pipeline:1 operating:1 --:3 current:1 list:1 drug:1 415:12 range:3 estimates:1 survey:1 analysts:2 broad:3 expertise:3 identifies:5 stock:1 its:3
stock_AMGN r_up	11:1 roundup:1 around:1 venture-capital:1 affiliates:1 protection:1 analysis:1 filed:1 news:1 bankruptcy:1
stock_AMGN r_down	raised:1 share:1 repurchases:1 looks:1 year:1 its:1 $:3 next:1 2:3 authorized:1 has:1 boost:1 board:1 's:1 company:1 shareholder:1 value:1 dividend:1 additional:1 billion:1 31:1 drug:1 quarter:1 first:1
stock_AMGN r_up	results:1 trade:1 session:1 looks:1 talks:1 year-earlier:1 its:1 $:4 rose:2 28:1 expectations:2 production:1 board:1 has:1 companies:1 after-hours:1 quarter:1 significantly:1 repurchases:1 growth:1 trading:1 year:1 slumped:1 margins:1 missed:1 shares:1 creative:1 masking:1 boost:1 avert:1 subscriptions:1 reported:1 restructuring:1 news:1 manufacturing:1 benefits:1 ahead:2 inspired:1 drug:1 analysts:1 nervous:1 first:1 fourth-quarter:2 raised:1 industrial:1 period:1 services:1 dividend:1 next:1 market:1 eye:1 additional:1 sports:1 2:3 overhead:1 authorized:1 expected:1 upbeat:1 fiscal:3 company:2 but:1 prices:1 94:1 keeping:1 grew:1 15:1 up:2 value:1 actively:1 were:1 31:1 slid:1 weaker:1 investors:1 share:1 sales:1 earnings:2 stock:1 's:5 income-tax:1 shareholder:1 included:1 data:1 cliff:1 billion:1 lower:2 charges:1 futures:1 costs:1 consumer:1 came:1
stock_AMGN r_up	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_AMGN r_down	150:1 guilty:1 agreed:1 one:1 brought:1 its:1 best:1 pharmaceutical:1 use:1 $:1 pay:1 research:1 charge:1 does:1 promoting:1 development:1 business:1 big:1 million:1 job:1 complicated:1 off-label:1 anemia:1 charges:1 companies:1 drug:1 settle:1 so:1
stock_AMGN r_down	150:1 providers:1 agreed:1 allegations:1 '':1 settlement:2 its:2 defraud:1 use:2 off-label:2 court:2 $:4 federal:2 pay:2 charge:1 health:1 promoting:1 care:1 ``:1 's:2 government:1 offered:1 million:2 judge:1 kickbacks:1 approved:1 anemia:2 helped:1 resolve:1 require:1 guilty:1 drug:2 illegal:1 promoted:1
stock_AMGN r_down	comment:1 twelve:1 seven:1 ten:1 providers:1 into:1 reduce:1 '':1 accused:1 involvement:1 high-profile:1 settlement:4 its:2 defraud:1 indicted:1 said:1 hide:1 $:5 eleven:1 federal:3 pay:2 charge:1 approved:2 failed:1 conspiring:1 health:1 details:1 employee:1 420:1 anemia:1 offered:1 brought:1 more:1 ``:1 's:2 commerce:1 allegations:1 company:1 million:3 use:1 illegal:1 were:1 eight:1 judge:2 court:2 off-label:1 bringing:1 than:1 additional:1 helped:1 resolve:1 attorneys:1 study:1 clients:1 guilty:1 bankers:1 drug:3 part:1 nine:1 risks:1 cholesterol:1 promoted:1 kickbacks:1 interstate:1 require:2 care:1
stock_AMGN r_up	comment:1 1.5:1 golf:1 companies:1 estimates:1 quarters:1 3.0:1 2.0:1 decisions:1 2.5:1 based:1 dinners:1 influence:1 per:1 current:1 few:1 income:1 =:5 appreciate:1 week:1 physicians:1 's:3 share:1 reps:1 free:1 operating:1 doctors:1 included:1 made:1 last:1 did:1 medical:1 list:1 n't:1 column:1 survey:1 analysts:2
stock_AMGN r_down	says:1 members:1 being:1 into:1 executive:1 say-on-pay:1 general:1 '':1 writes:1 relations:1 have:1 issues:1 rely:1 thinking:1 pay:1 explain:1 long:1 their:1 board:1 trend:1 has:1 today:1 more:1 development:1 ``:1 's:2 practice:1 shareholders:1 long-term:1 job:1 catalyst:1 they:1 resisted:1 investor:1 pulled:1 like:1 counsel:1 boards:1 touchy:1 corporate:1 best:1 companies:2 face:1 directors:1 expecting:1 policies:1 time:1 section:1 become:2 starting:1 defend:1 result:1
stock_AMGN r_up	roundup:1 venture-capital:1 around:1 analysis:1 news:1
stock_AMGN r_down	stocks:1 's:1 investors:1 believes:1 rally:1 chance:1 offers:1 gauge:1 fall:1 sharp:1 fear:1 wager:1 poised:1 500:1
stock_AMGN r_down	body:1 's:2 assets:1 managed:1 powerful:1 owned:1 former:1 also:1 governing:1 financier:1 team:1 cycling:2 investment:1 bank:1
stock_AMGN r_up	writedown:1 rethinking:1 ``:1 30:1 's:3 22:2 business:2 light:1 rise:1 morning:1 '':1 reads:1 options:1 including:1 after:1 big:1 comeback:1 strategic:1 its:1 best:1 $:1
stock_AMGN r_down	money:1 move:1 ``:1 back:1 '':1 held:1 accounts:1 downside:1 have:1 year:1 home:1 shining:1 funny:1 said:1 $:3 writes:1 there:1 reinvest:1 shares:1 actually:1 outside:1 much:1 permanently:1 earnings:3 lot:1 must-read:1 learned:1 include:1 we:1 's:3 plans:1 sitting:1 company:1 earlier:1 yesterday:1 most:1 increases:1 investments:1 29.1:1 billion:3 country:1 companies:1 cash:2 filing:1 securities:1 thing:1 stockpile:1 upside:1 overseas:1 spotlight:1
stock_AMGN r_down	move:1 swings:3 their:1 amid:1 needle:1 handful:1 companies:1 while:1 reports:1 few:2 see:1 health:2 earnings:3 others:1 wild:3 barely:1 stocks:1 health-care:1 slew:1 stock:2
stock_AMGN r_up	fiscal:1 unwelcome:1 avert:1 deal:1 ties:1 company:2 month:1 rivals:1 close:1 included:1 surprise:1 cliff:1
stock_AMGN r_up	them:1 separate:1 marketing:1 company:1 partnership:1 headquarters:1 teams:1 their:2 merging:1 moving:1 either:1 have:1 new:1 diabetes-drug:1 diabetes:1
stock_AMGN r_up	investors:1 money:1 into:1 style:1 have:1 out:1 profitable:1 mutual:3 jour:1 next:2 7:2 correction:2 more:1 buy:2 funds:3 after:2 ultimately:1 herd:1 most:1 du:1 than:1 categories:1 following:1 stock:1 pulled:1
stock_AMGN r_down	investors:1 money:1 into:1 style:1 have:1 profitable:1 mutual:3 wallflowers:1 jour:1 crowd:2 should:2 7:2 more:1 funds:3 ultimately:1 herd:1 most:1 du:1 than:1 categories:1 ignore:1 following:1 stock:1 pulled:1
stock_AMGN r_down	raised:1 significantly:1 pointing:1 settlements:1 tax:1 years:1 aggressive:1 adjustment:1 makers:1 bottom:1 federal:1 recorded:1 its:1 their:2 earnings:1 boon:1 2013:3 view:1 lower:1 taking:1 lines:1 taxes:1 prior:1 steps:1 quarter:1 first:1
stock_AMGN r_up	among:1 outlook:1 launching:2 projection:1 investors:1 biotech:1 over:1 revised:1 tax:1 hallmark:1 ninth:1 years:1 13th:1 phase:1 rate:2 comments:1 year:1 our:1 next:1 seek:1 its:6 even:1 giant:1 said:2 'll:1 would:2 patent:3 review:1 six:1 able:1 per-share:1 fight:1 revenue:1 few:1 earnings:2 meeting:1 international:2 2017:1 biosimilar:1 markets:1 2013:4 details:1 lowest:1 ``:1 '':1 saying:1 expirations:1 business:1 drugs:2 company:1 lose:1 lower:1 expansion:1 period:1 analyst:1 we:1 protection:1 grow:1 new:1 prepares:1 beginning:1 biosimilars:1 cliff:1 aggressively:1 peers:1 15:1 14:1 --:3 copycat:1 flow:1 cash:1 predicted:1 many:1 history:1
stock_AMGN r_up	reactions:1 least:1 founder:1 deaths:1 plunged:1 some:1 private:1 one:1 actively:2 trading:2 reports:1 kidney-disease:1 's:5 moves:1 its:1 84:1 rose:1 two:1 shares:3 session:1 take:1 expected:1 several:1 patients:1 higher:1 added:1 recently:1 offer:1 company:1 surges:2 notable:1 five:1 trade:1 stocks:2 response:1 after:1 rallied:1 12:3 16:1 movers:2 recall:1 climbed:1 companies:2 drug:1 severe:1 points:3 including:1 were:1 following:1 making:1 allergic:1
stock_AMGN r_down	biotech:1 all:1 least:1 costly:1 prompted:1 reactions:1 caused:1 some:1 billions:1 '':1 cost:1 trading:1 reports:1 kidney-disease:1 patient:1 86:1 its:1 85:2 deaths:1 death:1 plummet:1 missed:1 trials:1 delays:1 biosimilars:1 severe:1 shares:1 clinical:2 health:1 systems:1 has:1 patients:1 midday:1 allergic:1 ``:1 's:5 company:2 after:2 anticipated:1 involving:1 five:1 fatalities:1 recalls:1 anemia:3 several:1 versions:1 --:1 recall:3 could:1 obstacles:1 plunged:1 drug:5 facing:1 savings:1 stopped:1 pediatric:1 following:1 including:1 plunges:2 study:1
stock_AMGN r_up	securities:1 used:2 played:2 drugs:2 alleging:2 two:2 down:2 --:1 concerns:2 safety:2 treat:2 way:1 cleared:1 lawsuit:2 block:1 anemia:2
stock_AMGN r_up	case:1 securities:1 lower:1 fraud:1 shot:1 sending:1 class-action:1 back:1 down:1 court:1 suit:1 claims:1 effort:1
stock_AMGN r_up	named:1 's:1 lead:1 replacing:1 executive:1 drug:1 arm:1 retiring:1 former:1
stock_AMGN r_up	sector:1 deal:2 share:1 niche:1 existing:1 trading:1 value:1 another:1 year:1 market:1 gross:1 shareholders:1 documents:1 based:1 opened:1 giving:1 rose:1 six:1 shares:3 their:1 above:1 recent:1 price:1 more:1 head:1 run:1 offering:1 targeted:1 company:2 million:2 filed:1 sold:3 strong:1 continued:1 than:1 $:6 --:1 up:1 35:1 while:1 were:1 first:1
stock_AMGN r_down	roundup:1 venture-capital:1 around:1 analysis:1 news:1
stock_AMGN r_up	behavior:1 executive:2 including:1 have:1 cancel:1 recover:3 violates:2 pharma:1 would:1 also:1 make:2 able:1 bad:1 next:1 makers:1 their:2 biggest:1 firms:1 easier:2 's:1 buckling:1 payouts:3 rules:2 big:1 pressure:1 pay-for-performance:1 report:1 ethics:2 investor:1 level:1 --:1 should:1 taking:1 companies:2 drug:1 compensation:2 future:1 stopped:1 payments:1 policies:2 revising:2 executives:1 otherwise:2
stock_AMGN r_down	pharmaceutical:1 healthy:1 cells:2 after:1 focus:1 drug:1 leaving:1 tumor:1 while:1 agents:1 which:1 coming:1 alone:1 years:1 into:1 market:1 research:1
stock_AMGN r_down	firm:1 sending:1 driving:1 49:2 drugs:1 could:1 profit:1 deliver:1 shares:1 next:1 four:1 healthy:1 growth:1 year:1 higher:1
stock_AMGN r_up	billion:1 genomics:1 $:1 ripe:2 have:1 industry:1 profit:1 companies:2 opportunities:1 plenty:1 flurry:2 acquisition:1 investors:1 13.6:1 writes:1 mergers:2 shows:1
stock_AMGN r_down	scheduled:1 fiscal:1 dominate:2 's:1 second:1 watch:2 list:1 report:1 quarter:1 evidence:1 volume:1 course:1 run:1 trading:1 earnings:3 news:2 growing:1 rally:1 has:1 its:1 market:1
stock_AMGN r_down	biotech:1 investors:1 revenue:1 profit:2 results:1 trade:2 gadgets:1 second:1 session:2 higher:1 have:1 quickly:1 its:5 decade:1 giant:1 falls:1 may:1 addition:1 fears:1 expectations:1 shares:2 edge:1 their:1 program:1 expected:3 new:1 increasing:1 more:1 11:1 quarters:1 's:2 though:1 dropped:1 company:2 reporting:1 buyback:1 hoped:1 reported:1 short:1 demand:1 not:1 dividend:1 strong:1 than:2 raising:1 posted:1 fiscal:1 arrive:1 lost:1 notching:1 drop:1 companies:2 bag:1 while:1 actively:2 products:1 time:1 mixed:1 quarter:1 slightly:1 first:2
stock_AMGN r_up	closes:3 lower:3 leaders:1 among:1 movers:2 after:1 negative:1 while:1 market:1 were:1 territory:1 marginally:2 out:1
stock_AMGN r_down	sector:1 biotech:1 right:1 have:2 bubble:2 companies:1 year:1 some:2 rally:2 projected:1 regulatory:1 say:2 trading:1 been:1 reaching:1 seen:1 1990s:1 cold:1 blockbuster:1 bolstered:1 market:1 even:1 large:1 execution:2 now:1 indexes:1 names:1 no:1 since:1 question:1 due:1 hepatitis:1 next:1 late:2 everything:1 clinical:1 exuberance:2 earnings:1 new:2 's:1 it’s:1 go-go:1 run:1 string:1 index:1 drugs:1 big:1 highs:2 but:2 quite:1 whether:1 they:1 bull:1 not:1 stocks:2 multiple:1 all-time:2 healthy:1 industry:1 could:1 30:1 sclerosis:1 days:1 begun:1 times:1 herald:1 successes:1 analysts:2 tear:1 think:1 latest:2
stock_AMGN r_down	stock:2 right:1 up:1 four:1 see:1 raking:1 year:2 take:1 co-founder:2 previous:1 even:1 $:5 earned:1 away:1 increase:1 majority:1 much:1 too:1 which:1 more:1 's:1 filings:1 form:1 wo:1 price:1 million:3 tripled:1 awards:1 nearly:1 years:1 vast:1 made:1 last:1 did:1 according:1 n't:1 compensation:2 five:1 2012:1 options:1 came:1 executives:1
stock_AMGN r_up	sector:1 biotech:1 energy:1 sales:1 competition:1 year:1 declined:1 pharmaceutical:1 8.3:1 generic:1 patent:1 finally:1 which:1 bubble:1 market-beating:1 's:1 protection:1 bull:1 last:1 stocks:1 join:1 lost:1 amid:1 stampede:1 profit:1 fell:1
stock_AMGN r_up	delivered:1 now:1 blistering:1 's:1 gains:1 stocks:1 manager:1 has:1 buying:1 he:1
stock_AMGN r_down	pharmaceutical:1 pipeline:1 alliance:1 's:1 company:1 formed:1 five:1 medicines:1
stock_AMGN r_down	biotech:3 play:2 join:1 risk:1 protection:1 offer:1 ways:2 funds:1 writes:1 these:1 3:2 levels:1 boom:3 want:1 varying:1 you:1
stock_AMGN r_down	he:1 's:1 sectors:1 up:1 backing:1 certain:1 behind:1 believes:1 manager:1 truck:1 rally:1 has:1 left:1
stock_AMGN r_down	roundup:1 venture-capital:1 around:1 analysis:1 news:1
stock_AMGN r_down	froth:1 1.3:1 according:1 manager:1 value:1 estimated:1 blockbuster:1 no:1 generic:1 three:1 returns:1 finding:1 affecting:1 new:1 therapies:1 more:1 's:3 cocktail:1 million:1 here:1 cheaper:1 joint:1 years:1 than:1 treating:1 made:1 effective:1 avoiding:1 study:1 funded:1 disease:1 drug:1 severe:1
stock_AMGN r_down	expanded:2 1.3:1 cancer:1 give:1 cocktail:1 37:1 affecting:1 primary:1 related:1 according:1 down:2 actively:2 trading:4 shares:3 recently:2 blockbuster:1 index:3 use:1 said:1 4.1:1 $:1 million:2 no:1 agreeing:1 rose:1 endpoint:1 ovarian:1 40:1 estimated:1 combined:1 closed:1 deal:1 chemotherapy:1 joint:1 include:1 therapies:1 higher:1 treating:1 added:1 's:6 made:1 25:1 survival:1 after:1 effective:1 cheaper:1 hours:1 met:1 generic:1 fell:2 moving:1 127:1 part:1 stocks:3 new:1 than:1 session:2 four:1 lower:2 38:1 14:1 license:2 16:1 study:2 climbed:1 companies:3 disease:1 drug:2 more:1 severe:1 points:9 funded:1 were:3 five:1 late-stage:1 dropped:2
stock_AMGN r_up	buying:1 investors:1 feel:1 back:1 dividend:3 debate:1 even:1 hunters:2 shares:1 should:1 vs.:1 stock:2 do:1 play:2 choice:1 such:1 those:1 sound:1 both:1 stronger:1 can:1 writes:1
stock_AMGN r_down	regulator:1 said:1 's:2 disease:1 tumor:1 treatment:2 rare:1 has:1 approved:2 bone:1 first:1
stock_AMGN r_up	actively:1 index:1 added:1 's:2 increased:1 climbed:1 session:1 six:1 companies:1 shares:1 75:1 points:3 trading:2 were:1 15:1 stocks:1 higher:1
